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Résumé 
La signalisation extracellulaire par les nucléotides régule d'importants pro-
cessus physiologiques via les récepteurs purinergiques. Dans les poumons, les 
nucléotides extracellulaires sont impliqués dans la défense primaire en facili-
tant la clairance mucociliaire et en augmentant la sécrétion du surfactant. Cet 
ouvrage comprend deux parties: la première traite de l'étude du mécanisme 
de la libération des nucléotides, particulièrement de l'ATP, par les cellules 
A549 (une lignée utilisée comme système modèle des cellules alvéolaires); 
et la seconde partie est consacrée à une méthode d'imagerie que nous avons 
développée pour pouvoir éventuellement étudier l'implication des nucléotides 
extracellulaires dans le contrôle de la hauteur du liquide de surface (L8). 
1. Pour la première partie, des cellules A549 ont été insérées dans une 
chambre à perfusion maintenue à 37 0 C et la sécrétion des nucléotides a 
été induite par un choc hypotonique de 50%. La concentration de l'ATP 
extracellulaire a été évaluée à l'aide d'un essai luciférine-luciférase. Nous 
avons testé des agents connus pour intervenir dans l'exocytose et dans 
les voies de signalisation calcique et purinergique. L'inhibition de l'exo-
cytose a réduit significativement la sécrétion de l'ATP et ce résultat 
indique qu'une exocytose Ca2+ -dépendante est le principal mécanisme 
de sécrétion de l'ATP par les cellules A549. De plus, l'étude exhaustive 
du signal calcique a révélé que la sécrétion de l'ATP dépend entière-
ment de la mobilisation du Ca2+ des sources intracellulaires et qu'il 
provient essentiellement du reticulum endoplasmique, une source sen-
sible à la thapsigargine. Toutefois, une petite fraction du signal calcique 
provient d'une source non identifiée, insensible à la thapsigargine et af-
fectée par le pH intracellulaire. Les concentrations extracellulaires des 
divers nucléotides ont également été évaluées par HPLC. Nos données 
indiquent que les nucléotides sécrétés lors d'un choc hypotonique aug-
mentent la sécrétion de l'ATP par un phénomène de feedback positif 
autocrine/ paracrine. 
2. Le montage expérimental conçu pour l'étude du LS comprend une 
chambre d'observation équipée d'un système de contrôle de la tem-
pérature et de l'humidité pour prévenir l'évaporation, et montée sur un 
microscope à épifluorescence. Les cellules sont cultivées sur filtre dans 
des conditions air-liquide et le filtre est ensuite inséré dans la chambre 
d'observation de façon à ce que la mono couche soient orientée perpen-
diculairement à l'objectif. Ce dispositif permet d'avoir une vue de profil 
du LS marqué avec une sonde fluorescente et de suivre avec une haute 
résolution temporelle les variations de sa hauteur. 
Cette étude aura contribué à une meilleure compréhension des mécanismes 
physiologiques impliquées dans la défense primaire des poumons par les nu-
cléotides extracellulaires et que cette connaissance pourra éventuellement 
servir au développement des nouvelles thérapies contre des maladies liées à 
des problèmes de clairance mucociliaire. 
Mot clés: 
signalisation purinergique, ATP extracellulaire, signalisation calcique, méca-
nisme de la sécrétion, exocytose, défense pulmonaire, liquide de surface pul-
monaire, système optique, chambre à observation latéral, micrOScopie d'épi-
fluorescence 
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Abstract 
Extracellular nucleotides, acting via purinoreceptors, regulate important 
physiological pro cesses in most body tissues. In the airways, extracellular 
nucleotides are implicated in the primary defence mechanism by potentiat-
ing mucociliary clearance and surfactant secretion. Two different approaches 
for studying extracellular nucleotides on the lung epithelium are presented 
and divide this thesis into two parts. The first part focuses on the physio-
logical aspect of nucleotide release, especially ATP, from the alveolar type II 
cellline A549 and the second on the development of a side-viewing technique 
for the observation of ATP-dependent airway surface liquid (ASL) height 
variations: 
1. While previous results showed that cell-swelling induced ATP secre-
tion, and that this secretion was tightly correlated with an intracellu-
lar Ca2+ elevation, the present research was designed to establish the 
mechanism which is responsible for nucleotide release from A549 cells. 
Moreover, the source and the progress of the intracellular Ca2+ sig-
nal were thoroughly analyzed. In this study, nucleotide release from 
A549 cells was induced by a 50% hypotonie shock in a flow-through 
chamber at 37 0 C. Agents, known to interfere with the exocytotic 
process, intracellular Ca2+ signalling and purinergic signalling, were 
applied, and the ATP concentration in the perfusate aliquots was de-
termined with a luciferase-Iuciferin assay. The individual concentra-
tion of aIl nucleotides was determined by HPLC. The inhibition of 
the exocytotic pro cess significantly reduced ATP secretion and indi-
cated a Ca2+ -dependent exocytosis as the principal release mechanism. 
The study of the Ca2+ signal revealed that ATP release depended en-
tirely on Ca2+ mobilization from intracellular stores, primarily from 
the thapsigargin-sensitive endoplasmic reticulum and to a lesser ex-
tent from an unidentified thapsigargin-insensitive source, which was, 
however, sensitive to intracellular pHalterations. FinaIly, ceIl-swelling 
induced, Ca2+ -dependent ATP release from A549 ce Us was shown to 
be amplified by a positive autocrinejparacrine feedback of co-released 
nucleotides. 
2. The side-viewing imaging technique was designed and constructed for a 
potential time-resolved study of ASL height alterations upon stimula-
tion with extraceUular ATP. A custom-designed side-viewing chamber 
was mounted on the microscope stage and was equipped with a tem-
peraturejhumidity control system to keep an in vitro ceU culture in a 
physiological environment and to prevent the ASL from insensible water 
loss. The chamber was comprised of a housing including a perforated 
knob, which accommodated a filter insert with an air jliquid grown cell 
monolayer and aUowed perfusion of the basal side. The housing posi-
tioned the filter insert perpendicular to the microscope objective and 
enabled a direct observation of fiuorescently labeUed ASL through an 
epifiuorescence microscope. 
These two areas of study aim to contribute to a better understanding of the 
physiological mechanisms involved in the primary lung defence via extracel-
lular nucleotides. This knowledge is the basis for the development of novel 
therapies especiaUy against diseases of impaited mucociliary clearance. 
Keywords: 
purinergic signalling, extracellular ATP, Ca2+ -signalling, release mechanism, 
exocytosis, airway defence, airway surface liquid, optical system, side-viewing 
microscopy, epifiuorescence microscopy 
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Introduction 
In the lungs, on a surface of 140 m2 , the blood is separated from the air by 
a tissue barrier of only 0.5 - 30 /-Lm [11. This huge surface, which is almost 
directly exposed to the environment, risks being damaged resulting from 
contamination by bacteria, viruses and pollutants. To protect the lung from 
these harmful airborne insults, the respiratory tract has a range of powerful 
and effective defence mechanisms. Dysfunction of any of these mechanisms 
can result in respiratory diseases, among which cystic fibrosis (CF) is one of 
the most severe [21. 
Sneezing and coughing are reflex defence mechanisms, providing the most 
instantaneous protection against airway irritants. The non-reflex mechanisms 
are independent units, and consist of the following processes: 
• Physical defence: 
1. Air-conditioning is based on cooling, warming and humidification 
of the inhaled air through the evaporation of water from the airway 
surface liquid (ASL), which lines the air-conductive part of the 
respiratory tract [3]. 
2. Air-filtration is based on the elimination and deposition of inhaled 
particles on the ASL-covered ciliated epithelium. Its efficiency is 
augmented by the anatomic structure of the lung with its bronchial 
tree [1] . 
• Chemical defence is based on the ability of the ASL to buffer and dilute 
inhaled toxic substances [4, 5]. 
INTRODUCTION 2 
• Cellular def~nce consists of the innate immunity response1 to an invad-
ing microbe. The innate responses use phagocytic cells (neutrophils, 
monocytes, macrophages), cells that release infiammatory mediators 
(basophils, mast cells, and eosinophils), and natural killer cells [6, 7]. 
An important stage in cellular defence is the adhesion of the invading 
microbe to the airway fiuids, i.e. the ASL in the air-conductive part 
and the alveolar fiuid in the gas-exchange alveoli [8] . 
• Humoral defence is based on the secretion and effectivity of diverse 
biomolecules in the airway fiuids. These biomolecules can be classified 
as: antimicrobial proteins, immunoglobulins, cytokines and infiamma-
tory mediators, as weIl as antioxidants [9]. They can be released either 
continuously as a constant constituent of the airway fiuids (e.g. an-
timicrobial surfactant proteins in the alveoli [10]) or temporary during 
an innate immunity response (e.g. cytokines, infiammatory mediators 
[9]). 
In aIl of these non-refiex defence mechanisms, the airway fiuids, which line 
the entire respiratory tract, play a crucial role in the successful maintenance 
of a sterile environment: 
The ASL provides through its well-regulated periciliary fiuid and mucus 
layer the best conditions for an effective mucociliary clearance. In this 
clearance process, particles bigger than 2 - 3 /-Lm adhere on the mucus 
and are transported out of the airways by synchronous beats of cilia on 
epithelial cells. 
The alveolar fluid contains surfactant proteins, among other bioactive mol-
ecules, that are synthesized and secreted by alveolar type II cells (AT II), 
one of the major cell types in the alveolar epithelium. Surfactant pro-
teins, apart from their role in the reduction of surface tension in the 
lung, enhance phagocytosis by opsonizing2 bacteria and other parti-
cles [10, 12]. 
IThe innate immune system consists of the immune defence that lacks immunologie 
memory [61. 
20psonization is the process whereby particles become coated with molecules that allow 
them to bind to receptors on phagocytes [11]. 
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Surfactant secretion from AT II ceUs [13], mucus secretion from goblet ce Us 
[14], and ciliary beat frequency on ciliated ceUs [15, 16] are aIl stimulated by 
extracellular ATP through purinergic receptors. Airway fluid homeostasis is 
likewise controlled by extraceUular ATP through the regulation of transep-
ithelial Cl- transport 117]. 
This dissertation focuses on the significance of ATP and other nucleotides 
on the lung epithelium, which act as extracellular signalling molecules via 
purinergic receptors. Two different approaches for studying the involvement 
of extraceUular nucleotides in lung defence are presented here, and therefore 
divide this Ph.D. thesis into two parts. 
Part l, which comprises article 1 and article 2 (see sections 3.1 and 3.2, re-
spectively), deals with the investigation of the mechanism of Ca 2+ -dependent 
secretion of nucleotides and adenosine from A549 ceUs. A general introduc-
tion to extracellular ATP as a signalIing molecule is given in section 1.1. 
Section 2.2 describes our set-up system for ATP release and the analytical 
method for its quantitative evaluation via bioluminescence. The A549 celI 
line is a model system for the study of AT II cell function and is briefly char-
acterized in appendix A.1.2. Various types of mechanical stress, including 
membrane stretch and shear stress, provoke ATP-dependent surfactant se-
cretion from AT II ceUs [18, 19, and references therein]. For the investigation 
of the associated ATP and nucleotide secretion, we chose hypotonie shock as 
an in vitro example of mechanical stress. This choice was motivated by the 
following reasons: 
• Transient reorganization of actin cytoskeleton induced by hypotonie 
stress is quite similar to that induced by shear stress [19-21]. 
• Reported hypotonie stress-induced responses share sorne common char-
acteristics with those that are shear stress-induced: both of these 
stresses induce ATP release in the endothelium [22, 23]. 
• Shear stress-activated chloride current is similar to hypotonic stress-
activated volume-regulated anion channel (VRAC) current [24, 25]. 
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The investigation of hypotonie stress-induced ATP-release provides, there-
fore, significant information about its mechano-sensitive release mechanism. 
In addition, hypotonie stress can be easily applied on liquid-covered cell-
cultures (see appendix A.1), and does not require any sophisticated set-up, 
unlike mechanical stress. The magnitude of hypotonie stress can be easily 
controlled by the degree of solvent dilution. 
As previously reported, a hypotonie shock induces a Ca2+ signal that is 
tightly involved in ATP [26] and surfactant release [27] from A549 cells. Sec-
tion 1.2 off ers a general physiological insight into Ca2+ signalling, whereas 
section 2.3 addresses ratiometric imaging as a measuring technique for intra-
cellular Ca2+ alteration. For the extensive study of the ATP release mecha-
nism and the Ca2+ signal, pharmacological agents were used to interfere with 
the exocytotic process, the Ca2+ signal and purinergic signalling. A complete 
list of these agents with their description is provided in appendix A.3. 
Part II of this Ph.D. thesis concerns the design and construction of a side-
viewing method based on epifluorescence microscopy. The aim of this method 
is to achieve a time-resolved ('" 100 ms) observation of ASL height on in vitro 
cell cultures, which will potentially provide a possibility to study ASL height 
variations upon stimulation of ATP secretion. The technique is described in 
article 3, chapter 6. Basic properties of the ASL and its regulation via ex-
tracellular ATP are described in chapter 4. The fundamentals of microscopy, 
which were necessary for the development of this technique, are explained in 
chapter 5. AlI technical drawings of the side-viewing system are reproduced 
in appendix C. 
Every analytical method applied in the course of this Ph.D. project, Le. 
bioluminescent ATP evaluation, fluorescent intracellular Ca2+ imaging and 
fluorescent ASL height measurement, is based on the principles of lumines-
cence. Section 2.1 describes the princip les responsible for the similarities and 
differences between these methods. The conclusions and the outlook for both 
parts of this thesis are given jointly at the end of part II in chapter 7. 
Part 1 
Mechanism of ATP release 
Chapter 1 
Physiological background 
1.1 Extracellular ATP 
1.1.1 Introduction 
In 1929 Drury and Szent-Gyorgyi were the first to describe potential actions 
of extracellular adenosine 5'-monophosphate (AMP) and adenosine on the 
mammalian heart muscle [28]. Fundamental studies of the effect of adenine 
nucleotides on cardiovascular physiology followed and were reviewed in a 
book by Green and Stoner in 1950 [29]. A few years later, adenosine S'-
triphosphate (ATP) was shown to be released from the adrenal medulla and 
sensory nerves following stimulation [30, 31]. In 1963, Robert M. Berne 
published a paper proposing a possible role for adenosine in the control of 
blood fiow to the heart [32]. This work set the direction for the following 
years in the research field of extracellular signalling by adenosine. Ensuing 
studies on the transduction mechanisms triggered by extracellular adenosine 
were carried out by Sattin and RaIl [33]. 
In 1972 Burnstock postulated that ATP was a neurotransmitter involved in 
non-adrenergic, non-cholinergie responses of smooth muscles in the gastroin-
testinal tract and the bladder, and introduced the term "purinergic" [34]. 
With his comment entitled liDo sorne nerves release more than one trallsmit-
ter?" [35], he challenged the hitherto accepted Dale's principle, which stated 
that each neuron releases only one synaptic transmitter, and substantially 
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infiuenced the development of the concept of purinergic signalling. However, 
given the fact that ATP was initialIy recognized by Lipmann as the universal 
energy carrier of alIliving celIs in the early 1940s [36], Burnstock's work ex-
perienced resistance to this new concept. Only in the early 1990s was ATP 
finally recognized as an important signalling mole cule that mediates diverse 
biological effects via celI surface receptors - termed purinergic receptors [37]. 
To date, these receptors have been found in almost all organs, tissues and 
celIs in the body [38]. 
In 1978 Burnstock provided a basis for distinguishing two types of purinergic 
receptor families, named Pl (adenosine) and P2 (ATP, ADP and UTP, UDP) 
[39]. Since then, four subtypes of Pl receptors have been cloned: Al, A2A' 
A2B and A3 [40]. AlI Pl adenosine receptors are typical G protein-coupled 
(metabotropic) receptors (see page 21). 
The P2 receptors were further subdivided into a P2X family of ligand-gated 
ion channel (ionotropic) receptors and a P2Y family of metabotropic recep-
tors. Currently, seven subtypes of the P2X family and eight subtypes for the 
P2Y family have been cloned and functionalIy characterized [38]. 
1.1.2 Purinergic signalling in the lung epithelium 
P2 receptors are widely distributed throughout the lung. P2Y2, P2Y4 , and 
P2Y 6 are the predominant and the most relevant receptor types in airway 
epithelial cells. Several P2X receptor subtypes have also been identified, 
primarily the P2X4 receptor [38, 41]. 
A549 celIs, an in vitro model of the alveolar type II (AT II) epithelium (see 
appendix A.1.2), express the P2Y2 receptor, which responds equally to ATP 
and UTP, as well as the P2Y6 receptor, whose agonist is UDP and to a much 
smaller extent UTP and ATP [38,42]. Recently, they have been found to also 
express the UDP-glucose specifie Gi protein-coupled P2Y 14 receptor [43]. 
16HBE14o- celIs, a human bronchial epithelial celIline (see appendix A.1.1), 
express the P2X4 and P2Xs receptors, both activated through ATP, and the 
P2Y4 receptor, which responds to UTP and ATP [44,45]. 
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Purinergic receptors transfer various signaIs and cause diverse effects in air-
way epithelial cells. In AT II cells, surfactant release is stimulated and reg-
ulated via P2Y receptors [46, 47]. The most potent endogenous stimulus 
for surfactant secretion is extracellular ATP. Several second messengers are 
activated in AT II cells following agonist binding: intracellular Ca2+ is mo-
bilized, prostaglandin levels increase, and PKC is activated [13, 47]. 
ATP also exerts various effects on bronchial cells. Ciliated epithelial cells 
show an increase in ciliary activity in response to ATP enhancing mucocil-
iary transport [48, 49]. Goblet cells are induced to synthesize and secrete 
mucins in response to extracellular ATP [50, 51]. Clara, serous and ciliated 
ce Ils are stimulated by ATP and UTP to secrete Cl- and HCO; [52, 53]. 
AlI these effects are involved in the regulation of the airway surface liquid 
(ASL) volume. The ASL volume in turn is crucially involved in the efficient 
removal of noxious materials from the airway surfaces, and constitutes the 
lung's powerful primary defence mechanism (see chapter 4). 
Airway epithelial cells release nucleotides under basal conditions and, in am-
plified form, after stimulation (e.g. shear stress, hypotonie stress, stretch) 
[54-56]. These released nucleotides are metabolized by surface-attached ecto-
nucleotidases by sequential dephosphorylation (e.g. into ADP, AMP, and 
adenosine) [57]. This pro cess terminates the large transient effects mediated 
by ATP and UTP and produces a sustained P2Y6 receptor-mediated event 
[58, 59]. 
1.1.3 Release mechanisms of ATP 
The cytoplasmic level of ATP under normal metabolic conditions is 
5 - 10 mmol· 1-1• This concentration is essential for maintaining the mem-
brane potential and a low intracellular Ca2+ level, for assuring the synthesis 
of GTP and the activity of the G-proteins, for the signal transduction through 
various protein kinases, and for certain steps of exocytosis [60]. 
ATP and other nucleotides are also present in various types of organelles 
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especially in the ER and Golgi, where ATP is required for the phosphoryla-
tion of transmembrane and secretory proteins and for other energy-requiring 
processes, such as the dissociation of complexes between chaperones and cor-
rectly folded and assembled proteins, disulfide formation and protein poly-
merization [61, 62]. Since ATP and other nucleotides are heavily charged 
molecules, they cannot pass the membranes by simple diffusion. Therefore, 
specifie transporters are assumed to facilitate their uptake [61-64]. 
At first, it was assumed that the only source of extracellular ATP acting on 
purinoceptors was damaged or dying cells. But it is now recognized that 
ATP release following stimulation does not occur only through ceIllysis but 
primarily through a weIl-controlled physiological mechanism [65]. There is an 
active debate, however, about the precise transport mechanism(s) involved. 
There are at least three general mechanisms by which ATP release may occur 
[65, 66] (see Fig. 1.1 on page 10): 
Cytolysis during cell membrane damage or death - contributing to patho-
physiological mechanisms. 
Exocytosis of ATP-filled vesicles or granules. 
Facilitated diffusion through ATP release channels or through ATP trans-
porters (e.g. ABC proteins). 
For a long time, exocytosis was considered as the common release mechanism 
of neurotransmitters [67]. As a neurotransmitter, ATP is also believed to be 
released through exocytosis; however, non-exocytotic release has not been 
dismissed yet [37, 60, 68]. The evidence of Ca2+ dependence in the process 
of ATP release is typically consistent with regulated exocytosis [69] (see also 
section 1.2.2). 
For ATP release from non-neuronal ceIls, various transport mechanisms have 
been proposed, including ATP-binding cassette (ABC) transporters [70-72], 
connexin or pannexin hemichannels [73-75], plasmalemmal voltage-dependent 
anion channels (VDAC) [76], as weIl as vesicular exocytosis [26, 77, 78]. 
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Figure 1.1: Potential ATP release mechanisms: 
(A) cytolysisj (B) exocytosisj (C) facilitated diffusion - ATP channel, carrier 
protein ( transporter) 
10 
The biggest controversy arose when the cystic fibrosis transmembrane con-
ductance regulator (CFTR), one of the most common ABC proteins in eu-
cariotic organisms, was suggested to conduct ATP [71]. Since then, various 
papers have described the observation of ATP transport by ABC proteins 
[79]. On the other hand, many other studies have convincingly determined 
the inability of ABC proteins to transport ATP [80-83]. Various efforts were 
made to explain earlier daims to the role of ABC proteins as ATP channels, 
such as differences in experimental set up or conditions [79]. 
Other possibilities for an implication of CFTR on ATP release were also pro-
posed, such as the regulation of an associated ATP channel [84] or even the 
regulation of exocytosis [79]. 
To conc1ude, exocytosis appears to predominate as release mechanism, al-
though sorne cell types may also release ATP by several parallel mechanisms, 
such as by exocytosis and through the activation of VDAC-like channels. 
Whichever way ATP and other nucleotides are released from the cells, their 
extracellular importance is finally weIl established. 
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1.2 Intracellular calcium 
1.2.1 Overview 
Ca2+ in the organism 
Ca2+ is the most abundant metal ion in the body. An average adult body 
contains in total around 1 kg of calcium, 99% of which is a component of 
the skeleton in form of calcium phosphate and the remaining 1 % is present 
in the extracellular fluid3 and the cellular protoplasm4 [85]. 
The free Ca2+ level in the extracellular fluid is he Id close to 1 mM, which 
allows the body to manipulate the precipitation of phosphates by slightly 
modifying phosphate and Ca2+ concentrations and, in this way, to build up 
bones and teeth. In the cytosol of eukaryotic cells, the resting level of free 
Ca2+ is closely controlled to around 100 nM. The large gradient from extra-
cellular fluid to cytosol of about 10 000 is held up by actively pumping Ca2+ 
out of the cytosol, either into the extracellular space or into intracellular or-
ganelles, such as the endoplasmic reticulum (ER), which accumulates Ca2+ 
close to a concentration of 1 mM and serves as an intracellular Ca2+ store. 
The intracellular and extracellular Ca2+ level is further buffered by certain 
Ca2+ -binding proteins, such as parvalbumin, calmodulin and calbindin [86]. 
With the toolkit of intracellular Ca2+ stores, channels, pumps and Ca2+-
binding proteins of various binding affinity and kinetics, a cell is capable 
of precisely regulating alterations of the intracellular Ca2+ level both tem-
porally and locally. Accordingly, specific triggers can increase the cytosolic 
Ca2+ level up to 500 - 1000 nM in different spatial and temporal domains by 
opening channels in the ER and/or plasma membrane. These Ca2+ signaIs, 
in turn, can controllocalized pro cesses (e.g. exocytosis) and global responses 
(e.g. myocyte contraction) as weIl as responses of extremely wide time scale, 
from microseconds (e.g. activation of ion channels) to many hours, weeks, 
months or even years (e.g. synaptic plasticity, memory, long-term adapta-
3Extracellular fluid encompasses the blood plasma, the intersitial fluid and the 
lymph [Il]. 
4The protoplasm is the substance within a cell enclosed by the cell membrane. It 
encompasses the cytosol and all organelles [11]. 
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tion, neuronal ageing) [87]. Almost every cellular process - from fertilization 
to apoptosis - includes a Ca2+ -dependent step, making the Ca2+ ion the most 
versatile and universal signalling agent in advanced biological systems [88]. 
Properties of the Ca2+ ion 
The following properties make the Ca2+ ion suitable for this unique role: 
Ca2+ is a large divalent cation with a radius of 0.95 Â. It is widely available 
since it is abundant in most natural waters in the presence of common anions 
such as CI-, RCOi and NOi [86]. The charge-to-size ratio distinguishes the 
Ca2+ ion from ions of similar size, such as Na+, and from ions of equal charge, 
such as Mg2+ and Zn2+ [86]. It also provides the Ca2+ ion with a particularity 
in structure and thermodynamic affinity for certain classes of ligands, as well 
as in reaction rates, which are summarized under the following three points: 
• Structure 
Ions with a radius r 2: 0.75 A, such as Ca2+, allow irregular coor-
dination geometry, bond angle, bond distance, and high coordination 
numbers (7-10) in their complexes. This flexibility enables them to eas-
ily adjust to steric crowding5 . Ca2+ differs in this respect strongly from 
Mg2+ (r = 0.6 A) - an ion equally abundant in the body and essential 
for numerous biochemical pro cesses - which is strictly octahedral in 
symmetry, and from Zn2+ (r = 0.65 A) which is strictly tetrahedral 
in symmetry. Only conformational changes induced by binding to a 
Ca2+ ion will lead, therefore, to activation of Ca2+ -sensitive proteins. 
Based on the high coordination number, Ca2+ is, furthermore, an ideal 
cross-linking agent for proteins and biopolymers [86] . 
• Kinetics 
Ca2+ has a much lower tendency to form complexes than Mg2+, whose 
complexes with monodentate ligands, such as water, are relatively sta-
ble. Ca2+, in contrast, exchanges water very rapidly, with a rate close 
5Steric crowding occurs when a large number of functional groups belonging to one 
or several mole cules accumulate inside a restricted area - usually around an ion. It very 
often results in steric hindrance of the individual groups. 
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to the collisional diffusion limit of 1010 S-l. The activation speed of a 
protein through complexation of Ca2+ is, therefore, diffusion-limited, 
whereas the extent and duration of activation by a single Ca2+ ion is 
limited by the stability of the protein-Ca2+ complex [86] . 
• Binding 
In contrast to monodentate ligands, multidentate ligands can form very 
stable chelation complexes with Ca2+, whose stability constants exceed, 
in this case, those for Mg2+. Within a multidentate ligand, Ca2+ is 
even able to interact with neutral oxygen donors such as carbonyls and 
ethers. This increase in stability and affinity can be attributed to steric 
factors, which favour the bigger ion to accommodate the donor atoms 
in a more convenient way [86]. 
Discovery of Ca2+ as signalling agent 
The importance of Ca2+ for signal transduction was discovered by Sydney 
Ringer at the end of the 19th century. He showed that Ca2+ ions were indis-
pensable for fish survival, development of fertilized eggs, muscle contraction, 
and ceIl adhesion [89-93]. Shortly after, Locke [94], and then Overton [95], 
found that Ca2+ is necessary for signal transmission between nerve and mus-
cle. But only half a century later, a general theory of Ca2+ as a universal 
second messenger was promulgated by Lewis Victor Heilbrunn in his book 
An Outline of General Physiology [96]. There he wrote: "The reaction ofthis 
calcium with the protoplasm inside the ceil is the most basic of ail protoplas-
mic reactions." This theory was ignored for another couple of decades, until 
the invention of the patch clamp technique and the synthesis of fluorescent 
Ca2+ indicators paved the way for the establishment of Ca2+ signalling as 
the most ubiquitous and pluripotent signalling system involved in almost aIl 
known cellular pro cesses [97]. 
Nowadays, a vast number of research articles and reviews, dedicated to Ca2+ 
signalling, is being published every year. Many aspects of Ca2+ signalling 
(e.g. sources of Ca 2+, Ca 2+ channels and pumps, local and global signalling, 
and trigger and responses) in physiology and pathophysiology of diverse cell 
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systems are being addressed and investigated. 
The following two sections will introduce sorne of the principles of Ca2+ 
signalling by focusing this broad topic on the aspects that are relevant to 
this Ph.D. thesis, Le. the variety of intracellular Ca2+ stores, the types of 
Ca2+ events, the variety of stimuli that can trigger Ca2+ signalling, and, 
finally, exocytosis as an example for Ca2+ -regulated processes. 
1.2.2 Basics of calcium signalling 
Intracellular calcium stores 
As mentioned above, the concentration of free Ca2+ -ions in the cytosol is 
precisely regulated, and can rapidly increase in response to various types of 
stimuli. A rise in the cytosolic Ca2+ concentration can be caused by the 
opening of Ca2+ channels in the plasma membrane and/or by the release of 
Ca2+ from internaI stores. The major intracellular pool of Ca2+ is the ER 
with two subsets of Ca2+ release channels: the Ca2+ -gated Ca2+ release chan-
nel, generally known as ryanodine receptor (RyR) , and the IP3~gated Ca2+ 
release channel, referred to as IP3-receptor (IP3R) [98]. Almost aIl other or-
ganelles of an eukaryotic cell, such as the mitochondria, the nucleus, the Golgi 
apparatus, lysosomes and acidic secretory granules were also found to play 
a significant role in the shaping of cytosolic Ca2+ signalling in various cells 
[99-102]. AlI of these organelles have both specifie Ca2+ release channels and 
Ca2+ uptake mechanisms. A more recent concept of Ca2+ signalling involves 
even the cytoskeleton of the cell. Ca2+ storage at high-affinity binding sites 
of F-actin subunits were shown to be involved in the store-operated Ca2+ 
influx pathway, in Ca2+ spiking and oscillations, as well as in Ca2+ induced 
Ca2+ release (CICR) [103]. Figure 1.2 on page 15 illustrates the potential 
Ca2+ stores within a cell with the major transport pathways responsible for 
Ca2+ movemertt. Each of these stores will be briefly characterized in the 
following descriptions. 
The Endoplasmic Reticulum (ER) is an organelle found in aIl eukaryotic cells. 
Figure 1.2: Schematic drawing of a cell showing parts of its structure responsible for controlled intracellular Ca2+ 
movement. 
PTP, permeability transition pore; SOC, store-operated Ca2+ channel; PMCA, plasma membrane Ca2+ 
ATPase; ER, endoplasmic reticulum; IPsR, inositol-l,4,5-triphosphate receptor; RyR, ryanodine receptor; SERCA, 
sarcojendoplasmic reticulum Ca2+ ATPasej INM, inner nuclear membrane; ONM, outer nuclear membrane; cADPR, 
cyclic ADP-ribose 
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It forms a complex continuous network system of endomembranes which can 
be structurally divided into rough ER, smooth ER and nuclear membrane. 
The entire ER controls a wide range of cellular pro cesses such as synthesis 
and st orage of transmembrane and secretory proteins, lipids, steroids and 
other biomolecules [11]. Mainly the smooth ER also plays a central role 
in signalling processes by producing local or global Ca2+ fluctuations. It 
releases Ca2+ into the cytosol through RyR Ca2+ channels via CI CR and 
cyclic ADP-ribose (cADPR) activation [87], or through IP3R Ca2+ channels 
via IP3-induced Ca2+ release (II CR) [104]. The role of the ER as an internaI 
Ca2+ store and signalling organelle is supported by several families of proteins 
localized in the endomembrane as weIl as within the ER lumen: especially 
by the Ca2+ pumps, which belong to the sarcojendoplasmic reticulum Ca2+ 
ATPase (SERCA) type, three types of IP3R and three types of RyR Ca2+ 
release channels, as weIl as intraluminal Ca2+ -binding proteins most of which 
also serve as Ca2+ -regulated enzymes. It is, furthermore, supported by the 
high degree of organization with specialized regions that are localized close to 
areas where they can generate specific Ca2+ signaIs [104]. Since the ER has 
a finite capacity, its signalling function depends on the abundance of Ca2+ in 
its lumen. To prevent Ca2+ store depletion, the cell employs a store-operated 
entry mechanism to ensure a sufficient replenishment of the ER with Ca2+. 
The entry of Ca2+ takes place through store-operated Ca2+ channels (SOC) 
in the plasma membrane after their stimulation by an empty ER. The nature 
of the signal emanating from the ER and the identity of the SOCs were a 
matter of debate for 20 years. Only recently were two major players in the 
signalling and permeation mechanism discovered: an ER Ca2+ -sensor, called 
STIM16 , was found to be involved in the activation of SOCs by triggering 
Orai proteins, which constitute subunits of SOCs, to form a pore [105, 106]. 
The Mitochondria are functionally closely connected with the Ca2+ signalling 
function of the ER. They cooperate in generating Ca2+ signaIs of precise 
shape, the ER releasing Ca2+ and the mitochondria assisting in the recovery 
6STIMl is a single spanning membrane protein with an unpaired Ca2+ binding EF-
hand. 
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phase by rapidly sequestering it. After the recovery phase, the mitochondria 
return the sequestered Ca2+ back to the ER [107]. At equilibrium, most of 
the Ca2+ resides within the lumen of the ER. During a Ca2+ signal, Ca2+ 
moves from the ER lumen into the mitochondria, where it indu ces the gen-
eration of reactive oxygen species (ROS) [107]. ROS can feedback to the ER 
and sensitize its Ca2+ release channels. This ROS-dependent sensitization 
of the Ca2+ release channels is particularly important wh en the cell has to 
generate repetitive Ca2+ spikes [104, 108]. A prolonged shift of Ca2+ from 
the ER to the mitochondria induces a number of stress signaIs (including 
ROS) which triggers the onset of apoptosis by activating the formation of a 
permeability transition pore (PTP) [108]. 
The Nucleus is surrounded by a double membrane, the nuclear envelope, that 
separates it from the cytoplasm. Both of the membranes have characteristics 
of the ER, the outer nuclear membrane (ONM) containing a SERCA and 
the inner nuclear membrane (INM) containing IP3R and RyR Ca2+ channels 
[102]. The nuclear envelope contains large nuclear pores with a large ion 
conductance which is drastically reduced either after accumulation of Ca2+ 
inside the nuclear envelope or by transport of macromolecules through nu-
clear pore complexes [102]. Upon stimulation, many cells exhibit Ca2+ signaIs 
both in the cytosol and the nucleus. The following ways of nuclear Ca2+ sig-
nal generation exist: • Ca2+ may reach the nucleus directly from the cytosol 
through the nuclear pores [102]. • Nuclear Ca2+ signaIs can be triggered 
independently of cytosolic Ca2+ signaIs by direct release of Ca2+ from the 
nuclear envelope. IP3 , cADPR and nicotinic acid adenine dinucleotide phos-
phate (NAADP) were observed to indu ce such a release [102] .• Ca2+ cou Id 
be released to the nucleoplasm from Ca2+ containing microvesicles which re-
side in the nucleoplasm [102]. In contrast to the mitochondria and the ER, 
the nucleus does not act as a Ca2+ sink. Rather, the nuclear envelope is 
destined to slow down the cytosolic Ca2+ wave to the nucleus since a rise in 
nuclear Ca2+ controls specific nuclear pro cesses such as gene transcription, 
development, protein transport into the nucleus and cell growth [109]. 
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The Golgi Apparatus primarily pro cesses, sorts and packs macromolecules 
synthesized by the cell for secretion (exocytosis) or for use wi thin the cell. 
Changes in Ca2+ concentration either within the Golgi lumen or in the ad-
jacent cytosol regulate Golgi function. In addition, the Golgi apparatus 
contains a release and sequestration apparatus for Ca2+ which accumulates 
it to a concentration of around 300 J.LM [110]. The generation of IP3 stim-
ulates Ca2+ release from the Golgi through the IP3R release channel which 
is the only Ca2+ release channel found in the Golgi membrane. The Golgi 
apparatus contains, furthermore, two types of Ca2+ ATPases, one of which 
is a thapsigargin-sensitive SERCA and the other a thapsigargin-insensitive 
secretory pathway Ca2+ ATPase (SPCA) [110]. The Golgi collaborates with 
the ER - with different kinetics - in elevating cytosolic Ca2+ in response to 
IP3 stimulation and modulates the duration and pattern of cytosolic Ca2+ 
signaIs (1101. 
Lysosomes and Acidic Secretory Granules were found to be responsible for 
nicotinic acid adenine dinucIeotide phosphate (NAADP) induced Ca2+ re-
lease [111]. NAADP-sensitive Ca2+ channels are located on lysosome-related 
acidic organelles. These organelles are thapsigargin-insensitive and are loaded 
with Ca2+ by a H+ jCa2+ exchanger [111]. There has been a consider-
able amount of controversy regarding the ability of secretory granules to 
actively participate in the regulation of Ca2+ concentration in their environ-
ment. Since, however, exocytosis requires high local Ca2+ concentrations, it 
strongly suggests that Ca2+ release from secret ory granules is an appropriate 
signal [99]. 
The theory of F-Actin 7 -dependent Ca2+ signalling is based on the in vitro 
observation that F-actin is able to store and release Ca2+ within the physi-
ological concentration range of 20 - 1000 nM Ca2+ [103]. Ca2+ is bound to 
a high-affinity binding site of G-actin8 in a reversible manner. In the poly-
merized F-actin form, the Ca2+ binding site is inaccessibly hidden within the 
7F-actin or filamentous actin is a polymer of G-actin subunits [111. 
8G-actin or globular actin is the actin monomer which polymerizes above a critical 
concentration to F-actin [UI. 
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filament structure [103]. The Ca2+ -storing actin system has the following 
characteristics: • Monomeric ATP-G-actin is the high-affinity Ca2+ -binding 
species of the store exhibiting a pH-dependent K~a2+ = 2 8 nM [103] . 
• Monomeric ADP-G-actin is the low-affinity Ca2+ -binding species of the 
store with a 100-foid lower affinity for Ca2+ (K~a2+ 400 nM) compared 
to the high-affinity monomeric ATP-G-actin [103]. • Ca2+ bound to the 
high-affinity Ca2+ -binding site of F-actin can only be released upon depoly-
merization to G-actin monomers. The Ca2+ /Mg2+ exchange rate, k~xa2+, on 
F-actin is about 4 OOO-fold lower than on G-actin [103]. 
Spatiotemporal modulation of Ca2+ signaIs 
Since intracellular Ca2+ controls a large number of different pro cesses in the 
same cell, the spatial and temporal organization of cytosolic Ca2+ signaIs is 
of crucial importance. Stimulation of cells can evoke Ca2+ signaIs that are 
either local or global, depending on the agonist concentration and the length 
of the stimulation period [112]. Moreover, the following features of the Ca2+ 
signalling machinery control the localization of high-Ca2+ concentration: 
• Although the Ca2+ ion is very mobile in water, it diffuses only slowly in 
the cytosol due to the many high-affinity binding sites on relatively im-
mobile proteins, such as actin. The combination of the rapidly diffusible 
messenger IP3 with the slowly diffusible Ca2+ in succession enables the 
restriction of Ca2+ signalling events to a local area [86]. 
• Many effects of Ca2+ are initiated through binding to calmodulin (CaM). 
In these cases, the final response to the Ca2+ signal depends on both 
the local Ca2+ and CaM concentrations [113]. 
• Upon activation, elementary Ca2+ -releasing events are produced by the 
brief opening of a single or a small group of Ca2+ channels located in 
either the plasma membrane or in intracellular Ca2+ -storing organelles. 
These elementary events appear as localized plumes of Ca2+ around the 
channels and have been labelled with different names depending on the 
channel responsible for their formation: 1) A sparklet is formed as a 
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result of the brief opening of voltage-operated channels. 2) A spark is 
formed by the opening of RyR Ca2+ channels. 3) A puff results from 
the release of Ca2+ from IP3R Ca2+ channels [114]. 
• Of particular significance with regard to the spatiotemporal aspects of 
Ca2+ signalling is the pro cess of CI CR from both types of intracellular 
receptor channels, the IP3R and RyR. This Ca2+ sensitivity enables 
the Ca2+ released from one receptor to stimulate Ca2+ release from 
its neighbours, thereby causing a regenerative wave of Ca2+ release 
throughout the entire cytosol. EspeciaIly, puffs are the building blocks 
of intracellular Ca2+ waves in cells and are likely to be responsible for 
global Ca2+ signaIs [112]. 
• A close juxtaposition of mitochondria with a cluster of release channels 
can form a rapid and transient high-Ca2+ microdomain in the perimi-
tochondrial space (see page 16). 
• Intracellular pH is known to modulate IP3-induced Ca2+ release by 
altering binding of IP3 and Ca2+ to the receptor site [115, 116]. In 
addition, the activity of several membrane proteins, including channels, 
exchangers and pumps are pH sensitive. A change in intracellular pH 
may control, therefore, intracellular Ca2+ homeostasis [117-119]. 
As a result of the different Ca2+ influx pathways (see page 14) and the feature 
of the Ca2+ signalling machinery, the cell is able to precisely manipulate the 
location, size, shape and duration of intracellular Ca2+ elevation, enhancing 
greatly the versatility, accuracy and efficiency of Ca2+ signalling. 
Stimuli provoking calcium signalling 
Inside the ceIl, the Ca2+ ion acts as a secondary messenger, relaying signaIs 
received on the outer cell surface into the cell interior and amplifying their 
strength. 
The main stimuli that can trigger intracellular Ca2+ elevation are: 
• Biomolecules, which can be functionally classified as: 
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1. Hormones - chemical messengers, usually peptides or steroids, 
prod uced and released into the bloodstream by one tissue and 
affecting another [120]. 
2. Neurotransmitters - chemical messengers, such as acetylcholine, 
dopamine, etc., that transmit nerve impulses across a synapse [120]. 
3. Extracellular matrix components - including fibronectin, laminin, 
collagen, etc., that are involved in the transmission of mechanical 
stimuli via membrane-attached integrins [1211. 
4. Cytokines - regulatory proteins and peptides, e.g. interleukines 
and interferon, produced by cells of the immune system [122]. 
5. Extracellular nucleotides and adenosine - messengers involved in 
purinergic signalling (see chapter 1.1). 
• Environmental stimuli, such as: 
1. Physical stimuli (e.g. light [123], change in electrical potential 
difference [124], shear stress [125], osmotic stress [26, 126]). 
2. Chemical stimuli (e.g. extracellular oxidative stress [123], 
taste [123], odour [127]). 
AH molecular messengers bind to receptors on the outer side of the plasma 
membrane, which can be classified as: 
• Ionotropic receptors, which are ligand-gated ion channels that open or 
close in response to agonist binding [1281· 
• Metabotropic receptors, which are G-protein9 coupled receptors that 
dissociate into Ga and G,BI subunits upon agonist binding and then 
interact with effectors [129]: 
Ga can be subdivided into four main families: 
Ga. stimulates adenylyl cyclase and increases the level of cAMP. 
9 Guanine nucleotide-binding protein 
CHAPTER 1. PHYSIOLOGICAL BACKGROUND 22 
GUq stimulates phospholipase C and generates the second messen-
gers IP3 and diacylglycerol (DAG). 
GUi inhibits adenyly cyclase and lowers the level of cAMP. 
GUt increases cGMP Phosphodiesterase and lowers the level of 
cGMP. 
G.B1' directly regulates many proteins, including enzymes and channels. 
Ca2+ influx across the plasma membrane can, furthermore, occur via me-
chanically and voltage-activated Ca2+ channels. 
The primary trigger employed in the experiments conducted for this Ph.D. 
project was osmotic stress induced by a 50% hypotonic solution. It caused 
cell-swelling induced, Ca2+ -dependent ATP release. The justification for this 
choice of stimulus is stated in the introduction. The source and progress of 
the Ca2+ signal were studied extensively in the course of this Ph.D. project. 
The results are presented in section 3.2. 
Calcium signalling in regulated exocytosis 
Regulated exocytosis requires an elevation of intracellular Ca2+ concentra-
tion over the basal level of rv 100 nM. The extent of the fusion process is 
controlled by the magnitude and duration of local intracellular Ca2+ increase. 
Either full fusion of the vesicle or "kiss-and-run" fusion - where the vesicle's 
integrity is maintained and only transient release is achieved - is possible 
[130]. The required Ca2+ elevation may originate either from Ca2+ entry 
across the plasma membrane or from Ca2+ mobilization from internaI stores, 
or from both. Non-excitable cells rely on Ca2+ entry through ionotropic re-
ceptors as weIl as metabotropic receptor-activated second-messenger-induced 
mobilization of Ca2+ from intracellular stores [131]. 
Ca2+ regulation of exocytosis is achieved via the interaction with a number 
of distinct molecular targets located at or near the site of membrane fusion. 
Various proteins with Ca2+ -binding domains and Ca2+ -activated protein ki-
nases are involved in the regulation of exocytosis, including SNARE proteins, 
synaptotagmin, munc18, syntaxin, calmodulin, CaMKII, PKC and others. 
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Since a further description of these proteins and their function goes beyond 
the scope of this Ph.D. thesis, the interested reader is referred to the many 
detailed review articles which have been written on this topic [130, 132-138]. 
Chapter 2 
Theory of the experimental 
methods 
2 .1 Luminescence 
2.1.1 Overview 
Luminescence is a general term for any process in which photons are emitted 
from a system that was shifted to an excited electronic state by sorne form 
of energy [139]. Fig. 2.1 on page 25 presents a schematic depictionlO of 
vibrational and electronic transitions. 
Multiple mechanisms exist by which a system can be excited [139]. Table 1 
on page 26 lists the most important types of luminescence according to the 
excitation mechanism. Photoluminescence occurs after excitation with light 
(Le. radiation within the optical range - UV to IR), whereas chemilumi-
nescence appears as a result of a chemical reaction. Bioluminescence is a 
special form of chemiluminescence in presence of an enzyme. Photolumines-
cence and bioluminescence will be discussed more in depth as part of the 
techniques used in the course of this Ph.D. work. Special attention will be 
given to the phenomenon of fluorescence as a pathway for deactivation of 
photoluminescence. 
lOcalled Jablonski Diagram after the Polish photophysicist Aleksander Jablonski 
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l 
......,..----- } vibraUonal energy states 
S2~-'~---
A F 
R 
electronic 
So ------''----------- ground state 
Figure 2.1: Jablonski diagramll 
S Singlet state 
T Triplet state 
A Absorption (10- 15 s) 
F Fluorescence (10-9 - 10-7 s) 
P Phosphorescence (10-3 - 102 s) 
R Non-radiative relaxation (e.g. quenching) 
le Internai conversion (10- 14 - 10-11 s) 
ISe Intersystem crossing (10-6 - 10-5 s) 
DF Delayed fluorescence 
llThe distances between electronic states and vibrational states are not to scale. 
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Table 1: Various types of luminescence 
Term 
Photoluminescence 
Chemiluminescence 
Bioluminescence 
Cathodoluminescence 
Thermoluminescence 
Radioluminescence 
Electroluminescence 
Triboluminescence 
Sonol uminescence 
2.1.2 Photoluminescence 
Excitation mechanism 
Light 
Chemical reaction 
Electrons 
Heating 
X-rays, Q-, {3- or ,-rays 
Electric field or current 
Mechanical energy 
Sound waves in liquids 
Photoluminescence is the emission of light subsequent to the absorption of 
light. The absorbance A of light by a substance follows the law of Lambert-
Beer: 
It 19- = -êCl =-A 
10 
10 intensity of incident light [lx] 
It intensity of transmitted light [lx] 
ê molar absorptivity [m2 . mol-1] 
C concentration of absorbing molecules [mol·l- I ] 
depth of the sample [mJ 
(2.1) 
The molar absorptivity coefficient (also molar extinction coefficient) is an 
intrinsic measure of absorption strength of a substance at a specifie wave-
length. The absorbance A is higher, the higher the ê. The energy of absorbed 
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light is given by Planck's relation: 
E energy [J] 
N Avogadro's number 
c 
E = Nhl/ = Nh-À 
h Planck's constant [6.626 . 10-34 J . s] 
1/ light frequency [S-I] 
c velocity of light [2.998.108 m . S-I] 
À light wavelength [nm] 
(2.2) 
Electronic excitation of a substance occurs only if E corresponds to the dif-
ference in energy between its ground electronic state (Sa in Fig. 2.1, page 25) 
and the electronically excited state (SI or S2 in Fig. 2.1, page 25). 
Fluorescence is the radiative transition between excited state and ground 
state of the same spin multiplicity which occurs in a time frame of 10-9 -
10-7 s after excitation (called fluorescent life time Tf) [140]. Several pro-
cesses, such as quenching and intersystem crossing (see Fig. 2.1, page 25), 
compete with fluorescence for the deactivation of the vibrationally lowest 
excited state. Hence, the intensity of fluorescence If can be determined by 
following equation [140]: 
(2.3) 
If intensity of fluorescence [lx] 
la intensity of absorbed light (Jo - It) [lx] 
. . nurnber of events 
<I> f fractIOn of excIted molecules that fluoresce ( ) 
nurnber of photons absorbed 
Since every electronic state of a molecule has several associated vibrational 
levels, excitation and emission do not occur at one single wavelength, but 
over a range of wavelengths, called a spectrum. Before electrons return 
from the excited state to the ground state, they lose vibrational energy as 
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part of internaI conversion. As a result, the emission spectrum is shifted to 
longer wavelengths than the excitation spectrum, which is known as Stokes 
shift 12 [140]. The greater the Stokes shift, the less excitation and emission 
spectra overlap. As a result, it is easier to eliminate excitation light by ap-
propriate selection of excitation and emission filters for a better detection of 
the weaker fluorescence light. 
2.1.3 Bioluminescence 
Bioluminescence is the process of light production through oxidation of a 
compound catalyzed by an enzyme. The light production results from the 
generation of a product molecule in an excited state. In order to discard the 
excess of energy, the molecule either fluoresces or transfers its energy to a 
fluorescent acceptor (sensitized bioluminescence) [141]. Each chemilumines-
cent compound or group can produce no more than one photon of light. The 
quantum yield of bioluminescence is, therefore, the ratio of the total number 
of photons produced to the total number of substrate molecules utilized. It 
can be expressed as the product of several terms [141]: 
(2.4) 
total number of photons produced 
total number of substrate molecules utilized 
1>c chemical yield of product; in general, 1>c = 1 
1> f fraction of excited molecules that fluoresce 
1>ex fraCtion of product molecules produced in an electronically excited 
state 
Numerous examples of bioluminescence exist in nature, most notably the 
light emitted by the male firefly. Other examples include glow worms, cer-
tain mushrooms and various marine organisms [142]. In these organisms, 
a compound called luciferin reacts with an ATP-complex of the enzyme lu-
ciferase to form an excited oxidized molecule that subsequently emits light. 
12 after the Irish mathematician and physicist Sir George Gabriel Stokes 
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It is important to note that the names Iuciferin and Iuciferase are generic 
terms for the active agent in bioluminescent organisms, and that their ac-
tuaI moiecular structures differ significantly from organism to organism [142, 
143]. 
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2.2 ATP release chamber and ATP evaluation 
2.2.1 Evaluation of ATP 
General considerations 
Two methods are mainly used for the evaluation of ATP: the luciferase-
luciferin assay [144] and high-performance liquid chromatography combined 
with fluorescence detection (HPLC-F) of derivatized nucleotides [145]. Both 
techniques are very sensitive and allow the detection of ATP down to 
rv 0.5 pmol [144, 145]. The luciferase-Iuciferin assay is very simple and does 
not require any addition al handling of the sample. However, it allows solely 
the detection of ATP. On the other hand, HPLC-F enables a simultaneous 
detection of aU nucleotides and nucleosides from one sam pIe, but involves a 
derivatization step between collection and measurement. 
Radiolabelled ATP has also been used in the detection of ATP release. How-
ever, the incorporation of the radioactive label does not necessarily follow the 
uptake and release of endogenous ATP, and the released radioactive label is 
a mixture of ATP and other purines liberated from the cell. Consequently, 
it do es not provide a clear evaluation of the amount of released endogenous 
ATP [146]. 
Both methods, the luciferase-Iuciferin assay and HPLC-F, were applied in 
the scope of this Ph.D. work to evaluate ATP released from A549 cells upon 
hyptonic shock (see section 3.1 and 3.2). However, HPLC-F was performed 
elsewhere (by Dr. Silvia Kreda, University of North Carolina at Chapel Hill, 
Cystic Fibrosis/Pulmonary Research Treatment Center) and therefore will 
not be described here in detail. The luciferase-luciferin assay is elaborated 
in the following subsection. 
Luciferase-Iuciferin assay 
Fig. 2.2 on page 32 delineates the particular reaction steps of the formation 
of oxyluciferin and light in the presence of the enzyme luciferase. The first 
reaction catalyzed by luciferase is the formation of adenyl-D (- )-luciferin (an 
active form of luciferin) from D (- )-luciferin and ATP-Mg. The oxidation 
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of the acyl adenylate by oxygen leads to the formation of an enzyme-bound 
product molecule in the excited state. The complex decays to free luciferase 
and the ground-state oxyluciferin with the emission of light [147]. The lumi-
nescence intensity is proportion al to the ATP concentration if firefly reagents 
are present in excess [148]. 
At low ATP concentrations, luminescence rises to a maximum value and re-
mains constant for a minute or longer. As the ATP level increases, there is 
a rapid ri se to peak luminescence intensity foIlowed by a rapid decay due to 
product inhibition [149, 150]. 
The high specificity of the light reaction for ATP is the basis for the utiliza-
tion ofthis reaction for the evaluation of ATP. Other nucleoside triphosphates 
are inactive in light production and, importantly, only negligibly inhibit the 
reaction with ATP [151]. Sorne nucleoside triphosphates even support pho-
ton production due to the promotion of the dissociation of the oxyluciferin-
luciferase complex [152], or in the presence of transphosphorylases, due to 
the coupling of nucleoside triphosphates to ATP production [153]. 
The performance of the luciferase-Iuciferin assay has been enhanced by mod-
ifications of the luciferase enzyme, which increases its chemical and physi-
cal stability [144]. Furthermore, different reaction conditions, including the 
presence of particular cations or anions, and the type of solvent influence 
the activity of firefly luciferase, the kinetics of light emission, as weIl as the 
emission spectra and quantum yield of firefly bioluminescence. They have 
to be known or adequately chosen to correctly evaluate quantitative ATP 
measurements, and are therefore presented in the foIlowing paragraphs. 
EFFECT OF METAL IONS 
The bioluminescent luciferase-Iuciferin reaction requires a divalent cation. 
The actual substrate for the reaction is the ATP-Mg complex, while uncom-
plexed ATP competitively inhibits the reaction. Sorne divalent metal-ions 
can replace Mg2+, such as Mn2+ and Ca2+, which both enhance the biolu-
minescent reaction. On the other hand, cations such as Sr2+, ZnH , Cd2+, 
Ni2+ BaH Cu2+ Sn2+ CoH CaH Hg2+ as weIl as the lanthanide Gd3+ , , , , , , , , 
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ÙN~ Il =v: OOH + H .... H HO S S 
Luciferin 
Firefly 
luciferase 
+ 
ATP 
Mg"!+ f\H2 
HO ° (x:) 
DeN N~. 'Or'~_'O/~O---r: N H .... H H' ~'~ HO S S HO OH 
Adenyl-Iuciferin + PFi' 
DeN N OH H( HO S SJ 
Oxyluciferin + Hp + CO2 
Figure 2.2: Luciferase-Iuciferin bioluminescence 
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inhibit the reaction to various degrees [154, 155]. Millimolar and higher con-
centrations of aU cations except Mg2+, Ca2+ and Mn2+ inhibit luminescence 
strongly. The addition of monovalent metal salts al ways leads to the inhi-
bition of luciferase. The degree of inhibition varies depending on the anion 
part of the salt (see next paragraph) [155]. 
EFFECT OF ANIONS 
The activity of firefly luciferase was shown to be very sensitive to the pres-
ence of anions, and the amount of inhibition at a particular ionic strength 
was strongly dependent on the nature of the anion. The inhibitory effect of 
anions increases in the foUowing order: CI- < CO~- rv SO~- rv Br- < 
SO~- rv PO~- < N03" < r-« Cr20~-« Fe (CN)~- [155, 156]. The 
inhibition by these anions is non-competitive with respect to luciferin [155]. 
Arsenate AsO~- and other anions were used to reduce background light, 
which interfered with the detection of low levels of ATP. They are also used 
to inhibit peak fluorescence preventing the rapid decay in fluorescence inten-
sity at high ATP levels [150]. Na+, K+, and NHt cations have been found 
to have no influence on the extent of the inhibition of their anions [156]. 
EFFECT OF SOLVENTS 
At neutral and alkaline pH the colour of light emitted is yeUow-green, whereas 
at acid pH a red emission is observed using luciferase from Photinus pyralis 
[157]. The quantum yield for the bioluminescent reaction at alkaline pH 
is close to unit y, indicating the formation of an excited product-Iuciferase-
complex that is protected from solvent quenching [157]. 
Various solvents, such as polyvinylpyrrolidone, polyethylene glycols and non-
ionic detergents, stimulate the activity of firefly luciferase. The sol vents 
affect the oxidative reaction and enhance both peak light and total light 
emission [158]. 
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Figure 2.3: Chamber for hypotoilically indticed ATP reiease 
..10 • • ~ .. • 
2.2.2 Chamber for hypotonically induced ATP teÎease 
~ . '. . . '. ',': : . - . ~ .:-" .:. 
A low-volume, flow-through chamber was previously designed to coiiect Afp 
.' • ' '. ". .' ,. .' . ' .• ~ '.' . • ; • . " . :,:: :\ J ....•.. ~' _'. .. 
secreted during hypotonie challenge [26]. Fig. 2.3 on page 34 ilhisttates the 
. .' ",". . . . " . '.~: .. " < ./ ~ .' ><:" . ~ ..... / -~ .. , '! '; ; 
experimental set-up: .,,' , , 
A24 rrÙn x 60 mI? cover-gl,ass slip with an adherent celi motidl~yet i~ placed 
between two 6 mm-thiek polycarbonate plates, one bf therii oeatihga '0.'5 
mm~thi~k silicon 'gasket (cut o~t of a medieal grade ~iliton r~bbe(sh~e~). 
The cut-out' area of the silicon sheet is rv 6'00 mm2 . ", . ' 
th~ physiologie al br hypotonic solution are pumped from a resetvoit thtough 
.. .' . . . . .' . . " . 
an in~hne~e~ter ~nd enter the A'TP release chambet at il temp~raÜlté ~f 
37 0 C.', Âftei the perf~sion of th~ chamber with' the ~ell ip.bti~lay~t,' thé 
solution i~ 'collected' into fraction~' ôf 30 s to i ~iti, respective!;. Theft ATP 
c~Iitent, is' mé~sur~d by the 1 uëife~ase-l ucife~in ~ssay. " ':, "'J," " .' 
Thetime c~ur~e of ATP ~elèase cluring the e~p~riment can he evahiated ,h.Y 
the foliowing equation: 
, , 
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[ATP]rel = (Lu - Bk) . [T (L 1 D )] . ps· [10
6
] (2.5) 
n . Uini - e . sn qc 
[ATP] rel amount of ATP released 
Lu acquired luminescence [rLUp3 
Bk background fluorescence [rLU] 
Tn tonicity (e.g. 1 for isotonie; 0.7 for 30% hypotonie) 
LUini initial calibration with 100 nM ATP [(100 nM ATP)-l] 
De decrease in luminescence [rLU] 
sn sample number 
ps perfusion speed [ml. min-1] 
qc quantity of cells ("" 500 cells mm- 2 for A549) [confluent cells] 
Consequently, the unit for [ATP] rel is: 
[ 
100 pmoles ATP ] 
min· 106 confluent cells 
13relative light unit 
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2.3 Ratiometric imaging 
Ratiometric imaging is a fluorescence microscopie technique that takes ad-
vantage of the spectral shifts exhibited when fluorescent dyes bind to their 
target ions. Since intracellular ion measurements with ratiometric indica-
tors are relatively independent of uneven dye loading, cell thickness, photo-
bleaching effects and dye leakage, this method is generally given preference 
over non'-ratiometric imaging [159]. Various types of ratiometric imaging 
have been developed, including Fura-2 imaging of intracellular calcium and 
BCECF imaging of intracellular pH. 
2.3.1 Basic principles 
Requirements for the fluorescent indicator 
Fluorescent dyes used for ratiometric imaging are designed to have high se-
lectivity, but low affinity for the specifie ion in question. High selectivity 
assures an accurate and specifie measurement of ion concentration, whereas 
low affinity is necessary to avoid non-genuine alteration of intracellular ion 
concentrations as a result of ion binding to the dye [160]. Fast kinetics in ion 
binding is required for kinetic studies of intracellular ion alterations [159]. 
Large absorbance and large fluorescence changes resulting from ion binding 
are also essential attributes for an effective performance of the dye [161]. 
Experimental set-up 
Ratiometric imaging by means of microscopy requires an epifluorescence mi-
croscope (see page 171) equipped with a CCD or other type of detector, and a 
computer for system control and image processing. A multi-filter wheel with 
two different excitation filters are controlled by the computer and placed in 
the path of excitation light. Fluorescent images are recorded with the de-
tector, digitized and stored. A subsequent image analysis and processing 
enable quantification of spatial and temporal distribution of ion concentra-
tion within the cell [159]. To avoid photobleaching and phototoxicity, low 
CHAPTER 2. THEORY OF THE EXPERIMENTAL METHODS 37 
levels of excitation energy, short exposition time and high sensitivity detec-
tors should be used. 
Loading of the ce Ils 
Most fluorescent indicators are membrane-impermeable. Various dye-Ioading 
procedures were developed, ofwhich some are considerably invasive to the cell 
[159]. In contrast, derivatization of the indicators to acetoxymethyl (AM) 
esters renders them cell-permeable, and enables them to passively diffuse 
across the intact cell membrane. Inside the cell, ubiquitous intracellular es-
terases hydrolyze the AM group and release the ion-sensitive polyanionic, 
cell-impermeable indicator. The final intracellular concentration and the 
degree of hydrolyzation of the indicator, which can reach up to several milli-
molar [161], depends on various factors, including type of indicator, cell type, 
loading concentration of indicator, number of cells, loading time, loading tem-
perature and potential pre- and post-treatment of cells [159]. The loading 
medium should not contain any amino acids or amines because they may 
cleave the AM esters and prevent loading. The nonionic and nondenaturing 
detergent Pluronic® F-127 (see page 277) is frequently added to help dis-
perse the indicator in the loading medium, especially at low loading tempera-
tures. Sorne problems during the cellioading process have been encountered 
[162, 163]: 
1. Indicators may be sequestered in non-cytoplasmic compartments (Le. 
cytoplasmic organelles) either due to incomplete hydrolysis of the AM 
ester or mediated by organic anion transport systems; 
2. Loaded cells may actively and passively lose dye, either due to incom-
pIete hydrolysis of the AM ester or mediated by organic anion transport 
systems. 
The following solutions have been found: 
1. Sequestration of the fluorescent indicator can be avoided through low 
loading temperatures (15-33 0 C) or through pre-chilling at 4 0 C before 
loading the cells [162). 
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2. Ratiometric measurements help to minimize the impact of indicator 
leakage on experimental data (see above). However, active extrusion 
of anionic indicators from cells by organic ion transporters should be 
reduced by performing experiments at lower than physiologie temper-
atures (15 - 33 0 C) or by applying inhibitors such as probenecid (see 
page 279) or sulfinpyrazone [163]. 
2.3.2 Calcium imaging 
Calcium indicators shift their absorption spectrum and change their emitted 
fluorescence intensity in response to [Ca2+] i alterations in the range between 
0.3 . Kd and 10 . Kd [159]. A description of the ratiometric Ca2+ chelator 
Fura-2 is given on page 270. To estimate [Ca2+L, fluorescent intensities 
(Àem = 520 nm) are acquired for Àexl = 340 nm and Àex2 = 380 nm and 
entered into the following equation [164]: 
R 
F3800 
F380• 
(2.6) 
equilibrium dissociation constant for Ca2+ and Fura-2, according 
to [164]: rv 224 nM at 37 0 C 
Ratio (F340 / F380 ) of measured fluorescence intensity 
ratio (F340 / F380 ) of fluorescence intensity, formed at minimum 
Ca2+ concentration 
ratio (F340 / F380 ) of fluorescence intensity, formed at maximum Ca2+ 
concentration 
fluorescence intensity for Àex2 - 380 nm at minimum Ca2+ 
concentration 
fluorescence intensity for Àex2 - 380 nm at maximum Ca2+ 
concentration 
For in situ calibration of Fura-2, ionomycin (see page 272) is used as ionophore 
to equilibrate the controlled external ion concentration with the ion concen-
tration within the cell [165]. The calibration procedure is complex and rather 
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imprecise and is, therefore, avoided if a qualitative analysis is sufficient. 
2.3.3 Intracellular pH 
The pH indicator BCECF is characterized on page 266. Intracellular pH mea-
surements with BCECF are accomplished by measuring the pH-dependent 
fluorescence intensity (Àem = 535 nm) for Àex1 = 490 nm and for its isosbestic 
point14 of Àex2 = 440 nm. They are entered into the following equation [166]: 
(R- Rmax) 
pH = pK + log (Rmax _ R) (2.7) 
pK pK value for BCECF under experimental conditions (pKa = 6.98) 
R ratio (F495 / F440 ) of measured fluorescence intensity 
Rmax ratio (F495 / F440 ) of fluorescence intensity at maximum calibrated 
BCECF is commonly calibrated in situ using the K+ /H+ ionophore nigericin 
in the presence of 100 - 150 mM K+ to equilibrate internai and external 
pH [167]. 
14 At the isosbestic point, the fluorescence spectrum of an indicator is independent of 
the ion concentration. 
Cl1apter 3 
Articles: Mechanism of ATP 
release 
3.1 ARTICLE 1: Calcium-dependent release of 
adenosine and uridine nucleotides from 
A549 cells 
3.1.1 Preamble 
Previous results from this group showed that hypotonie shock-induced ATP 
release from A549 cells was tightly correlated with an intracellular Ca2+ sig-
nal. This finding suggested that ATP release from these cells is triggered by 
an intracell ular Ca 2+ elevation and pointed toward a Ca 2+ -dependent exocy-
totic release mechanism [26]. 
The objective of this research was to reassess and to strengthen the assump-
tion of a Ca2+ -dependent exocytotic ATP release mechanism from A549 cells 
and to further analyze the potential co-release of other nucleotides, i.e. ADP, 
AMP, adenosine, UTP and UDP. 
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3.1.2 Jlrticle 
Tat ur , S.; Kreda, S.; Lazarowski, E.; Grygorczyk, R. 
Calcium-dependent release of adenosine and uridine nucleotides from A549 
cells. Purinergic Signalling, Epub 25 July 2007. 
Reproduced on pp. 42-72 with permission. 
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Abstract 
Extracellular nucleotides play an important role in lung defense, but the release 
mechanism and relative abundance of different nucleotide species secreted by lung 
epithelia are not weil defined. In this study, to minimize cell surface hydrolysis, we 
used a low-volume, flow-through chamber and examined adenosine and uridine 
nucleotide concentrations in perfusate aliquots of human lung A549 cells challenged 
by 50% hypotonie shock. ATP, ADP, AMP, and Ado were quantified in HPLC 
analysis of fluorescent etheno derivatives, and UTP and UDP were measured using 
HPLC-coupled radioenzymatic assays. After the onset of hypotonie shock, ATP, 
ADP, UTP, and UDP in the perfusates increased markedly and peaked at 
approximately 2.5 min, followed by a graduai decay in the next 15-20 min; peak 
changes in Ado and AMP were relatively minor. The peak concentrations and fold 
increment (in brackets) were: 34±13 nM ATP (5.6), 11±5 nM ADP (3.7), 3.3±1.2 nM 
AMP (l.4), 23±7 nM Ado (2.1), 21 nM UTP (>7), and Il nM UDP (27). Nucleotide 
release was almost completely abolished from cells loaded with the calcium chelator 
BAPTA. Under isotonic conditions, elevation of intracellular calcium with the 
calcium ionophore ionomycin (5 pM, 3 min) also released nucleotides with kinetics 
and relative abundance as above, albeit less robust. ADP:A TP (1 :3) and UDP:UTP 
(1 :2) ratios in perfusates from stimulated cells were markedly higher than the 
cytosolic ratios of these species, suggesting that an NDP-rich compartment, e.g., the 
secretory pathway, contributed to nucleotide release. Laser confocal microscopy 
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experiments illustrated increased FMI-43 uptake into the plasma membrane upon 
hypotonie shock or ionomycin treatment, consistent with enhanced vesicular 
exocytosis under the se conditions. In summary, our results strongly suggest that 
calcium-dependent exocytosis is responsible, at least in most part, for adenosine and 
uridine nucleotide release from A549 cells. 
Keywords: Ca2+ dependence, exocytosis, hypotonie shock, lung epithelial ceIls, 
nucleotide secretion 
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Introduction 
ExtraceHular nucleotides control a diverse range of physiological processes by 
interacting with a large group of cell surface P2Y and P2X receptor families [1-3]. In 
the lungs, extracellular nucleotides regulate airway surface liquid homeostasis and 
mucociliary clearance by modulating epithelial ion and fluid transport as weil as 
ciliary beating [4]. In alveoli, ATP is a potent secretagogue that stimulates type II cel! 
surfactant secretion. Nucleotide levels on airway surfaces, measured in vitro and ex 
vivo, show dynamic changes due to the combination of basal and stimulated release 
and their rapid metabolism by several groups of membrane-associated and secreted 
soluble ecto-enzymes. These ecto-enzymes extend the signaling potential of A TP by 
converting it to Ado, a ligand of the AI-3 family of G protein-coupled receptors [1,4-
7]. 
Nucleotide release is stimulated by cell mechanical perturbations, such as 
shear stress, membrane stretch, medium change, hyposmotic swelling and hypoxia 
[1,8]. It is now recognized that mechano-sensitive ATP release occurs from healthy 
cells via physiological processes, which do not involve cell damage. Numerous 
reports have suggested that the cystic fibrosis transmembrane conductance regulator 
(CFTR) and other members of the superfamily of A TP-binding cassette transport 
proteins serve as a conductive pathway for A TP release, or regulate an associated 
A TP channel. However, other groups using patch-clamp, lipid-bilayer and 
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luminometry techniques, have not found any detectable CFTR-mediated or CFTR-
regulated ATP release (reviewed in [1]). Volume-regulated anion channels (VRAC) 
and voltage-dependent anion channels (VDAC, porins or maxi cr channels) are 
known to have considerable permeability to cations and large organic anions, and 
several laboratories have implicated these channels in cell swelling-induced A TP 
release and the autocrine regulation of cell volume. However, recent studies have 
demonstrated that conductive pathways, including VRAC, VDAC and stretch-
activated channels, are not involved in cell swelling-induced A TP release from A549 
cells [1,9,10]. FinaIly, connexin hemichannels also have been proposed to mediate 
A TP release, but their role in this process in a physiological setting is not always 
clear [1]. 
While conductive release mechanisms are still being debated, exocytotic A TP 
release is weIl established in excitatory ceIls, blood platelets and ch rom affin cells. 
Furthermore, there is growing experimental evidence supporting such a release 
mechanism also by epithelial and other non-excitatory cells. In particular, we have 
recently demonstrated that cell swelling-induced A TP release from A549 and 
16HBE140- epithelial cells and NIH 3T3 fibroblasts is tightly correlated with 
intracellular Ca2+ elevations; it is abolished in ce Ils loaded with the Ca2+ chelator 
BAPTA or by low temperature, strongly suggesting the involvement of Ca2+-
dependend exocytotsis [10]. Whether release of other nucleotides from epithelial cells 
CHAPTER 3. ARTICLES: MECHANISM OF ATP RELEASE 47 
also involves Ca2+-dependent exocytosis remains incompletely explored. Such 
studies, however, are complicated by nucleotide hydrolysis at the airway surface, 
which makes it difficult to assess the magnitude and relative abundance of different 
nucleotide species released. Therefore, we used a flow-through cham ber to minimize 
cell surface hydrolysis. 
We found that hypotonic shock markedly increased ATP, ADP, UTP, and 
UDP concentrations in perfusates, which peaked at approximately 2.5 min. 
Nucleotide release was almost completely abolished from cells loaded with the 
calcium chelator BAPT A and, under isotonic conditions, could be evoked by 
elevation of intracellular calcium with the calcium ionophore ionomycin. High 
nucleotide diphosphates (NDPs) concentrations in perfusates of stimulated cells 
suggested that an NDP-rich compartment, e.g., the secretory pathway, contributed to 
this release. Together with real-time FMI-43 fluorescence experiments, our results 
strongly indicate that calcium-dependent exocytosis is a major mechanism of 
adenosine and uridine nucleotide release from A549 cells. 
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Materials and Methods 
Cells 
Human lung carcinoma A549 cells were grown in DMEM supplemented with 10% 
FBS, 2 mM L-glutamine, 56 V/mL penicillin-G and 56 Jlg/mL streptomycin sulfate. 
AIl constituents of the culture media were from GIBCO-BRL (Burlington, ON). A TP 
efflux was measured from cell monolayers grown to confluency on 24x60-mm glass 
coverslips. Fura-2 calcium imaging and FMI-43 microscopy experiments were 
performed on cells grown on circular 15-mm diameter no. 1 glass coverslips. 
Nucleotide efflux assay 
To measure nucleotide efflux during hypotonic challenge with high temporal 
resolution, we used a custom-designed low-volume (300 JlL), flow-through chamber, 
as described previously [10]. Briefly, 24x60-mm glass coverslips with confluent cell 
monolayers of ~500 eells/mm2 were mounted in the chamber and perfused with warm 
(37°C/in-line heater - Warner Instrument Co., Hamden, CT) Ringer solution at the 
rate of 1.3 mL/min. The Ringer solution contained (in mM): 110.5 NaCl, 24 
NaHC03, 1.3 KCl, 1 MgCh, 1 CaCh, 2.5 Na2HP04, 2.5 KH2P04, 1.2 K2HP04, 10 
glucose; pH 7.4 was maintained by bubbling with 5% C02. After an equilibration 
period in isotonic solution (5-15 min), a 50% hypotonie solution was applied, and the 
perfusate was continuously collected for 30-s intervals during the initial burst of A TP 
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secretion (0-5 min) and during 1 min elsewhere. Nucleotide concentrations in the 
samples were evaluated by high-performance liquid chromatography ( HPLC) 
analysis, as described below. For studies in absence of extracellular calcium, CaCh 
was omitted and the solutions were supplemented with 0.1 mM EGT A. The 50% 
hypotonic solution was prepared by appropriate reduction of salt concentration while 
divalent cation concentrations were kept constant. 
HPLC quantification of adenine and uridine nucleotides 
UTP concentrations were quantified by UDP-glucose pyrophosphorylase-based 
reaction [11]. Briefly, 100-).11 samples were incubated in the presence of 0.5 U/mL 
UDPglucose pyrophosphorylase, 0.5 U/mL inorganic pyrophosphatase, 1.6 mM 
CaCb, 2 mM MgCb, 25 mM HEPES (pH 7.4), and -100,000 cpm 1 ).1M 
[14C]glucose-lP. Incubations lasted 1 h at 30°C. Reactions were terminated by 
heating the samples at 95°C for 2 min. Conversion of [14C]glucose-IP to [14C]UTP 
was determined by HPLC (Shimadzu) via a Nova Pack C18 column and ion pairing 
mobile phase. Radioactivity was measured on-fine with a Packard F1o-0ne detector. 
Assay sensitivity was 1 pmol (3 nM in 100-).11 sarnples) 
UDP was quantitatively phosphorylated in the presence of [l2p1ATP, usmg 
nuc1eoside diphosphokinase (NDPK). Briefly, 100-).11 samples containing 0.1 U/ml 
NDPK, 0.1 ).1Ci 60 nM [y32p]ATP, 1.6 mM CaCh, 2 mM MgCh, and 25 mM HEPES 
(pH 7.4) were incubated for 5 min at 30°C. Reactions were terminated by heating the 
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samples at 95°C for 2 min. The resulting conversion of [y32p]ATP to [y32P]UTP was 
monitored by HPLC [12]. A calibration curve employing known amounts of UDP 
was chartered in parallel during each assay. This as say allows UDP quantification 
with sensitivity of20 fmol (0.2 nM in lOO-ill samples). 
Etheno derivatization. Samples (200 Ill) were derivatized for 30 min at 72°C in the 
presence of 1.0 M chloroacetaldehyde and 25 mM Na2HP04 (pH 4.0). The resulting 
fluorescent I,N6-ethenoadenine derivatives were analyzed by HLPC (Waters), in a 
Hamilton PRP-XIOO anion exchange column, as described previously [4]. Etheno (E)-
ATP, s::ADP, E-AMP, and e-adenosine were quantified with a sensitivity of 200 fmol 
(1 nM in 200-1l1 samples). 
FMI-43 studies 
Bulk exocytosis was quantified in A549 cells as changes in the fluorescence intensity 
of FMI-43 incorporated into the plasma membrane [13,14], and recorded by real-
time confocal microscopy. Cells were washed with Hank's Balanced Salt Solution + 
20 mM HEPES + 2 mM MgCh and 1.6 mM CaCh (HBSSH) or with HBSSH devoid 
of calcium (HBSSH 0 Ca). They were mounted onto the stage of a Leica SP2 AOBS 
confocal microscope equipped with HCX Apo L63x NA 0.9 immersion Leica lens 
and a 488 nm Argon laser. Experiments were initiated by incubation of the cells with 
3 IlM FMI-43. Cells were incubated for at least 10 min, and hypotonic shock was 
applied by decreasing salt concentration 33% while maintaining calcium, magnesium 
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and FMI-43 concentrations constant. Altematively, cells incubated with FMI-43 in 
HBSSH or HBSSH 0 Ca were stimulated with 5-10 ).lM ionomycin. Real-time 
recording was performed by laser scanning in the xz axes with a galvostage, initially 
every 10 and then every 30 s for the time periods indicated in the figures. Ove raIl 
fluorescence intensity changes associated with the plasma membrane were estimated 
by measuring the intensity value associated with each pixel through time. The entire 
apical membrane compartment displayed in a confocal plane and 5 random regions of 
basolateral and sub-apical domains were analyzed, normalized to basal values 
(time=O) and averaged for each region. Cell swelling was estimated as a change of 
cell height in the xz plane at different time points, normalized to basal values, and 
averaged. 
Fura-2 calcium measurements 
To load Fura-2, ceUs were incubated (1 h, 37°C, 5% C02) in physiological solution 
containing 25 !lM Fura-2-AM + 0.02% Pluronic® F 127 and 2.5 mM probenicid. This 
was followed by 30 min de-esterification period in physiological solution containing 
probenicid. The physiological saline solution was comprised (in mM) of: 140 NaCI, 5 
KCI, 1 MgClz, 1 CaCh, 10 glucose and 10 HEPES, pH 7.4, adjusted with NaOH. 
50% hypotonic medium was prepared by reducing the salt concentration while 
keeping divalent cation concentration constant. For calcium imaging, coverslips with 
Fura-2-loaded ce Ils were mounted in the imaging/perfusion chamber attached to the 
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heated platform (Warner Instruments Co.) on the stage of an inverted microscope 
(Nikon TE300). The cells were exposed to alternate (200 ms) illumination at 340 and 
380 nm with a high-pressure mercury lamp (100 W) via interference filters (Chroma 
Technology, Brattleboro, VT) mounted on a filter wheel (Sutter Lambda 10-C, Sutter 
Instrument Co., Novato, CA) and a dichroic mirror (510/540 nm, Chroma 
Technology). Fluorescence images were recorded at 15- to 60-s intervals with the 
digital camera and stored for later analysis. 
Chemicals 
For calcium imaging experiments, Fura-2-AM was obtained from Molecular Probes, 
Invitrogen Corp. (Burlington, ON). Probenicid, Pluronic® F127 and ail other reagents 
were from Sigma Aldrich (Oakville, ON). 
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Results 
Kinetics of nucleotide release 
Figure 1 shows an example of the time-course of nucleotide release induced by 50% 
hypotonie shock. For cIarity, the release of adenine and uridine nucIeotides appears 
on separate graphs: A and B, respectively. The kinetics of release were remarkably 
similar for ail nucleotides; after the onset of hypotonie shock nucleotide 
concentration increased rapidly, peaking at ~2.5 min, followed by a graduai decay in 
the next 10-15 min. The average peak values from several separate experiments are 
shown in Figure lC. Interestingly, ATP was the major species at the peak of 
stimulated release, whereas for basal release, Ado was the predominant species. The 
rank order of nucleotide abundance at the peak was: A TP > Ado ~ UTP > ADP ::::: 
UDP > AMP. Relative increases of nucIeotide concentrations at the peak were also 
the highest for NTPs and NDPs (ATP 5.6-fold, ADP 3.7-fold, UTP >7-fold, UDP 27-
fold), whereas the increase was smaller for AMP and Ado (1.4-fold and 2.l-fold, 
respectively). 
RaIe of [Ca +2J; 
To investigate the role of [Ca +2]j in adenine nucleotide release, we tested the effect of 
the Ca2+ ionophore ionomycin. In the absence of hypotonie shock, exposure to 5 \lM 
ionomycin for 3 min induced transient nucleotide release from A549 cells: Figure 2A. 
This release reached a peak at approximately 1.5 min, i.e. slightly earlier and at 
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somewhat lesser absolute peak amplitude compared to that induced by 50% 
hypotonic shock. Otherwise, the kineties and relative nucleotide abundance were 
similar for both stimuli. Almost complete inhibition of swelling-induced adenine 
nucleotide release was observed for A549 cells loaded with the Ca2+ chelator 
BAPTA, compared to control untreated cells of the same batch tested in parallei 
experiments: Figure 2B and C, respectively. Fura-2 fluorescence [Ca +2]j 
measurements confirmed a dramatic reduction of the [Ca+2]j response to 50% 
hypotonie shock in BAPTA-Ioaded cells: Figure 2D. These experiments demonstrate 
that elevation of [Ca+2]j was required to trigger adenine nucleotide release from 
A549 epithelial cells. 
FMI-43 fluorescence changes implicate vesicular exocytosis 
Strong calcium dependence of nucleotide release may indieate the involvement of 
vesieular exocytosis. To further explore this possibility, bulk exocytosis was 
examined by real time confocal mieroscopy in cells bathed in FMI-43. Fluorescence 
intensity associated with the plasma membrane increased rapidly by incorporation of 
the soluble probe into the membrane and remained almost constant after 5 min in 
non-stimulated cells. Plasma membrane-associated fluorescence intensity rose rapidly 
(~20 s) with hypotonic shock stimulation. This change was accompanied by increased 
cell volume seen as increment of cell height: Figure 3A and B. Cell volume peaked at 
about 3 min, followed by a regulatory volume decrease in the next 10-15 min (data 
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not shown). A similar plasma membrane associated FMI-43 fluorescence intensity 
increase was observed in the absence of hypotonic shock, when the cells were 
stimulated with ionomycin, in the presence but not in the absence of calcium in the 
bathing solution: Figure 4. These data indicate that both hypotonic shock and 
ionomycin stimulated bulk exocytosis in A549 cells. 
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Discussion 
In this study, we used the flow-through chamber and an etheno derivatization 
me as ure ment technique to examine the kinetics of nucleotide release from A549 lung 
epithelial cells induced by hypotonic shock. We demonstrated that ATP, ADP, AMP, 
Ado, UTP and UDP appeared in the perfusates with the same kinetics, peaking at 
-2.5 min (Figure 1), which coincided with the peak of [Ca +2]j elevation evoked by 
hypotonic shock: Figure 2D. Similar tight temporal correlation between the [Ca+2]j 
signal and A TP release, measured by luciferase-luciferin luminescence assay, was 
reported previously for A549, 16HBE140· epithelial cells and NIH-3T3 fibroblasts 
[10]. Such a close temporal association suggests that hypotonic shock-induced 
elevation of [Ca +2]j is a trigger for the release of nucleotides. This was supported by 
the strong inhibitory effect of the intracellular Ca2+ cheletor BAPTA-AM and the 
induction of nucleotide release in the absence of hypotonic shock solely by the rise of 
[Ca +2]j with ionomycin. These data demonstrate tight Ca2+ -dependence of nucleotide 
release, and point to a Ca2+ -dependent exocytotic mechanism. It should be noted, that 
the bulk [Ca +2]j changes shown in Figure 2D, likely represent superposition of 
spatially separated, distinct [Ca +2]j responses, one evoked directly by hypotonic shock 
and the other due to autocrine/paracrine actions of the released nucleotides on P2Y 
receptors. The latter effects might be minimized, at least partially, by continuous 
perfusion, which reduced nucleotide concentration in the bulk of the chamber far 
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below the ICso of P2Y receptor activation, however, this possibility requires further 
study. 
Consistent with a Ca2+ -dependent exocytotic mechanism, FM 1-43 fluorescence 
studies revealed enhanced incorporation of the probe into the plasma membrane 
induced by hypotonic shock or ionomycin treatment. Increased plasma membrane-
associated FM 1-43 fluorescence intensity was a measure of the cumulative amount of 
membrane added by exocytosis [13]. FMI-43 fluorescence increased rapidly during 
the tirst 20 s of hypotonic shock: Figure 3. Interestingly, the initial fluorescence 
increment exceeded the cell surface increase estimated from xz confocal scans. In our 
previous study using a dual-image 3D cell reconstruction technique [15], we observed 
only a Il % to 30% surface increase of single substrate-attached A549 cells swollen 
in 50% hypotonic solution [10]. This difference could be attributed, in part, to 
different method of cell height and surface evaluation in that study as weil as 
differences in swelling responses of single isolated cells compared to confluent cel! 
monolayer. However, a similar discrepancy between FMI-43 fluorescence, cell 
surface and membrane electrical capacitance has been also reported by others, e.g. 
with pituitary lactotrophs, where the dense granules docked into the plasma 
membrane, were intensely stained by FMI-43, in addition to the membrane added to 
the cel! surface [16]. Therefore, the divergence of fluorescence and the cell surface 
changes seen in our study with A549 cel!s may be also result in part, from FMI-43 
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staining of the lipophilic content of fused vesicles, in addition to the staining of fused 
vesicular membranes. The FM 1-43 dye is often employed to fluorescently mark 
surfactant-containing lamellar bodies in alveolar type II (A TIl) cells [17,18], and 
A549 cells, a model of A TIl cells, also contain granules enriched in surface active 
phospholipids [19]. However, the exact contribution of such granules to increased 
FM 1-43 fluorescence in stimulated A549 cells was out of the scope of the present 
investigation and will require future direct study. 
Vesicle exocytosis may be mechanistically associated with nucleotide release 
in 2 ways: nucleotides can be delivered to the extracellular medium as cargo 
molecules within exocytotic vesicles, or, alternatively, secreted from the cytosol via 
vesicle-associated nucleotide-conducting channels or transporters, transiently 
expressed at the plasma membrane as a consequence of vesicle-plasma membrane 
fusion. Analysis of the relative abundance of different nucleotide species that appear 
in the extracellular medium may help to distinguish between these 2 mechanisms. 
A TP and UDP-sugars accumulate in the lumen of the secretory pathway up to 20-50 
fold above their cytosolic concentrations, and luminal utilization of these molecules 
generates ADP and UDP. UDP is the major uridine nucleotide detected in ER/Golgi 
fractions [20] and, eventually, a UDP-selective apyrase (UDPase) converts UDP to 
UMP [21]. ER/Golgi ADP and UMP are exchanged for cytosolic ATP and UDP-
glucose via specific transporters [22-25]. Since intraluminal nucleotides are not 
subject to the mechanisms that retrieve resident ER/Golgi proteins, they are predicted 
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to remain within trafficking vesicIes, and to be released to the extracellular space 
from the secretory pathway. Our results suggest that this mechanism Iikely accounted 
for UDP release from A549 cells. Figure 1 C illustrates that hypotonie stimulation 
promoted a sharp increase in UDP levels, with a UTP:UDP concentration ratio of2:1. 
Since the cytosolic UTP: UDP ratio is > 1 0: 1 [26], our results suggest, at least in part, 
a vesicular rather than a cytosolic source of UDP and, as a corollary, of ATP and 
ADP. 
In summary, our results provide strong evidence for Ca2+-dependent vesicular 
exocytosis as a major mechanism of adenosine and uridine nucleotide release from 
A549 epithelial cells induced by hypotonie stress. Part of this release involves 
vesicles of the protein secretory pathway. Further investigations are needed to cIarifY 
the origin and contribution of other vesicular pools as weIl as the mechanisms and 
sources of intracellular Ca2+ elevations that evoke nucleotide secretion. 
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Figure legends 
Figure 1. Transient nueleotide release from A549 eells indueed by 50% 
hypotonie shoek. 
Time-course of adenosine (A) and uridine (B) nucleotide release observed in 
response to 50% hypotonic shock. A representative experiment is shown, out of 4 
performed under the same conditions. Hypotonic shock was applied at t=O min and 
was preceded by 15-min equilibration in isotonic solution. C, Basal (t=O min) and 
peak (t=2.5 min) nucleotide concentrations detected in perfusates. Average values ( 
±S.D.) are from 3-4 experiments, such as in A and B, except for UTP and UDP, 
which are from a single experiment. * due to the limited sensitivity of UTP 
evaluations (:::::3 nM), the basallevel ofUTP was found to be below the detection limit 
and was not shown. 
Figure 2. Effeet of intraeellular Ca2+ modulators on nucleotide release. 
(A) In the absence of hypotonie shock, application of 5 !-lM ionomycin resulted in 
transient nucleotide release with kinetics similar to that induced by hypotonic shock. 
An example, out of n=2 similar experiments, is shown. Loading A549 cells with the 
Ca2+ chelator BA PT A almost completely inhibited hypotonic stress-induced 
nucleotide release compared to controls that were run in parallel: Band C 
respectively (n=2). Effect of BAPTA on the [Ca2+]j response is shown in D. The 2 
traces represent changes of the Fura-2 fluorescence ratio at 2 excitation wavelengths, 
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À.340/À.380, in response to 50% hypotonie shock, applied at t=O min, in control and 
BAPTA-Ioaded cells. Note that the rapid peak of the [Ca2+]j response was abolished 
in BAPTA-Ioaded cells. Similar responses were observed in n=4 experiments. 
Figure 3. Effeet of hypotonie shoek on FMl-43 surface membrane staining. 
A. Confocal FMI-43 fluorescence images of confluent A549 cells after 20 min of 
dye loading in isotonie solution, followed by 50% hypotonie shock stimulation. The 
images depict the xz scans of the cell monolayer at different time points. Note the 
increase in cell size and fluorescence intensity consistent with hypotonie shock-
induced cell swelling and heightened bulk exocytosis. 
B. Time-course of FMI-43 plasma membrane fluorescence and cell height changes 
during hypotonie shock. 
Figure 4. Effeet of ionomyein on FMl-43 surface membrane staining. 
A. Confocal FMI-43 fluorescence images of confluent A549 cells prior to and after 
4-min exposure to 5 J.!M ionomycin in the presence of extracettutar calcium. The 
images show the the xz scans of the cell monolayer at different time points. Note the 
increase in fluorescence intensity after ionomycin stimulation, indicating enhanced 
exocytosis. 
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B. Time-course of FM 1-43 plasma membrane fluorescence changes of unstimulated 
cells (~ CON), and cells during ionomycin treatment in the presence (. ION) or 
absence (. ION 0 Ca) of extracellular calcium. 
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3.1.3 FUrther unpublished results 
The A549 cell line has characteristics of alveolar type II (AT II) cells (see 
page 253) whose primary function is to synthesize and secrete surface-active 
material. AT II cells contain typical organelles such as mitochondria, ER, 
microperoxisomes, various filaments and microtubules, as weIl as unique or-
ganelles referred to as lamellar bodies (LB), which contain layers of sur-
factant [1681. Pulmonary surfactant forms a thin monolayer at the air-water 
interface of the alveolar epithelium and reduces surface tension in the alveoli. 
In addition, i t also plays a role in the protection against infection (see page 2). 
Structurally, surfactant is a homogenous material consisting of rv 80% sat-
urated and unsaturated glycerophospholipids (mainly phosphatidylcholine 
(PC)), rv 12% neutral lipids (predominantly cholesterol) and rv 8% proteins 
(predominantly surfactant proteins SP-A, SP-B, SP-C, SP-D, but also en-
zymes and other proteins) 11691. Whereas the secretion of phospholipids was 
shown to be mediated solely by the exocytosis of LBs [170], the secretion of 
N-ethylmaleimide-
sensitive fusion 
protein blockage 
Inhibition of vesicle 
formation with 
monensin 
Disassembling of 
Goigi-complex with 
brefeldin A 
Microfilament 
disruption with 
cytochalasin D 
Microtubule 
disruption with 
nocodazole 
Figure 3.1: Seleeted steps of the seeretory pathway and their inhibitors 
Munc18, mammalian homologue of une-18; NSF, N-ethylmaleimide-sensitive 
factor; SNAP-25, synapto-somal-assoeiated protein of 25 kDa 
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proteins seems to be more complex. While the small hydrophobie polypep-
tides SP-B and SP-C are localized inside the LBs and co-secreted with the 
LB contents, the large hydrophilic proteins SP-A and SP-D are secreted in a 
LB-independent manner [171, 172]. 
Since the principal release mechanism of ATP from A549 cells upon hypotonie 
shock was shown to be vesieular (see section 3.1.2), the question arises if ATP 
might be released as a by-product from LBs or rather by a LB-independent 
pathway. In order to be able to discuss this question, the different steps of the 
secret ory pathway will first be outlined in general terms. The experiments 
examining the secretory steps leading to ATP release will then be analysed 
in comparison with the biogenesis of LBs and the release of surfactants. 
Fig. 3.1 on page 73 depicts selected steps and pro teins of a typical secretory 
pathway: the smooth ER, rich in a wide variety of enzymes, is involved in the 
synthesis of lipids, triglycerides, and steroids, whereas the rough ER is the 
site of the synthesis of (secretory) proteins. Some secretory products are then 
transported to the Golgi apparatus (GA) where they are modified (e.g. by 
glycosylation, phosphorylation) and sorted [173]. ATP and other nucleotide 
derivatives, which are required as energy source or as substrates for protein 
modification, are transported into both of these organelles, the ER and the 
GA, through specifie transporters in exchange for the analogous monophos-
phate [174]. The vesicles destined for secretion are transported and stored 
close to the plasma membrane, ready to be released upon an appropriate 
signal [173]. The fusion of the vesicles with the plasma membrane involves 
many different proteins (see section 1.2.2, page 22) of which only three are 
presented in the figure (SNAP-25, Munc18, NSF). 
The significance of the particular steps in the secretion process depends on 
the cell type and varies between the different secretory products. In or-
der to compare cell-swelling induced ATP release form A549 cells with the 
LB-dependent secret ory pathway in AT II cells, various inhibitors, such as 
brefeldin A (BFA), monensin, nocodazole, cytochalasin D and N-ethylmaleimide 
(NEM), which interfere with the secret ory pathway, were used. Their targets 
and functions are indicated in fig. 3.1 on page 73. 
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Table II; Peak and total release of ATP after interfering with the secret ory 
pathway 
Agent 
Brefeldin A 
Monensin 
Nocodazole 
Cytochalasin D 
N -ethylmaleimide 
Il Peak ATP releaseG 
59 ± 7c 
19 ± 8C 
42 22 c 
33 ± 6c 
6 ± 4C 
"Data are mean ± S.D. as percentage of control. 
bnumber of experiments 
cp < 0.05 
Total ATP releaseG n b 
81 3c 3 
45 15c 3 
56 20 c 3 
56 5c 4 
8 6c 4 
BFA was previously used by Osanai et al. [175, 176] to study the involvement 
of the GA in protein and lipid trafficking to the LBs in cultured AT II cells. 
The disruption of the GA by BFA (2.5 - 10 J-lg/ml for 15 min) completely 
blocked protein secretion but did not alter PC secretion. It was, furthermore, 
demonstrated that PC was transported to the LB via a Golgi-independent 
and SP-B via the Golgi-dependent pathway. It appears, therefore, that sur-
factant components take different pathways to reside in the LBs. 
Fig. 3.2a on page 77 shows the time course of cell-swelling induced ATP re-
lease from A549 cells after the incubation with BFA (10 J-lg/ml for 2.5 h). The 
peak was reduced to 59 7% and the total amount to 81 3% (cf. table II). 
This result indicates that the major part of released ATP originates from a 
source that by-passes the GA, suggesting an at least partly LB-dependent 
pathway. 
Monensin alters, on the one hand, protein transport in association with ultra-
structural changes in the GA. In this regard, treatment of AT II cells from rat 
lung with monensin (lJ-lM for 1 h) was found to inhibit the rate of sialylation 
and secretion of SP-A [177]. On the other hand, the effect of monensin seems 
to be also related to its fun ct ion as H+ ionophore by collapsing H+ gradients 
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of acidic compartments (see 274). For instance, a normal posttranslational 
proteolysis of proSP-C occurs in acidic intracellular compartments, includ-
ing LBs, and is inhibited by monensin (2 J.LM for 1 h) [178]. Chander et 
al. reported that LBs maintain an acidic interior (pH 6.1 or lower) which is 
generated by an energy dependent pro cess [179]. 
The pretreatment of A549 cells with monensin (10 J.LM for 18 h) strongly 
reduced ATP peak secretion upon 50% hypotonic shock to 19 ± 8% and the 
total amount to 45 ± 15% (cf. table II, page 75 and fig. 3.2b, page 77). 
Considering that the majority of ATP release occurs on a GA-independent 
pathway (see BFA), it seems unlikely that the strong effect of monensin is 
only caused by the inhibition of the trans GA function. The reduction could 
have been, moreover, caused by ATP depletion from the LBs due to the 
attempt to counteract the uncoupled H+ flux and to maintain the pH gradi-
ent. Should this be, indeed, the case, the strong inhibition of ATP release 
by monensin wou Id speak in favour of a LB-dependent ATP release path-
way. Further experiments with agents that induce an elevation of vacuolar 
pH could clarify this point. Since a reduction of cytosolic ATP could also 
affect the amount of mechanism-independent ATP secretion, monensin and 
aIl other agents were tested for a potential influence on the intracellular ATP 
level. For this purpose, the treated cells were washed twice with cold PBS 
and lysed in a 0.1 M NaOHjO.5 mM EDTA mixture. The cell lysates were 
incubated at 60 0 C for 20 min and frozen at _20 0 C. The ATP levels were 
measured by the standard luciferinjluciferase assay. None of the agents was 
found to influence the intracellular ATP level of A549 cells under the exper-
imental conditions (data not shown). 
The cytoskeletal elements (microfilaments and microtubules) have two op-
posite roI es in respect to vesicle secretion: one advancing secretory vesi-
cles toward the plasma membrane and the other impeding vesicle fusion 
with the plasma membrane by forming a physical barrier. In AT II celIs, 
a microtubule-based mechanism delivers LBs to the plasma membrane [180] 
and a su bplasmalemmal actin filament system forms a mechanical hindrance 
that has to be transiently depolymerized to allow LB membrane fusion and 
CHAPTER 3. ARTICLES: MECHANISM OF ATP RELEASE 
50% Hypotonie shock 
350 50% Hypotonie shoek 
500 300 
<1> <1> 250 
., 400 <II 
Sl <Il .91 200 ~ 300 l!! 
a. ---control a. 
~ -'-BFA ~ 150 200 
100 
100 1 50 
0 0 
-5 5 10 15 -5 5 10 15 
... 
<1> 200 
'" 
., 
<1> 
~ 150 
a. 
l-
ca: 100 
50 
0 
-5 
Time [min] 
(a) Brefeldin A 
~·-control 
-. - nocodazole 
5 10 15 
Time[min] 
250 
:ll-
<Il 
., 
~ 150 
a. 
~ 100 
50 
Time [min] 
(b) Monensin 
---control 
-.- cytochalasln D 
5 10 
Time[min] 
(c) Nocodazole ( d) Cytochalasin D 
250 
tU 200 
'" <Il
.91 
~ 150 
a. 
~ 100 
50% Hypotonie shock 
-·-control 
-.- N-ethylmaleimide 
500j,--~==---,~------,==;---, 
r-' ............. --------------
• i ~ ~ 
Time[min] 
(e) N -ethylmaleimide 
15 
Figure 3.2: Time-course of ATP release after interfering with the secretory 
pathway 
ATP release unit: [pMolesj (min. 106 conf!.. cells) J, (see section 2.2.2) 
77 
CHAPTER 3. ARTICLES: MECHANISM OF ATP RELEASE 78 
exocytosis [181]. 
The exposure of A549 cells to nocodazole (20 p,M for 18 h), which disassem-
bles microtubules, led to a reduction of peak ATP release to 42 ± 22% and of 
total ATP release to 56 ± 20% (cf. table II, page 75 and fig. 3.2c, page 77). 
These data indicate the involvment of microtubules in the translocation of 
ATP containing vesic1es to the site of exocytosis and support the hypothesis 
that hypotonically released ATP might be a co-secretagogue of surfactant 
from LBs. 
The role of actin filaments in the pro cess of surfactant secretion from AT 
II cells was previously examined among others by the application of cy-
tochalasins. These studies gave, however, controversial results since both a 
reduction as well as an increase in the release of surfactant was measured 
[182, 183]. This inconsistency may be explained with the limited specificity 
of cytochalasins binding to different cellular target sites. The complex inter-
action with the microfilament network might result rather in a redistribution 
of actin than in its disassembling [184, 185]. In A549 cells, the exposure to 
cytochalasin D (2 p,M for 18 h) inhibited the peak of ATP release to 33±6% 
and the total amount of ATP release to 56 ± 5% (cf. table II, page 75 and 
fig. 3.2d, page 77) indicating an involvment of microfilaments in celI-swelling 
induced ATP release. 
The two results indicate that ATP release upon 50% hypotonie shock from 
A549 cells depends on an intact microtubular system as well as on functional 
microfilaments for a well-controlled exocytotic process. ATP is, thus, medi-
ated by the microtubule-microfilament system, similar to surfactant release. 
Little is known about the molecular machinery that regulates the exocytosis 
of lamellar bodies [172]. Only recently, components of the vesicle fusion ma-
chinery of AT II cells have been identified. These include SNARE proteins 
synaptobrevin-2, syntaxin-1, soluble NSF attachment proteins SNAP-23 and 
SNAP-25 [186], as well as the N -ethylmaleimide sensitive fusion protein 
(NSF) and o:-SNAP proteins, which disassemble SNARE complexes [187]. 
NEM has been, furthermore, found to interfere with the transport of pro-
teins from the ER on account of a NEM-sensitive component distinct from 
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the NSF [188, 189] and to have stimulatory and inhibitory effects on various 
ion channels [190]. 
The incubation of A549 cells with the thiol-alkylating agent NEM (1 mM for 
15 min) almost completely blocked cell-swelling induced ATP release, only 
leaving 6±4% of its peak and8±6% of its total amount (cf. table II, page 75 
and fig. 3.2e, page 77) demonstrating the substantial contribution of exo-
cytosis to the ATP release mechanism. NEM-inhibited ATP release might, 
however, not only be a result of a direct interference with the fusion process 
on the plasma membrane, but also of an interference with sorne intracellular 
pro cesses and/or with potentially other release pathways. 
In conclusion, these experiments give an interesting insight into the exocy-
totic pathway responsible for cell-swelling induced ATP release from A549 
cells. It seems that ATP is released in big part as a co-secretagogue of sur-
factant in a LB-dependent pathway. The partial inhibition of ATP release 
with BFA suggests that both a GA-dependent pathway, accountable for SP-
B transport to the LBs, and a GA-independent pathway, accountable for PC 
transport to the LBs, contribute to cell-swelling induced ATP secretion. The 
strong inhibitory effect of monensin on ATP release might only be partially 
a result of GA disruption. It could be, moreover, explained by a direct ac-
tion on the acidic LBs as a H+ ionophore, leading to ATP depletion over the 
effort to maintain the pH gradient. Finally, the cytoskeleton was shown to 
play an important, however, not yet defined role in ATP-release. So far, no 
conclusions can be drawn as to the implication of a LB-independent path-
way. More experiments are necessary to confirm and to further analyse the 
proposed pathways and sorne of them are suggested in the following points: 
• All specified inhibitors were applied in the above discussed experiments 
in a relatively high concentration and for a rather long period of time. 
It could be, therefore, interesting to repeat the experiments with con-
centrations and incubation times similar to the ones used for the studies 
of surfactant secretion. This would make it easier to compare the two 
sets of data. 
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• Information about the co-released products upon hypotonie shock could 
clarify the relative contribution of LB-dependent and LB-inde pendent 
pathway of ATP release. For this purpose, the perfusate aliquots could 
be analysed for their content of surfactant components by HPLC com-
bined with a matrix-assisted laser desorption/ionization mass spec-
trometer (HPLC-MALDI-MS), in addition to the ATP concentration 
by the luciferin/luciferase assay. 
• To verify the suggested hypothesis for the inhibitory effect of mon-
ensin on ATP release, the intralamellar pH could be increased by aci-
dotropic agents (e.g. NH4CI, methylamine, chloroquine, amantadine) 
followed by a stimulation of ATP release. The incubation time should 
be relatively long to allow a potential intralamellar ATP depletion (see 
incubation time of monensin) without affecting cell viability. 
• To further examine the role of the cytoskeleton in cell-swelling induced 
ATP release, various other agents, which have a well-defined effect on 
the cytoskeleton (e.g. jasplakinolide, latrunculin A), could be tested 
for their impact on ATP release. 
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3.2 ARTICLE 2: Ca2+ -dependent ATP release 
from A549 cells involves synergistic 
autocrine stimulation by co-released uridine 
nucleotides 
3.2.1 Preamble 
Section 3.1 deals with the analysis of nucleotide co-release from A549 cells 
upon hypotonie shock and confirms a Ca2+ -dependent exocytotic release 
mechanism. 
The objective of this research was to specify the origin(s) of the intracellular 
Ca2+ elevation and to further analyze the components of the Ca2+ signal 
leading to the exocytosis of ATP. 
3.2.2 ~rticle 
Tatur, S.j Groulx, N.; Orlov, S.N.; Grygorczyk, R. 
Ca2+ -dependent ATP release from A549 cells involves synergistic autocrine 
stimulation by co-released uridine nucleotides. Journal of Physiology - Lon-
don, 584(2):419-435, October 2007. 
Reproduced on pp. 82-133 with permission. 
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SUMMARY 
Extracellular A TP is a potent surfactant secretagogue but its origin in the 
alveolus, its mechanism(s) of release and regulatory pathways remain unknown. 
Previously, we showed that hypotonie swelling of alveolar A549 cells induces Ca2+_ 
dependent secretion of several adenosine and uridine nuc1eotides, implicating 
regulated exocytosis. In this study, we examined sources of intracellular Ca2+ 
([Ca2+]j) elevation evoked by acute 50% hypotonie stress and the role of autocrine 
purinergic signaling in Ca2+-dependent ATP release. We found that ATP release does 
not directly involve Ca2+ influx from extracellular spaces, but depends entirely on 
Ca2+ mobilization from intracellular stores. The [Ca2+]j response consisted of slowly-
rising elevation, representing mobilization from thapsigargin (TG)-insensitive stores 
and a superimposed rapid spike due to Ca2+ release from TG-sensitive endoplasmic 
reticulum (ER) Ca2+ stores. The latter could be abolished by hydrolysis of 
extracellular triphospho- and diphosphonuc1eotides with apyrase; blocking 
P2Y 21P2Y 6 receptors of A549 cells with suramin; blocking UDP receptors (P2Y 6) 
with PPADS; emptying TG-sensitive stores downstream with TG or caffeine in Ca2+_ 
free extracellular solution; or blocking the Ca2+-release inositol 1,4,5-triphosphate 
receptor channel of the ER with 2-aminoethyl diphenylborinate. These data 
demonstrate that the rapid [Ca2+]j spike results from the autocrine stimulation of 
IP3/Ca2+-coupled P2Y, predominantly P2Y6, receptors, accounting for ~70% of total 
Ca2+ -dependent A TP release evoked by hypotonie shock. Our study reveals a novel 
paradigm in which stress-induced A TP release from alveolar cells is amplified by the 
synergistic autocrine/paracrine action of co-released uridine and adenosine 
nuc1eotides. We suggest that a similar mechanism of purinergic signal propagation 
operates in other cell types. 
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INTRODUCTION 
Extracellular nucleotides, such as A TP and UTP, are important autocrine-
paracrine mediators in most tissues. In the distal lung, A TP is a potent secretagogue 
that stimulates type II cell surfactant secretion (Rooney, 2001). In the airways, 
through interactions with purinergic receptors, ATP, UTP, UDP, and adenosine 
control the volume of airway surface liquid by regulating transepithelial ion transport 
rates (Lazarowski et al., 2004), activating cilia beating (Geary et al., 1995) and mucin 
secretion (Lethem et al., 1993) and thereby mobilizing the mucociliary clearance 
process that removes noxious materials from the airways. Despite the physiological 
relevance of responses triggered by extracellular nucleotides in the lungs, little is 
known about their origin on the epithelial surface and the release pathways. 
Increasing evidence suggests that extracellular A TP functions as a stress-responsive 
molecule, and mechanically-induced ATP release is a cell-regulated process that does 
not involve cell lysis. In particular, mechanical stresses, such as stretch, shear, media 
change or osmotic stress, have been shown to evoke A TP release from many cell 
types. Except in freshwater drowning, lung epithelia are seldom exposed to hypotonic 
shock. It represents, however, an experimentally-convenient and frequently-used 
surrogate of mechanical stress, with which it shares many common characteristics, 
including induction of A TP release, transient cytoskeleton reorganization, 
intracellular Ca2+ ([Ca2+]j) elevation and stimulation of other signaling pathways 
(Koyama et al., 2001). We have shown recently that swelling-induced ATP release 
from lung alveolar A549 cells, bronchial epithelial 16HBE140- cells and NIH 3T3 
fibroblasts tightly correlates with [Ca2lj elevation, indicating the involvement of 
Ca2+-dependent exocytosis (Boudreault & Grygorczyk, 2004a). We also 
demonstrated that besides ATP, significant amounts of ADP, UTP and UDP are co-
released from A549 cells by hypotonic shock (Tatur et al., 2007). Mechanical stresses 
and hypotonic cell swelling are known to induce elevations of [Ca2+]j, which may 
involve Ca2+ influx from extracellular spaces and/or mobilization from intracellular 
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stores. Furthermore, once released, extracellular nucleotides cou Id have paracrine-
autocrine effects on metabotropic P2Y receptors expressed on the surface of airway 
epithelia. Because stimulation of P2Y receptors is coupled to elevation of [Ca2+]i, it 
may lead to nucleotide-induced enhancement of A TP release. Indeed, A TP-induced 
A TP release from astrocytes, cou Id play a role in Ca2+ wave propagation (Anderson 
et al., 2004). 
In this study, we investigated hypotonie stress-induced A TP release from 
A549 cells and exat:nined the role of Ca2+ influx and mobilization from intracellular 
stores. We also examined the contribution of the autocrine effects of released 
nucleotides on [Ca2+]i signaling and ATP release. 
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METHons 
Cells 
Human lung carcinoma A549 cells were grown in Dulbecco's Modified Eagle 
Medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 56 UlmL 
penicillin-G and 56 flg/mL streptomycin sulfate. AlI culture media constituents were 
from GIBCO-BRL (Burlington, ON). ATP efflux was measured from cell 
monolayers grown to confluence (- 500 cells*mm-2) on 24x60 mm glass coverslips. 
Cell volume was quantified from cells plated at low density on 22x22 mm glass 
coverslips, white Fura-2 calcium imaging experiments were performed with cells 
grown on circular 15-mm diameter glass coverslips. 
Solutions and chemicals 
Physiological isotonie solution (IS) contained (in mM): 140 NaCI, 5 KCl, 1 
MgCh, 1 CaCh, 10 glucose and 10 TES, pH 7.4, adjusted with NaOH. 50% 
hypotonie saline (HS) was prepared by reducing NaCI concentration to 70 mM white 
keeping divalent cation concentration constant. In sorne control experiments, 
solutions with the same reduced NaCI content were used, while iso-osmolarity was 
maintained by adding 140 mM mannitol. Osmolarity of the solutions was checked 
with a freezing point osmometer (Micro Osmometer 3300, Advanced Instruments 
Inc., Norwood, MA) and was 316 mOsm for IS, 161 mOsm for HS and 316 mOsm 
for HS with added mannitol. For studies in the absence of extracellular calcium 
([Ca2+]o), CaCh was omitted and the solutions were supplemented with 0.1 mM 
ethylene glycol-bis(l3-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) to chelate 
trace Ca2+. Ali reagents, including Pluronic® F127 and probenecid, were obtained 
from Sigma-Aldrich Canada, Ltd., Oakville, ON. For calcium imaging", Fura-2-AM 
was procured from Invitrogen-Molecular Probes, Kingston, ON. Apyrase (2 U/ml), 
bafilomycin (1 flM), glycyl-L-phenyl-B-naphthylamid (GPN, 100 flM), 
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carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP, 10 !-lM), suramin (100 
!-lM) as weIl as modulators of [Ca2+]j, 2-aminoethyl diphenylborinate (2-APB, 75 
!-lM), caffeine (l0 mM), ruthenium red (100 !-lM) and thapsigargin (TG, 1 !-lM), were 
purchased from Sigma-Aldrich Canada, Ltd. 6-N,N-Diethyl-f3,y-dibromomethylene-
D-adenosine-5'-triphosphate (ARL 67156) was bought from Calbiochem (San Diego, 
CA). ln general, the cells were pre-treated for 30 min in IS with the indicated 
concentration of the test compound. The experiments were th en conducted in the 
absence of the inhibitor in case of bafilomycin, GPN and TG. By contrast, 2-APB, 
caffeine, ruthenium red, and suramin were also present during A TP efflux 
experiments by including them in the perfusate solutions. Thus, they were also 
present in perfusate aliquots used to evaluate A TP content by luciferase 
bioluminescence. Therefore, al! these compounds were tested for their ability to 
directly interfere with luciferase bioluminescence (see below). 
ATP efflux assay 
A TP efflux during hypotonie challenge was measured with high temporal 
resolution using a custom-designed, low-volume (325 f.tL), flow-through chamber, as 
described previously (Boudreault & Grygorczyk, 2004a). Briefly, a 24x60 mm 
coverslip with confluent cell monolayer was mounted in the chamber and perfused 
with a warm (37°C/in-line SF-28 heater, Wamer Instrument Co., Hamden, CT) 
solution at 1.3 mL/min. After an equilibration period in IS (5-15 min), 50% hypotonic 
shock was applied by HS perfusion (t=O), and the perfusate was co!lected 
continuously at 30-s intervals during the initial burst of A TP secretion (0-5 min) and 
every 1 min thereafter. A TP in the samples was quantified by a luciferase-Iuciferin-
based assay, using A TP Assay Mix and A TP Assay Mix Dilution Buffer supplied by 
Sigma-Aldrich Canada, Ltd. ATP release rates were expressed in pmol/(min* 106 
cells). Total ATP release was calculated by summing aIl ATP values collected, 
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starting from the application of hypotonie shock until the release rate returned to 
baseline, typically after about 15 min. 
AIl test compounds that were added to the extracellular solution during the 
A TP efflux experiments were also examined for their ability to directly interfere with 
luciferase bioluminescence. We found strong inhibition of bioluminescence by 
suramin (see inset in Figure SA), moderate by caffeine, and weak by 2-APB. The 
color of ruthenium red-containing solution also interfered with bioluminescence 
detection and contributed to inaccuracies in ATP evaluation. To correct for these 
inhibitory effects, calibration of luciferase-Iuciferin luminescence versus A TP 
standards was always performed in the presence of these reagents. 
Statistical significance was determined by paired (-test, and P < 0.05 was 
considered significant. 
[ctl+); measurements 
For [Ca2+]i measurements, cells were loaded (1 h, room temperature) with 10 
~ Fura-2-AM in physiological solution containing 0.02% Pluronie® F127 and 2.5 
mM probenecid, followed by a 30-min de-esterification period in IS containing 
probenecid and the desired inhibitor (see below). For fluorescent imaging, a coverslip 
with Fura-2-loaded cells was mounted in an imaging/perfusion chamber (RC-20, 
volume 48 J.lI) attached to a heated platform (P-5, Wamer Instrument Co.) on the 
stage of an inverted microscope (Nikon TE300). The imaging chamber was perfused 
continuously with a warm solution (37°C) via an in-tine heater (SF-28, Warner 
Instrument Co.) at -0.5 ml/min. The cells were iIluminated for 100 ms with alternate 
Iight wavelengths of 340 and 380 nm, using a high-pressure mercury lamp (100 W) 
via interference filters (Chroma Technology, Brattleboro, VT) mounted on a filter 
wheel (Sutter Lambda IO-C, Sutter Instrument Co., Novato, CA) and a dichroic 
mirror (510/540 nm, Chroma Technology Corp., Brattleboro, VT). Fluorescence 
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images were recorded at 15-s intervals with the digital camera and stored for later 
analysis. Fura-2 measurements are presented as the fluorescence F340/F380 ratio. In 
sorne experiments, to chelate intracellular Ca2+, cells were loaded with BAPTA-AM 
(25 IlM) for 30 min at room temperature in physiological solution. 
Ali test compounds that were added to the extracellular solution during Ca2+_ 
imaging experiments were examined for their potential interference with Fura-2 
fluorescence. To do so, control cell-free experiments were performed with Fura-2 
solution in the cuvette, and fluorescence was measured in the presence and absence of 
the test compound at 340 nm and 380 nm excitation wavelengths with a SPEX 
FluoroMax spectrofluorimeter (Edison, NJ, USA). Only ruthenium red affected 
fluorescence noticeably and was, therefore, not used in [Ca2+]i imaging experiments. 
Cell volume evaluation 
To evaluate the volume changes of substrate-attached cells, we deployed an 
upgraded version of the 3D imaging technique described in our previous work 
(Boudreault & Grygorczyk, 2004b;Groulx et al., 2006). Briefly, the method involves 
3D reconstruction of cell shape based on cell images acquired in two perpendicular 
directions. Side-view and top-view cell images were acquired at 10- to 60-s intervals 
prior to hypotonic challenge and at 5- to 30-s intervals during the challenge, to 
closely foIlow rapid ceIl volume changes. The 3D topography of the ceIl surface was 
reconstructed by a dual image surface reconstruction technique (Boudreault & 
Grygorczyk, 2004b). This technique generates a set of topographical curves of the 
cell surface from its digitized profile and base outline. Cell volume, surface and 
height were calculated from such a reconstructed cell topographical mode!. Ali 
calculations were carried out entirely with MatLab (MathWorks, Inc., Natick, MA). 
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RESULTS 
We previously showed that hypotonie stress-induced ATP release from A549 
cells was triggered by [Ca2Ji elevation, but the sources and mechanism of Ca2+ 
mobilization were not determined. In this study, we examined the contribution of 
different intracellular Ca2+ stores to hypotonie stress-evoked [Ca2+]i responses and 
their role in triggering A TP release from A549 cells. We also investigated the 
involvement of [Ca2+]i signaIs resulting from autocrine purinoreceptor stimulation by 
secreted nucleotides. Throughout this study, the kinetics of ATP release, [Ca2+]i 
responses and cell volume changes evoked by acute 50% hypotonie stress were 
measured in parallei experiments. 
Role of extra cellular Ca2+ 
We first examined the role of Ca2+ influx from the extracellular spaces in 
hypotonie shock-evoked A TP release and [Ca2+]i responses. Under control 
conditions, with 1 mM CaCh in the extracellular solution, 50% hypotonie shock 
rapidly increased the A TP release rate, reaching a peak at approximately 2 min and 
followed by decay that lasted approximately 15 min, before retuming to baseline 
(Figure lA). To abolish calcium influx from the extracellular spaces, experiments 
were carried out with nominally Ca2+-free extracellular solutions containing 0.1 mM 
EGT A to chelate any trace of Ca2+. Wh en the cells were perfused with a Ca2+ -free IS 
for up to 10 min, the kinetics and amount of released A TP, induced by subsequent 
application of a Ca2+-free HS, were indistinguishable from those observed in parallel 
control experiments performed in the presence of Ca2+ (Figure 1 A). Longer, up to 40 
min, pre-incubation in Ca2+-free IS slightly altered the time course of hypotonie 
shock-evoked ATP release, reducing the peak and total amount of secreted A TP, but 
the changes remained statistically insignificant. These experiments demonstrated that 
hypotonie shock-induced A TP release does not directly require Ca2+ influx from the 
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extracellular spaces, but depends entirely on Ca2+ mobilization from intracellular 
stores. 
Figure 1 B shows the typical [Ca21j response of A549 cells to 50% hypotonie 
shock with Ca2+ present in extracellular solution. The response, represented by the 
Fura-2 fluorescence F34o/F38o ratio, consisted of a slow, pre-spike elevation initiated 
at the onset of hypotonie shock (t = 0), lasting approximately 0.5 min (see inset in 
Figure lB), and followed by a rapid 'spike at about 1.5 min. After the peak, [Ca2+]j 
decayed to a level that was significantly above baseline. This sustained [Ca21j 
elevation lasted as long as the cells remained in HS (at least 20 min) and returned to 
baseline only after re-perfusion with IS. Thus, kineticaIly, it appears that the [Ca2+]j 
response to hypotonie shock consists of two superimposed components, a slowly-
rising response that includes the pre-spike and post-spike sustained elevation, and a 
rapid spike (see also Figures 2B and 3 below). Figure IC examines the impact of 
extraceIlular Ca2+ removal on basal [Ca2+]j under isotonie conditions and its response 
to 50% hypotonie shock. During short (3-5 min) incubation in Ca2+-free IS, basal 
[Ca2+]j decreased slowly, consistent with a steady Ca2+ leak from the extracellular 
spaces, but the subsequent response to Ca2+-free HS remained unaffected (data not 
shown). However, longer (> 1 0 min) incubation in Ca2+ -free IS graduaIly reduced the 
peak [Ca2+]j response to HS, and after 30-40 min incubation, it was significantly but 
not completely diminished (Figure 1 C). Interestingly, the pre-spike and sustained 
post-spike [Ca21j elevation remained almost unaffected in these experiments. The 
results suggest that the rapid [Ca2+]j spike induced by hypotonie shock is due to Ca2+ 
mobilization from intracellular stores, which are graduaIly depleted during ceIl 
incubation in Ca2+-free solution. In contrast, the slow component of the [Ca2+]j 
response remained unchanged even after prolonged Ca2+-free incubation and, thus, 
likely represents Ca2+ mobilization from different intracellular source(s). 
The fact that prolonged Ca2+-free incubation significantly reduced the rapid 
[Ca2+]j spike but had no effect on ATP release suggests that part of the ATP response 
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is Ca2+-independent, or that the remaining [Ca2+]i signal is sufficient to trigger a full 
A TP response. Indeed, the latter seems to be the case, because BAPT A chelation of 
intracellular Ca2+ almost completely abolished both [Ca21i elevation and A TP release 
induced by 50% hypotonie shock (Figure ID). This experiment confirms the 
conclusion of our previous study that hypotonie shock-induced A TP reJease from 
A549 cells depends entirely on [Ca2+]i signaling (Boudreault & Grygorczyk, 2004a). 
Interestingly, we noticed that residual [Ca2+]i and A TP responses to hypotonie shock 
varied between individual experiments, likely reflecting the variable efficiency of 
BAPTA loading and/or the spatiotemporal dependence of intracellular Ca2+ buffering 
by BAPT A in A549 ceUs. 
In our experiments, we applied hypotonie shock by perfusing cells with a HS 
made by reducing NaCI content. When the cells were presented with a solution of the 
same reduced NaCI content but with iso-osmolarity kept constant with added 
mannitol, no responses were observed (Figure lE). This result demonstrates that 
[Ca2+]j and A TP release responses evoked by HS are caused by reduced osmolarity 
and not by changes in ionic strength. During 50% hypotonie shock, cell swelling 
reached a peak at 2-3 min; this was followed by a regulatory volume decrease (RVD) 
(Figure IF). Removal of extracellular Ca2+ may change the kinetics of cell swelling 
or RVD, and could thus contribute to altered [Ca2+]i responses. To verify this, cell 
volume changes evoked by 50% hypotonie shock were investigated in Ca2+_ 
containing and Ca2+-free solutions. As Figure IF shows, the kineties, extent of 
hypotonie swelIing and subsequent RVD in A549 cells were not different in the 
presence or absence of extracellular Ca2+. 
Role of TG-sensitive Co!+ stores 
To examine, in more detail, the nature of the intracellular Ca2+ stores 
contributing to the complex [Ca21i response induced by hypotonie shock, we applied 
pharmacological tools acting on specifie stores or release mechanisms. The 
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endoplasmic reticulum (ER), the most eminent and active Ca2+ store in most cells 
(Brini & Carafoli, 2000), was the first target of our investigation. In Ca2+ -containing 
IS, acute addition of TG (1 ~M), a specifie, irreversible inhibitor of the sarco-ER 
Ca2+ pump (SERCA) (Thastrup et al., 1990), produced significant Ca2+ mobilization. 
However, despite large [Ca2+]j responses, it induced only negligible A TP release 
(Figure 2A). When the cells were pre-treated with TG (1 ~M) for 30 min in Ca2+-free 
IS to empty the intracellular Ca2+ stores, and then challenged by Ca2+-free HS, the 
rapid [Ca2+]j spike was completely abolished, while the slow component of the [Ca2+]j 
response remained unaffected (Figure 2B, top panel). Thus, it confirms that the rapid 
spike and the slow component of the hypotonie shock-induced [Ca2+]j response 
represent Ca2+ mobilization from two different stores, one of which is TG-sensitive 
and the other TG-insensitive. The peak rate of hypotonie shoek-indueed ATP release 
from TG-treated cells was significantly reduced to 42 ± 8% of that observed with 
control, untreated cells (n = 6; Figure 2B, lower panel). As a result, total A TP release 
was also reduced but to a lesser degree (62 ± 3% of control, Table 1). These data also 
indicate that both ci+ stores contributed to ATP release; the rapid [Ca2+]i spike 
involving TG-sensitive stores was c10sely correlated with the rapid peak of A TP 
release. However, with cells having their TG-sensitive stores depleted, hypotonie 
shock induced only a slowly-rising [Cili response, representing Ca2+ mobilization 
from TG-Însensitive stores, and a significantly slower rate of A TP release was 
observed (Figure 2B, lower panel). 
Using 30 cell imaging, we also verified that swelling and the RVO of TG-
treated cells were similar to those seen with untreated cells (n 4, data not shown). 
Therefore, the effects of TG treatment on ATP release cou Id be entirely attributed to a 
specifie action of TG on Ca2+ signaling. 
Two major types of Ca2+-release receptor channels, ryanodine (RyR) and 
inositoI 1,4,5-trisphosphate (IP3R), may be invoIved in Ca2+ mobilization from TG-
sensitive stores such as the ER (Galione & Churchill, 2002). Cell pre-treatment (30 
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min, 37°C) with caffeine (10 mM), or 2-APB (75 !lM), modulators of RyR and IP3R 
respectively, had a similar effect on [Ca2+]j responses to Ca2+-free hypotonie shock as 
TG, Le., they completely abolished the rapid Ca2+ mobilization spike, while the 
slowly-rising component remained unaffected (Figure 3, top panel). These two 
compounds also diminished the peak rate of A TP release to 56 ± 4% and 58 ± 6% of 
control values, respectively (Figure 3, bottom panel). Table 1 summarizes the effects 
of several RyR and IP3R modulators on A TP secretion induced by 50% hypotonie 
shock in Ca2+-containing and Ca2+-free solutions. It confirms that both RyR and IP3R 
play a role in this process. From Table 1, it is also apparent that simultaneous 
application of TG, caffeine and 2-APB did not completely abolish A TP secretion. 
The residual ~30% of total A TP release was therefore due to Ca2+ mobilization from 
TG-insensitive Ca2+ stores. When the ER-Ca2+ store modulators (TG, 2-APB, 
caffeine, ruthenium red) were tested in the presence of extracellular Ca2+, the time-
course of cell swelling-induced ATP release displayed larger variability, with a 
slightly higher peak and a shallower decline, compared to experiments performed in 
the absence of extracellular Ca2+ (data not shown). This could be attributed to Ca2+ 
entry via store-operated plasma membrane Ca2+ channels (SOC), such as Trp 1 and 
Trp6, which are expressed in A549 cells (Brough et al., 2001 ;Xue et al., 2000). 
However, the difference in total A TP released remained statistically insignificant (see 
Table 1). It should be remembered, however, that most of the pharmacological 
modulators in our study have limited specificity, e.g. 2-APB likely has many targets 
affecting not only IP3R-mediated Ca2+ release but also Ca2+ influx via SOC, 
phospholipase C (PLC) activity and IP3 production (Padar et al., 2005). 
Role of extracellular ATP degradation and autocrine effects of secreted nucleotides 
To minimize the hydrolysis of secreted A TP by ecto-nucleotidases, our A TP 
release experiments were carried out in a custom-made flow-through chamber 
(internaI volume = 325 !ll), which was continuously perfused at the rate of 1.3 
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ml/min, providing complete solution replacement in the experimental chamber every 
-15 s. This allowed us to maintain the bulk A TP concentration in the chamber below 
100 nM, even at the peak of A TP secretion (Boudreault & Grygorczyk, 2004a). This 
approach, however, may not completely prevent A TP degradation or the autocrine 
effects of secreted nucleotides. If ecto-nucleotidases are located in close proximity to 
A TP release sites, a significant fraction of extracellular A TP could be hydrolyzed 
before it is washed away from the cellular surface. Furthennore, the local cell surface 
concentration of A TP and other co-released nucleotides may go much higher than in 
the bulk perfusate, and may thus be sufficient to activate P2Y receptors. To assess the 
extent of A TP degradation at the cell surface in our experiments, release was studied 
in the presence of 100 JlM ARL 67156, an A TP analog and selective inhibitor of 
ecto-A TPases, which shows 300-fold greater selectivity for ecto-A TPase versus P2Y 
receptors (Drakulich et al., 2004;Berra-Romani et al., 2004). As Figure 4 
demonstrates, ARL 67156 significantly enhanced A TP content in perfusate aliquots 
and, at the peak, the rate of A TP release observed in the presence of ARL reached 
146 ± 5% of control values (n=4, Table 2). Thus, in the absence of ARL 67156, 
despite continuous perfusion, a significant fraction of secreted A TP was hydrolyzed 
by cell surface ecto-ATPases. However, we did not notice the contribution of secreted 
nucleotidases to A TP degradation in our experiments, because A TP concentration in 
perfusate aliquots remained stable at room temperature for at least 1-2 h after 
collection. 
We have previously reported that upon hypoosmotic challenge, several other 
nucleotides besides ATP are secreted from A549 cells, in particular, significant 
amounts of UTP and UDP have been detected (Tatur et al., 2007). These nuc1eotides 
may have autocrine/paracrine effects by acting on P2Y and P2X receptors. However, 
the contribution of ionotropic Na +- and Ca2+-permeable P2X receptors to the 
autocrine effects is unlikely, because the responses were independent of Ca2+ influx 
from the extracellular spaces, as demonstrated in Figure 1 above. Therefore we 
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focused on P2Y 2 and P2Y 6 receptors that were found on the AS49 cell surface 
(Schafer et al., 2003;White & Bumstock, 2006;Xue et al., 2000). Activation of these 
IP3/Ca2+-coupled receptors could provide a positive feedback loop, where nucleotide-
induced [Ca2+]i elevation could further enhance Ca2+-dependent nucleotide release, a 
mechanism similar to A TP-induced A TP release reported in astrocytes (Anderson et 
al., 2004). To investigate this possibility, [Ca2+]i responses and ATP release induced 
by hypotonic shock were examined in the presence of 100 !lM suramin, a nonspecific 
P2Y receptor antagonist. Figure SA (top panel) shows that the peak [Ca2li response, 
representing release from TG-sensitive stores, was drastically reduced in the presence 
of suramin. The peak rate and cumulative A TP release were also significantly 
reduced to 10 ± 1 % and 32 ± 21 % respectively of control values (Figure SA, bottom 
panel and Table 2). The reduction of A TP release could not be attributed to the strong 
inhibitory effect of suramin on luciferase bioluminescence reaction, because this was 
corrected by using suramin-containing ATP standards (see inset in Figure SA). Thus, 
the above experiments strongly suggest that the autocrine stimulation of P2Y 
receptors and the IP3/Ca2+ signaling pathway contribute significantly (~70%) to ATP 
secretion evoked by hypotonic shock. This was further confirmed in experiments 
performed in the presence of apyrase (2 U/ml; 30°C), an enzyme which hydrolyzes 
the triphospho- and diphosphonucleotides (Figure SB, left panel). The rapid [Ca2+]i 
spike, which represents Ca2+ mobilization from TG-sensitive stores, was almost 
completely abolished, demonstrating that it was, in fact, evoked by the autocrine 
effects of rapidly-secreted extracellular tri- and diphosphate nucleotides acting on 
P2Y receptors. These experiments also showed that secreted nucleotides are 
susceptible to hydrolysis by exogenously-added apyrase. When similar experiments 
were performed with hexokinase (10 to 20 U/ml; 30°C), which, in the presence of 10 
mM glucose, effectively converts nucleotide triphosphates (ATP, UTP) into 
diphosphates (ADP, UDP) (Lazarowski et al., 1997), no effect on the peak [Ca2li 
response was observed (Figure SB, right panel). Ifhexokinase was indeed effective in 
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removing nucleotide triphosphates in these experiments, the result may suggest that 
autocrine stimulation of the peak [Ca2+]i response cou Id be attributed mainly to UDP, 
acting on the P2Y6 receptor, and/or ADP, acting on the P2YJ receptor, while UTP, 
ATP acting on the P2Y2 receptor seems to play a less prominent role. We addressed 
this point further in the experiments presented below. 
Because of the wide and nonspecific effects of suramin (Zhang et al., 1998), 
to examine the involvement of P2Y!, P2Y2 and P2Y6 receptors more explicitly, we 
tested their known antagonist and agonists. Figure 5C shows that PPADS, a more 
specific P2Y 6 receptor antagonist, aboli shed the hypotonic shock-induced peak 
[Ca2+]i response and strongly inhibited peak ATP release (by ~76%), effects that were 
similar to that of suramin and consistent with the prominent ro le of P2Y 6 receptors. In 
the absence of hypotonic shock, direct bulk addition of 10 J,tM UDP, a selective P2Y6 
receptor agonist, or 100 IlM UTP, a selective P2Y 2 receptor agonist, induced a 
significant [Ca21i response but small ATP release, which at the peak amounted only 
to ~ 1 % to 6 % respectively, compared to that induced by 50% hypotonie shock 
(Figure 5D and E). We also verified that contaminating A TP levels in 100-IlM UTP 
and 10-JlM UDP samples were negligible «0.1 nM), assuring that A TP detected in 
the perfusate indeed originated from UTP- or UDP-induced cellular A TP release. 
Exogenous ATP, which is equipotent with UTP at P2Y2 receptors, also induced a 
significant [Ca2+]i response (Figure 5F, left panel). These results confirm that both 
P2Y2 and P2Y6 receptors are functionally expressed in A549 cells. Recently, the 
presence of UDP-glucose (UDP-glc)-specific P2Y I4 receptors was reported in A549 
cells (Muller et al., 2005). In our hands, however, 10 IlM UDP-glc did not evoke any 
detectable [Ca21i responses in A549 cells (Figure 5F, left panel), suggesting that 
P2Y 14 receptor expression may vary between different laboratories, e.g., due to 
different number of celI passages or culture conditions. Interestingly, 10 J,tM ADP or 
2-MeSADP, a P2Y 1 receptor agoni st, evoked a strong, although transient, short-
lasting «1 min) [Ca2+]i spike (Figure 5F, right panel). Such a transieIit response is 
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consistent with the reported fast desensitization of P2Y] receptors observed in other 
cell types (Palmer et al., 1998). To deterrnine if the P2Y] receptor significantly 
contributes to autocrine [Ca2li responses during hypotonic shock, hexokinase 
experiments, such as those in the Figure 5B (right panel), were repeated in the 
presence of the P2Y 1 receptor antagonist A3P5PS (1 J.lM). We found no effect of the 
antagonist on the hypotonic shock-induced [Ca2li response in these experiments (not 
shown), demonstrating that P2Y l receptors do not contribute significantly to the 
autocrine effects noted in our study. 
Collectively, the above results confirrn that A549 cells express functional 
P2Y 2 and P2Y 6 receptors and, in addition, suggest thefunctional expression of P2Y 1 
receptors. Although ail three receptors are functionally present, only P2Y 6 seems to 
play a prominent role in autocrine [Ca2+]i signaling during hypotonie shoek-evoked 
nucleotide release. 
Role of TG-insensitive Ca1+ stores 
The above experiments demonstrated an important role of purinoreeeptor-
mediated Ca2+ mobilization from TG-sensitive Ca2+ stores in hypotonie shoek-
induced ATP release. Here, we investigated the role of the TG-insensitive part of the 
[Ca2+]i response, whieh is seen as a slowly-rising, sustained component during 
hypotonie shoek (see e.g., Figures 2B and 3). Acidic eompartments, sueh as 
lysosomes, are being recognized as a part of TG-insensitive Ca2+ stores (Galione & 
Churchill, 2002); therefore, we examined the effect ofbafilomycin, an inhibitor ofthe 
Iysosomal H+-Ca2+ exehanger, and GPN, whieh disrupts lysosomal organelles. Both 
of these agents did not affect the peak rate or total A TP released from A549 cells 
induced by hypotonie shoek (Table 1), demonstrating that TG-insensitive Ca2+ 
mobilization in A549 cells involves stores other than aeidie-Iysosomal compartments. 
Next, we examined the modulators of mitoehondrial funetion: FCCP, a proton 
ionophore whieh depolarizes the inner mitoehondrial membrane and reduees the 
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electrochemical driving force for Ca2+ uptake, and oligomycin, inhibitor of F IIFO 
A TP synthase. Figure 6A shows that both modulators were without effect, suggesting 
that mitochondria also do not contribute to the TG-insensitive Ca2+ response evoked 
by hypotonic shock. 
The actin cytoskeleton is known to regulate diverse cellular processes, 
including secretion and Ca2+ signaling. Sorne studies even suggest that the actin 
cytoskeleton itself may be part of intracellular Ca2+ stores (Janmey et al., 1998;Lange 
& Brandt, 1996;Lange, 1999). We, therefore, explored the possibility that in our 
experiments the actin cytoskeleton may function as a TG-in sensitive Ca2+ store. To 
perform such studies in isolation from TG-sensitive stores, the contribution of the 
latter was eliminated by pre-treating cells with TG in Ca2+-free solution for 30 min to 
completely empty them. We found that disruption of actin filaments with latrunculin 
had no effect on hypotonic shock-induced, TG-insensitive Ca2+ responses or on 
corresponding A TP release (Figure 6B). Disruption of actin filaments with 
cytocholasin D was also without effect (data not shown). Similarly, induction of actin 
polymerization with jasplakinolide had no effect on the Ca2+ response, while ATP 
release showed only slightly slower kinetics, with the peak rate and total A TP release 
not being affected significantly (Figure 6B and Table 1). In contrast, in control cells 
not treated with TG, cytocholasin D had a significant (~70%) inhibitory effect on 
ATP release (Table 1). Thus, the intact cytoskeleton has an important role in 
modulating A TP release from cells with functional TG-sensitive stores. However, it 
has no direct role in Ca2+ storage and mobilization from TG-insensitive stores and 
corresponding A TP release. 
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DISCUSSION 
The present study examined different sources of [Ca2+]i elevations induced by 
acute hypotonie stress in A549 cells and their role in stimulating Ca2+ -dependent A TP 
release. We found that ATP release depends entirely on Ca2+ mobilization from 
intracellular stores. Both TG-sensitive and TG-insensitive stores are involved, 
contributing approximately 70% and 30% respectively to total A TP released by 
hypotonie shock. Importantly, we also found that despite rapid perfusion of the 
experimental chamber, autocrine stimulation of P2Y receptors by co-released uridine 
and adenosine nucleotides plays a major role in amplifying the initial hypotonie 
stress-induced [Ca2+]i response and further promoting ATP release. 
Two eomponents of the [Ca2+fï response to aeute hypotonie stress 
The [Ca2+]i response induced by acute 50% hypotonie shock in A549 cells 
consisted of two superimposed, kinetically-different components. Both were due to 
Ca2+ mobilization from intracellular stores, while Ca2+ influx from extracellular 
spaces was not directly involved. The rapid [Ca2+]i spike originated from Ca2+ 
mobilization from TG-sensitive stores, such as the sarco- endoplasmie reticulum, and 
was abolished when the stores were depleted by blocking SERCA with TG, or by 
activating RyR Ca2+ release channels with caffeine, under Ca2+-free conditions to 
prevent refilling the stores. Antagonists of IP3R (2-APB) and RyR (ruthenium red) 
also inhibited the [Ca2+]i spike and A TP release (Table 1), indicating that Ca2+ 
mobilization via both channels plays a role in triggering A TP secretion. RyR may 
contribute to the propagation of [Ca21i signaling via cyclic ADP-ribose and Ca2+_ 
induced Ca2+ release mechanism (Galione & Churchill, 2002). Interestingly, full 
inhibition of the rapid [Ca2+]i peak by 2-APB, a non-competitive IP3R Ca2+ release 
channel antagonist (Figure 3), suggests that this component of the hypotonie shock-
induced [Ca21i response results from activation of plasma membrane receptor(s) that 
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couple with the IP3/Ca2+ signaling pathway. Indeed, autocrine activation of P2Y 
purinoreceptors was confirmed in a further study, and is discussed below. 
The absence of the rapid spike after pre-treatment with TG revealed the 
slowly-rising [Ca2lj component originating from a TG-insensitive intracellular 
source. Beside the ER, the mitochondria and the nucleus appear to be crucial for the 
generation of Ca2+ signaIs of high spatiotemporal complexity (Brini & Carafoli, 
2000). However, both organelles are implicated in the buffering and uptake of 
cytosolic Ca2+ rather than initiating and extending Ca2+ signaling (Brini & Carafo li , 
2000). Hence, they are unlikely to be responsible for the TG-insensitive part of the 
hypotonic shock-induced Ca2+ signal. Indeed, the modulators of mitochondrial 
function, FCCP and oligomycin, were without effect on the TG-insensitive Ca2+ 
response to hypotonic shock. Furthermore, experiments with bafilomycin and GPN, 
which interfere with the Ca2+-storage capability of acidic compartments, showed that 
they are not involved in triggering ATP release, suggesting the involvement of Ca2+ 
stores different from acidic lysosomal compartments. Interestingly, even prolonged 
~40-min absence of extracellular Ca2+ had no effect on the slow [Ca2+]j component, 
indicating that TG-insensitive stores may not be of an organellar nature and 
prompting us to examine the hypothesis that actin may act as a non-organellar Ca2+ 
store (Lange & Brandt, 1996;Lange, 1999). However, our experiments with agents 
that promote either actin polymerization or depolymerization were without significant 
effect on hypotonic shock-induced Ca2+ mobilization from TG-insensitive stores and 
corresponding A TP release. Thus, the nature of this slow [Ca2+]j response component 
remains incompletely understood. 
Earlier reports with other cell types showed that [Ca2+]j elevations caused by 
hypotonic shock could either result from Ca2+ influx across the plasma membrane 
and/or from Ca2+ release from internaI stores (McCarty & O'Neil, 1992;Sanchez et 
al., 2003;Tinel et al., 2000;Wu et al., 2001;Wu et al., 1997). In our experiments, Ca2+ 
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influx did not play a direct role in either the slow or rapid peak of the [Ca2+Ji response 
to acute hypotonie shock, although the prolonged absence of extracellular Ca2+, led to 
partial depletion of TG-sensitive stores and reduction of the rapid [Ca2+]i peak. These 
differences may be due to the different cell types studied and experimental 
conditions. Our experiments were petformed with substrate-attached cells at 37°C, 
while some other studies utilized ceUs in suspension or at room temperature. Because 
the rapid peak of [Ca2li responses results from the autocrine/paracrine purinergic 
loop in A549 cells, other factors may include the differential expression of P2Y 
receptors, differences in nucleotide release and the expression of different plasma 
membrane Ca2+-permeable channels. 
Ca2+ and ATP release. 
Our previous study demonstrated a tight correlation between [Ca2+Ji 
elevations and ATP release in A549, 16HBE140' and NIH-3T3 fibroblasts during the 
initial ~5 min of hypotonie stress (Boudreault & Grygorczyk, 2004a). The present 
work shows correspondingly that maneuvers which eliminated the rapid [Ca2li spike 
also significantly reduced the rate of A TP release. Complete emptying of TG-
sensitive stores by pharmacological maneuvers reduced, by up -70%, the total A TP 
release evoked by subsequent 50% hypotonie shock (Table 1). The remaining -30% 
of ATP release could be attributed to the slow [Ca2+Ji signal originating from TG-
in sensitive stores. Interestingly, TG on its own provoked quite significant [Ca2+]i 
elevation, but in contrast to hypotonie shock, induced only minor ATP release. We 
previously observed that the strong [Ca2+]i signal generated by application of the 
Ca2+-ionophore ionomycin produced relatively minor ATP release (Boudreault & 
Grygorczyk, 2004a). Both experiments imply that other factor(s) besides global 
[Ca2+]i elevation modulate A TP release from A549 cells. For example, the 
spatiotemporal dependence of [Ca2li signaling is now a widely recognized feature of 
this universal second messenger, which restricts the Ca2+ action to specifie 
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intracellular microdomains, allowing the fine control of cell function (Oheim et al., 
2006;Spat, 2006). Thus, relatively minor A TP release might indicate that A TP release 
sites are distant from TG-induced Ca2+ mobilization sites. Moreover, besides Ca2+, 
other signaling pathways not investigated in this study have been implicated in the 
regulation of A TP release, including tyrosine kinase, RhofRho kinase and PB-kinase 
(Grygorczyk & Guyot, 2001 ;Koyama et al., 2001). 
Sorne studies found that onJy a fraction of hypotonie shock-induced A TP 
release could be inhibited by loading cells with intracellular Ca2+ chelator BAPT A-
AM, which suggests a Ca2+-independent release mechanism (Okada et al., 2006). 
Mobile Ca2+ buffers, such as BAPT A, provide an efficient mechanism to spatially 
restrict the [Ca2+]j increase (Oheim et al., 2006), but its efficiency in preventing Ca2+_ 
triggered vesicular exocytosis will critically depend on the distance between Ca2+ 
release sites and secretory vesicles. Ca2+ transients might be highly localized, 
reaching as high as 5 ).lM to 30 ).lM at submembrane microdomains (reviewed in 
(Oheim et al., 2006). Thus, despite a high Ca2+-binding rate, BAPTA may not 
completely prevent localized [Ca2+]i increases. This may be especially the case for 
highly-differentiated primary epithelial cells, where secretory vesic1es may co-
localize with submembrane Ca2+ stores. Further studies are required to explore the 
effectiveness of BAPTA in preventing hypotonie shock-induced submembrane 
[Ca2+]j transients and A TP release from such cells. 
Role of the autocrine/paracrine loop in ATP release 
Our data demonstrate that the rapid [Ca2+]i peak induced by hypotonie shock 
results entirely from the autocrine/paracrine effects of released nuc1eotides acting on 
IP3/Ca2+ signaling pathway-coupled P2Y receptors. This conclusion is supported by 
the following experimental evidence. The rapid [Ca2Jj peak could be almost 
completely aboli shed by: (i) the hydrolysis of extracellular triphospho- and 
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diphosphonueleotides with apyrase, but not hexokinase; (ii) bloeking P2Y reeeptors 
with the non specifie P2Y receptor antagonist suramin; (iii) bloeking the P2Y6 
reeeptor with its more specifie antagonist PPADS, but not the P2Y1 reeeptor 
antagonist A3P5PS; (iv) blocking the ER Ca2+-release IP3R channel with its 
antagonist 2-APB downstream of the P2Y receptor; or (v) eompletely emptying ER 
stores with TG or eaffeine. 
We have reeently reported that several adenine and uridine nucleotides are 
transiently released from A549 cells in response to hypotonie shoek (Tatur et al., 
2007). Importantly, apart from ATP, significant amounts of UTP, UDP and ADP 
could be deteeted in eell perfusates (A TP > UTP > UDP > ADP). Therefore, released 
nucleotides, by interacting with their specifie receptors, cou Id contribute to 
autocrine/paracrine signaling in A549 cells. In this study, by investigating [Ca2+]j 
responses to the bulk addition of UTP, ATP, or UDP, we confirmed the functional 
expression of P2Y 2 and P2Y6 receptors respectively (Clunes & Kemp, 1996;Zhao et 
al., 2000), but not UDP-glc-specific P2Y14 receptors (Muller et al., 2005) in A549 
eells. Interestingly, we also found evidence for the functional expression of the ADP 
receptor P2YI. Based on their functional presence, we eoncIude that, in princip le, the 
three P2Y receptor subtypes may contribute to the autocrine effects of released 
nucleotides. In partieular, the involvement of P2Y 6 reeeptor was further confirmed by 
using its more specifie antagonist PPADS, which almost completely abolished the 
hypotonie shoek-induced rapid [Ca21i peak and signifieantly diminished A TP 
release, while the P2Y 1 reeeptor antagonist A3P5PS had no deteetable effeet on the 
rapid [Ca2+]j response. This suggests an important role for P2Y 6 receptor in the 
autocrine/paracrine loop. The relative contribution of P2Y 2 reeeptors could not be 
independently determined in complementary experiments because selective P2Y2 
receptors antagonists are not available commercially. However, complementary 
support that P2Y6 but not P2Y2 receptors are the main players in the autocrÏne [Ca2+]i 
response was provided by experiments with apyrase and hexokinase. Apyrase, by 
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hydrolyzing nucleotide tri- and diphosphates, eliminates the agonists of both P2Y 2 
and P2Y 6 receptors, completely abolishing the peak [Ca2+]i response. However, 
hexokinase, which eliminates only agonists of P2Y 2 receptors by converting UTP and 
ATP into UDP and ADP (Lazarowski et al., 1997), had no noticeable effect. 
Based on our data, we propose the following mechanism of hypotonie shock-
induced A TP release. Upon hypotonie shock, initial Ca2+ mobilization likely occurs 
from TG-insensitive stores, seen as the slowly-rising pre-spike in Figure 1 B. This 
initial [Ca2+]i elevation triggers the vesicular exocytosis of adenosine and uridine 
nuc1eotides which, via autocrine/paracrine activation of Gq protein-coupled P2Y 
receptors, stimulates the PLC/IP3 signaling pathway, leading to subsequent activation 
of IP3R Ca2+ release channels of the ER. At this point, Ca2+ -inducd Ca2+ release via 
RyR will also contribute to [Ca2+]i signal propagation. The enhanced [Ca2+]i signal, 
seen as the rapid [Ca2li spike in Figure lB will, in turn, further promote Ca2+_ 
dependent A TP release. Such nucleotide-promoted nuc1eotide release likely leads to 
almost full depletion of exocytosis-available vesicular pools in A549 cells, since after 
~5 min, the rate of A TP release does not tightly correlate with the [Ca2li signal any 
longer. As a result, after the initial peak, the rate of ATP release decays towards 
background, despite significantly elevated [Ca2li (Boudreault & Grygorczyk, 
2004a;Grygorczyk & Boudreault, 2005). 
The proposed mechanism might be a general scheme of hypotonie or 
mechanical stress-induced A TP release from other cell types, although the specifie 
players of the autocrine loop may vary, depending on the type of P2Y receptor 
expressed by a given cell and its ability to release different adenosine and uridine 
nuc1eotides. In the particular case of A549 cells, UDP acting on P2Y 6 receptors seems 
to have a prominent role. As exemplified by the effect of the ecto-A TPase inhibitor 
ARL in our experiments, extracellular nuc1eotide metabolism, and possibly their 
interconversion, may also have an important role in regulating nuc1eotide release and 
autocrine signaling and requires future investigation. Our findings may have 
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interesting implications for the regulation of surfactant secretion by alveolar type II 
cells. Although the stimulatory effect of stretch and involvement of P2Y 2 receptors in 
surfactant secretion are well-established (Dietl & Haller, 2005;Rooney, 2001), the 
contribution of other P2Y receptors remains unclear. Our study suggests an important 
role of P2Y 6 receptors in synergistic autocrine/paracrine stimulation of the IP3/Ca2+ 
signaling pathway after stress-induced nucleotide release from A549 cells, a modei of 
type II pneumocytes. The resulting amplification and spatiotemporal extension of the 
[Ca2ii signal may influence severa} steps of surfactant secretion, including lameHar 
body fusion, pore-opening and surfactant dispersion (Dietl & Haller, 2005). 
In summary, our study demonstrates an important role of autocrine purinergic 
signaling in hypotonic stress-induced A TP release. The autocrine loop amplifies the 
initial stress-evoked Ca2+ response, accounting for the majority (-70 %) of released 
A TP. Our study aiso provides a novel paradigm in which stress-induced A TP release 
from alveolar A549 cells is amplified predominantly by the autocrine/paracrine action 
of co-released UDP acting on P2Y6 receptors. We propose that such synergistic 
effects of co-released nucleotides may be a general mechanism of purinergic signal 
propagation and amplification in other ceIl types. 
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Table 1. 
Peak ATP release Total A TP release 
Agent [Ca·1o Absence of [Ca21" [CaL1o Absence of [CaL+] 0 
Action % of control n P % of control n P % of oonlro1 ij P % of control ± n P 
±SD ±SD ±SD SD 
2-APB IP3R inhibition 70±2 3 <0.05 58±6 3 <0.05 108 ± 1 < 0.05 
Caffeine RyR stimulation 65 ± 12 6 v.VJ 56±4 3 <0.05 60 ± 15 6 
Ruthenium Red RyR inhibition 51 ±4 3 v.VJ 'J :1::> 3 <0.05 72±5 3 <0.05 75 ± 12 > 0.05 
• Thapsigargin (TG) ER-Caz+ -pump inhibition 44± 14 7 < 0.001 42±8 6 < 0.001 94±31 6 >0.05 62±3 < 0.001 
2-APB + caffeine 31 ±9 3 <0.05 30±6 <0.05 
+TG 
Bafilomycin Ca2+-Wexchanger 104± 9 3 > 0.05 98±3 3 >0.05 
inhibition 
GPN lysosome disruption 105 ± 28 3 > 0.05 108 ± 13 3 >0.05 
BAPTA [Caz+]i chelating agent 10 ± 2 3 <0.05 Il ± 2 3 <0.05 
Cytochalasin D inhibition of actin 33 ±6 3 <0.05 56± 5 3 <0.05 
polymerization 
%ofTG± %ofTG±SD 
SD 
Jasplakinolide + induction of actin 97 ± 15 3 >0.05 135 ± 10 3 > 0.05 
TG polymerization 
Latrunculin A + disruption of micro fila- 88±9 3 >0.05 121 ± 9 3 > 0.05 
TG ment-mediated processes 
Table 2. 
Peak ATP release Total ATP release 
Agent [Ca2Jo [Ca2Jo 
Action % of control ± SD n P % of control ± SD n P 
ARL Ecto-nucleotidase inhibition 146 ± 5 4 < 0.05 
Suramin P2X, P2Y receptor inhibition 10 ± 1 3 < 0.001 32 ± 21 3 < 0.05 
PPADS P2Y 6 receptor inhibition 24± 2 3 < 0.001 35 ± 10 3 < 0.05 
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Table 1. 
Effeet of Ca2+ signaling and eytoskeleton modulators on 50% hypotonie shoek-
indueed A TP release from A549 eells. 
Table 2. 
Modulation of hypotonie shoek-indueed ATP release by selected inhibitors of eeto-
nucleotidases and P2Y receptors. 
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FIGURE LEGENDS 
Figure 1. Role of extraeellular Ca2+ in hypotonie shoek-indueed ATP release, 
[Ca21i and eell volume responses. 
A. Time-course of A TP release induced by 50% hypotonie shock (t = 0) from 
confluent A549 cell monolayers. The data points shown as (.) represent ATP 
eftlux observed with 1 mM Ca2+ present in the perfusate throughout the 
experiment (n = 4). The data points shown as (.) and (~) represent ATP eftlux 
observed in the absence of extracellular Ca2+ when it was removed 10 min and 40 
min before hypotonie shock, respectively (n = 3 and n = 4 respectively). Peak 
and total A TP releases were not significantly different between the three 
experimental groups. 
B. Time-course of the hypotonic shock-induced [Ca21j response in A549 cells in 
Ca2+ -containing HS. The response consisted of a slow pre-spike elevation 
initiated at the onset of hypotonic shock (t = 0), a rapid spike at about 1.5 min, 
and a sustained after-spike [Ca2+]j elevation, which returned to baseline after the 
cells were re-perfused with physiological IS. The inset shows the initial [Ca2+]j 
response acquired with higher temporal resolution, clearly demonstrating the 
existence of a pre-spike. 
C. Effect of extracellular Ca2+ removal on the hypotonic shock-induced [Ca2+]j 
response. The three representative traces (out of n 3 to 4 independent 
experiments) show the Fura-2 fluorescence F34ofF380 ratio response to hypotonie 
shock recorded with Ca2+ present throughout the experiment (.), or after removal 
ofextracellular Ca2+ for 17 min (.) or 40 min (~) before Ca2+-free 50% HS was 
applied. Note the significant reduction of the peak [Ca2+]j response in ceUs 
incubated for 40 min in Ca2+ -free extracellular solution. 
D. The [Ca21i and ATP responses to hypotonie shock are abolished in BAPTA-
loaded (25 !lM, 30 min) cells; representative of n = 3 independent experiments. 
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E. The [Ca2+]j and ATP responses, upper and lower panels, respectively, are evoked 
by reduced osmolarity, not ionie strength. The control traces (e) refer to 
responses triggered by HS that had 50% reduced NaCI content. When the cells 
were perfused with HS complemented with mannitol ta maintain iso-osmolarity 
(see Methods), no responses were observed (.); representative of n = 3 
independent experiments. 
F. 50% hypotonie shock-induced volume responses of single, substrate-attached 
A549 cells in Ca2+-containing (left panel) and Ca2+-free (right panel) solutions. 
Thin fines represent data from individual single-cell experiments, and sofid fines 
represent a fit to the average data (±S.D.; n 3 ta 4). Ccli swelling and RVD were 
similar for bath experimental conditions. 
Figure 2. Modulation of the cell swelling-induced [Ca2+h response and ATP 
release by TG. 
A. Time course of [Ca2+]j changes (top panel) and ATP release (bottom panel) in 
response to the acute addition of 1 )lM TG in Ca2+-free IS. Each trace is 
representative of 3 independent experiments. 
B. Top panel: Hypotonic shock-induced [Ca2+]i response in TG-treated cells, 
representative of 4 independent experiments. Bottom panel: Hypotonie shock-
induced A TP release from TG-treated cells, representative of 6 independent 
experiments. (e) refers to control cells incubated for 30 min in Ca2+-free 
solution prior ta the experiment, and (T) refers to cells incubated for 30 min in 
Ca2+-free solution containing 1 )lM TG. 
Figure 3. Role of RyR and IP3R in the cell swelling-induced [Ca2+]j response and 
ATP release. 
Hypotonic shock-induced [Ca2+]j response (top panel) and ATP release (bottom 
panel) in caffeine (T) and 2-APB (.) pre-treated cells. Representative traces are 
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shown out of n 3 independent experiments; control (.) refers to the [Ca2li response 
in untreated ceUs. Ali experiments were performed in Ca2+-free solutions. 
Figure 4. B10cking ecto-ATPases enhances peak ATP release. 
Effect of the ecto-ATPase inhibitor ARL 67156 (100 f.1M) on hypotonie shock-
induced A TP release. Control experiments (.) were performed in the presence of 
[Ca2l o without the addition of inhibitor; (.) represents the time course of ATP 
release in the presence of [Ca2+]o and ARL. Representative traces out of n 4 are 
shown. 
Figure 5. Role of autocrine/paracrine purinergic signaling. 
A. Effect of hypotonie shock on [Ca2+]j (top panel) and A TP release (bottom panel) 
after blocking purinergic receptors with suramin ( ... ); (.) refers to the control 
response in the absence of suramin. Representative traces out of n = 3 
independent experiments are shown. Inset in bottom panel: Calibration curve of 
luciferase-Iuciferin luminescence (in relative light units, RLU) versus standard 
ATP concentrations: (.) refers to ATP standards in IS; (0) refers to ATP 
standards in IS containing 100 f.1M suramin. Similar effect of suramin on 
luciferase-Iuciferin luminescence was observed in HS. 
B. Effect of apyrase ( ... , left panel), or hexokinase ( ... , right panel) on the hypotonie 
shock-induced [Ca2li response. Apyrase (or hexokinase) was added 3 min prior 
to and throughout hypotonie shock. On each panel, a representative trace out of n 
3 independent experiments is shown. Control (.) refers to untreated cells. Ali 
experiments were performed in the presence of 1 mM extraeellular Ca2+ and at 
30°C, not as usually at 37°C, in accordance with the optimal temperature of the 
enzyme activity. Therefore, the extent of peak reduetion by apyrase at 37°C 
might be slightly different. 
CHAPTER 3. ARTICLES: MECHANISM OF ATP RELEASE 119 
C. Effect of the P2Y6 receptor antagonist PPADS on hypotonie shock-induced ATP 
release and the [Ca2Jj response. 100 IlM PPADS was added to cells 30 min 
before the application of hypotonie shock and was present throughout the 
experiment were performed in Ca2+-containing solutions. For each condition, a 
representative experiment out of n = 3 is shown. (.) refers to untreated cells, and 
(.) refers to PPADS-treated cells. 
D. Effect of 10 IlM UDP, a P2Y6 agonist, on the [Ca2Jj response (representative of 
n 3) and ATP release (average ± S.D. of n = 3), top and bottom panels, 
respectively. 
E. Effect of 100 IlM UTP, a P2Y2 agonist, on the [Ca2+:h response (representative of 
n = 3) and ATP release (average ± S.D. of n = 3), top and bottom panels, 
respectively. 
F. Left panel: Effect of 10 IlM A TP (.), a P2Y2 agonist, and 10 IlM UDP-glc (.), a 
P2Y 14 agonist, added at t 0, on the [Ca2+]j response. Note that UDP-glc had no 
effect, although the cells did respond robustly to the subsequent addition of UTP 
(.). Right panel: 10 IlM ADP or 2-MeSADP, agonists ofP2Y1 receptors, evoked 
short-lasting [Ca2+]i tesponses that were kinetically different from those observed 
for other nucleotides, shown in D and E. For these experiments, ADP was pre-
treated with lOU/mI of hexokinase in the presence of 10 mM glucose for 1 h at 
room tempe rature to remove any contaminating ATP and UTP. For each 
condition, a representative experiment out of n = 3 is shown. 
Figure 6. Role of mitoehondria and aetin in the TG-insensitive [Ca2+]i response 
to hypotonie shoek. 
A. Effect of FCCP and oligomycin (OM), on the hypotonie shock-induced [Ca2+]j 
response. Cells were pre-treated for 30 min with 10 IlM FCCP + 1 IlM TG, or 10 
IlM OM + 1 IlM TG, in Ca2+-free IS for 30 min prior to the experiment. 
Experiments were performed in the absence of extracellular Ca2+. (.) refers to 
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TG-treated cells, (.) refers to FCCP + TG-treated cells, and (v) refers to OM + 
TG-treated cells. For each condition, a representative experiment out of n 3 is 
shown. 
B. Effect of jasplakinolide (JASP), an inducer of actin polymerization, and 
latrunculin A (LA), a microfilament-disrupting agent, on the hypotonie shock-
induced [Ca2ii response (top panel) and ATP release (bottom panel). The cells 
were pre-treated for 2 h with 1 !lM JASP, or 1 h with 1 !lM LA, and with 1 !lM 
TG for 30 min in Ca2+-free IS prior to the experiment. Experiments were 
performed in the absence of extracellular Ca2+. (.) refers to TG-treated cells, (.) 
refers to LA + TG-treated cens, and ( ... ) refers to JASP + TG-treated cells. For 
each condition, a representative experiment out of n 3 is shawn. 
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A. 
0.93 15 + Thapsigargin 
15 
1i! 
~ 0.90 
Il. 
0.87 
0 5 10 15 
~100 
IS + Thapsigargin ~ 
.li.! 15 B 
QI"" </1 c: 
!II 8 
Je'" I!! ;: 50 
~ ~!: 
«.5.. 
« 
tI) 
..!2 
0 
E 
..e. 
0 
0 5 10 15 
Time [min] 
CHAPT ER 3. ARTICLES: MECHANISM OF ATP RELEASE 
B. 
-5 
-5 
0.82 50% Hypotonie shoek 
0.80 
-.-eontrol 
0.78 
- ... - pre-treated with TG 
0.76 
0.74 
o 5 10 15 
~ 200 50% Hypotonie shoek 
~ ~-------------------------~ 
150 
o 5 
Time [min] 
10 15 
126 
CHAPTER 3. ARTICLES: MECHANISM OF ATP RELEASE 
-5 
Figure 3 
50% Hypotonie shock 
-.-control 
-,,- caffeine 
-·-2-APB 
o 5 10 15 
50% Hypotonie shock 
~ 3004---------------------------
- . 
8 250 e'\ ~ .g 1 • -.- control 
CIl 8 200 • '. -,,- caffeine 
i "'e 1 ~ -.-2-APB Il. Oc 150 ~ §. .. . ~ 100 / J" ... ~., . 
o /." ... ", ~-. 
E e "'.... 'e_ 
.E. --- -. "~~=!:.=.=.=.-I 
-5 0 5 10 15 
Time [min] 
127 
CHAPTER 3. ARTICLES: MECHANISM OF ATP RELEASE 128 
Figure 4 
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3.2.3 Further unpublished results 
The origin of the thapsigargin (TG)-insensitive Ca2+ -elevation was further 
analyzed in the context of sorne publications reporting that various cell types 
responded to osmotic challenge with changes in intracellular pH (pHi) and 
that these changes were associated with alterations in intracellular Ca2+ [191, 
192]. 
When A549 cells were exposed to a 50% hypotonic solution, they responded 
with a short rise and a subsequent slow decrease in pHi to about pH 6.9. As 
soon as the cells were reperfused with isotonic solution (18), the pHi returned 
to its initial value of about pH 7.1 (see Fig. 3.3, page 134). The ce Ils were 
next exposed to 1 /LM ionomycin and to isotonic solutions containing 40 
mM sodium acetate (NaOAc) or 20 mM NH4CI (in exchange to NaCI), and 
intracellular Ca2+ as weIl as pHi alterations were measured by ratiometric 
imaging (see section 2.3). 
Figure 3.3: Time-course of intracel-
lular pH and Ca2+ upon application 
of a 50% hypotonie shock; represen-
tatives of n = 3 independent exp er-
iments each 
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AIthough the intracellular Ca2+ level increased very strongly upon treatment 
with ionomycin, a Ca2+ -ionophore (see page 272), the corresponding pHi al-
teration was very small and rather negligible (see Fig. 3.4, page 134). In 
contrast, intracellular alkalization as well as acidification with NH4Cl and 
NaOAc also evoked intracellular Ca2+ alterations (see Fig. 3.5, page 135). 
It has to be considered that the observed alterations in the intracellular Ca2+ 
level associated with the pHi changes IDight be an artifact of a pH-dependence 
of the Ca2+ -affinity to Fura-2, even though the fluorochrome has been con-
sidered relatively insensitive to pH changes [1641. However, an acidification 
would protonate Fura-2, decrease thereby its Ca2+ -binding ability and di-
minish the magnitude of Ca2+ -bound fluorescence as weIl as the associated 
fluorescence ratio - an effect opposite to that which was actually observed. 
To be able to interpret the observed responses of A549 ce Ils to NH4CI and 
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to N aOAc, the physiological role of these mole cules will be briefly reviewed 
in the following two paragraphs: 
The Ammonium Cation, NHt, is produced in the body during amino acid 
catabolism [193]. It is a weak acid (NHt + H20 ;::::± NH3 + H30+; pKa = 9.25 
at 25 0 C, pKa = 9.15 at 37 0 C [194]) and appears, therefore, mainly in the 
protonated form as ammonium cation NHt at the physiologic pH range of 
7.1-7.415 . The major metabolic pathway responsible for the removal of NHt 
is the synthesis of nontoxic urea in the liver via the ornithine cycle [193]. 
During the exposure of cells to ammonium salts, the lipophilic free base NH3 
can passively penetrate cell membranes. In the cell, NH3 protonates again 
(NH3 + H20 ;::t NHt + OH-; pKb = 4.75 at 25 0 C [194]) leading thereby 
to an intracellular alkalization. Different cell types show divers responses 
following the uptake of NH3 /NHt. In addition to the effect of NHt on 
metabolism and divers cellular pro cesses (for further information see [195-
199]), NHt was shown to induce an intracellular Ca2+ rise in a variety of cell 
types either from internaI Ca2+ stores or through Ca2+ influx. The increase 
in intracellular Ca2+ was mainly a result of the ammonia-induced intracel-
lular alkalization [200-202]. However, also pH-independent pathways were 
reported, where NH3 /NHt seem to directly affect proteins involved in the 
Ca2+ signalling pathway [203, 204]. 
The Acetate Anion, AcO-, is found in the blood plasma in a concentration of 
< 0.2 mM [205, 206]. After the intake of ethanol, the concentration can ri se 
by as mu ch as 20-fold [207]. Cells take up AcO- from the blood plasma and 
use it either as a source of energy [208, 209] or they transform it to acetyl 
coenzymeA (acetyl-CoA), an activated form of AcO- [210]. 
Free acetate is a week base (AcO- + H20 ;::t AcOH + OH-; pKb = 9.25 
at 25 0 C [194]) and its conjugate acid readily permeates the cell membrane. 
Inside the ce Il , acetic acid deprotonates again and causes thereby an intra-
cellular acidification. In addition to the intracellular acidification, AcO- was 
shown to also induce in sorne cases an intracellular Ca2+ increase. Similarly to 
150nly 1 - 2% exists in the deprotonated form NH3 . 
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NHt, acetate-induced intracellular Ca2+ rise was shown to be triggered either 
through a pH-dependent or through an unknown pH-independent pathway 
[211-213]. 
Obviously, both ions are endogenous substances to whose exposure cells may 
react in various ways. Most important in regard to the present study is the 
observation that both ions evoke in vitro a pHi alteration and a concomitant 
intracellular Ca2+ elevation, which, however, do not necessarily have to be 
interrelated. 
The experiment, in which the intracellular Ca2+ in A549 cells was increased 
with the aid of ionomycin (see Fig. 3.4, page 134), reveals that an intracel-
lular Ca2+ increase only insignificantly altered the pHi. This result indicates 
that - in case of an existing correlation between the pHi alteration and the 
intracellular Ca2+ signal - the pHi should affect the intracellular Ca2+ level 
and not vice versa. 
The exposure of A549 cells to NHt as weIl as the removal of extracellular 
AcO- (see Fig. 3.5, page 135), led to an intracellular alkalization as weIl as to 
a transient increase in intracellular Ca2+ with a relatively fast return to the 
initial baseline after around 3 min. In contrast, the exposure to AcO- as weIl 
as the removal of extracellular NHt led to an intracellular acidification and 
to an increase in intracellular Ca2+, which declines slower than during alka-
lization (removal of NHt) or stays on an elevated level (exposure to AcO -). 
Interestingly, the A549 cells responded to the first stimulus, the exposure to 
NHt (alkalization) or to AcO- (acidification), with a smaller Ca2+ signal 
than to the second stimulus, the removal of NHt (acidification) or AcO-
(alkalization). The differences in the size of the Ca2+ signaIs in response to 
the alkalization upon the exposure to NHt and the removal of AcO-, re-
spectively, may emanate from the fact that in one case the alkalization was 
induced on resting cells and in the other case on already stimulated ceIls; 
the same explanation may apply to the differences in the magnitude of the 
Ca2+ signaIs following intracellular acidification in response to the exposure 
to AcO- and the removal of NHt. 
The described observations indicate a potential pH-dependence of the Ca2+ 
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signal since it seems unlikely that NHt and AcO-, two ions of completely dif-
ferent chemical properties, evoke Ca2+ signaIs whose patterns are of similar 
shape during intracellular alkalization (transient increase) and acidification 
(slow decrease or sustained elevation). Furthermore, the hypothesis that 
NHt and AcO- were responsible for a pH-inde pendent Ca2+ elevation would 
rather imply that only the exposure to these ions induces a Ca2+ increase 
and not their removal. 
In conclusion, the discussed experiments show that a 50% hypotonic shock 
induces a pHi alteration in A549 cells, which is not evoked by the intracellular 
Ca2+ signal. Although there is evidence that the pHi alterations may, in 
turn, induce an intracellular Ca2+ signal in A549 cells, further experiments 
are essential to clarify the possiblity of a pHi-induced thapsigargin-insensitive 
Ca2+ -increase. The follwing experiments could give additional information 
about the interrelation of pHi and the intracellular Ca2+ level: 
1. pHi alterations of different magnitude: 
• The exposure of A549 cells to NHt and AcO- concentrations (5 
40 mM), which induce similar pHi changes, could reveal a possible 
correlation between the magnitudes of the pHi alterations and the 
concomitant Ca2+ signaIs. 
• The application of different ammonium salts (e.g. NHt Cl-, NHt 
AcO-, NHt SO~-, C'{Ht)2 CO~-) would induce pHi alterations 
of different magnitudes while keeping the NHt concentration con-
stant. A resulting Ca2+ signal of equal magnitude in aIl cases 
(except for NHt AcO-) would imply its ammonium-dependence 
and pH-independence. 
2. NHt- and AcO--independent pHi alterations: 
• An intracellular alkalization can be induced with alkylated ammo-
nium derivatives (e.g. tetramethylammonium). If the ammonium-
induced Ca2+ signal was pH-independent, tetraalkylammonium-
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induced alkalization should not trigger any intracellular Ca2+ sig-
nal. 
• The modification of the extracellular pH results, usually, in a par-
allel pHi alteration. A correspondent intracellular Ca2+ signal 
would prove the potentiality of pH-dependent Ca2+ signalling in 
A549 cells. 
• The inhi bi tion of the Na + /H+ exchanger in the A549 plasma mem-
brane with 5-(N,N-dimethyl)-amiloride (DMA) leads to an intra-
cellular acidification [214]. Also in this case, a correspondent intra-
cellular Ca2+ signal wou Id prove the potentiality of pH-dependent 
Ca2+ signalling in A549 cells. 
To examine the thapsigargin-sensitivity of the potentially pH-dependent Ca2+ 
signal, the ab ove mentioned experiments should be carried out on thapsigar-
gin-pretreated cells. To ensure, furthermore, that the pHi alterations do 
not induce any Ca2+ influx from the extracellular fluid, Ca2+ -free solutions 
should be used during the experiments. 
Proof of a pH-dependence of the thapsigargin-sensitive Ca2+ -signal would 
rise the two following questions: 
1. What is the origin of hypotonie shock-induced acidification? 
2. How does the intracellular pH affect the intracellular Ca2+ level? 
Several potential sources of intracellular acidification are known: 
• Mitochondria: uncoupled mitochondria were reported to cause intra-
cellular acidification as weIl as intracellular Ca2+ increase [215]. 
• Na+ /H+ -exchanger (NHE): NHE is known to be a major carrier in-
volved in the regulation of both cytosolic pHi and cell volume [216]. 
• H+-carriers other than NHE: the CI- /HC03"-exchanger or Na+-HC03" 
cotransporter, as weIl as other ion channels were also involved in intra-
cellular acidification [217-219]. 
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Various mechanisms of intracellular Ca2+ elevation due to pHi changes have 
been described as follows: 
• Ca2+ was released from intracellular storages, such as acidic compart-
ments [2201. 
• Ca2+ was released from TG-sensitive compartments, Le. the ER [221, 
222]. 
• Ca2+ -influx was observed through pHi-sensitive Ca2+ -permeable, non-
selective cation channels [223]. 
• A decrease in pH reduced the Ca2+ -binding affinity of EF-hand proteins 
[224] and may thereby increase the cytosolic Ca2+ homeostasis. 
According to section 3.2.2, mitochondria do not play a role in the TG-
insensitive Ca2+ elevation. Moreover, acidic compartments and Ca2+ -influx 
from the extracellular space were aiso excluded from participating in the Ca2+ 
signal. Hence, further experiments are necessary to investigate the other po-
tential origins of pHi decrease and the associated intracellular TG-insensitive 
Ca 2+ increase. 
Part II 
Development of a side-viewing 
technique 
Chapter 4 
Airway surface liquid -
Physiological background 
4.1 Characteristics of the ASL 
The conducting airways (trachea, bronchi, bronchioli) are lined by a thin 
layer of airway surface liquid (ASL), which plays an important role in the self-
cleaning mechanism of the lung - the airway mucus clearance. The efficiency 
of airway mucus clearance depends in large part on the height and the prop-
erties of both of the ASL components, the mucus layer and the underlying 
periciliary liquid layer (PCL). The mucus layer is an adhesive, viscoelastic gel 
generated by secreted high-molecular weight mucins (MUC5AC, MUC5B). 
The viscoelastic properties, and hence the transportability, of this layer are 
determined by the entanglement of the polymeric mucins with "sticker" pro-
teins and, importantly, by the hydration of this layer. This layer entraps 
airborne particles and bacteria, inhibits bacterial growth and biofilm16 for-
mation and protects the airways from fluid loss [226]. At its inner surface, 
the mucus layer interfaces with the PCL layer, which has been reported to 
vary from 7 to 70 p,m in height and was recently suggested to be comprised 
of grafted mucins and other molecules such as cell surface glycolipids [227]. 
This design likely accounts for the important interdependence of the hydra-
16 A biofilm is a complex aggregation of microorganisms highly resistant to antimicrobial 
agents [225]. 
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tion status of the mucus layer and PLC. In the form of grafted brushes, 
it provides, furthermore, very low friction, enabling efficient ciliary beating 
[227, 228]. 
For a long time, ciliary activity and mucin secretion were thought to be 
the principal determinants of airways mucus clearance. While both are very 
important, it is now believed that airway surface hydration is the most im-
portant variable in controlling the efficiency of mucus clearance [229]. The 
dehydration of the ASL and the associated reduction in ASL height causes 
the following impairments: 
• a highly viscoelastic, adhesive mucus layer; and 
• collapse of the PCL, and loss of its lubricant properties that separate 
the mucus layer from the cell surface. 
The combined loss of the PCL lubrication and the increased adhesiveness of 
the mucus layer results in the adhesion of mucus to the airway surfaces [229]. 
4.2 Regulation of the ASL 
The significance of accurate ASL regulation becomes apparent in the genetic 
disease cystic fibrosis (CF) which is characterized by ASL depletion followed 
by mucus stasis and chronic infection [229]. The regulation of ASL height is 
extremely complex, and it is still not completely understood. In normal air-
way epithelia, ASL height is under the control of a finely tuned balance of Na + 
absorption through the apical membrane epithelial Na + channel (EN aC), and 
Cl- secretion, mediated by two apical membrane Cl- channels, the cystic fi-
brosis transmembrane conductance regulator (CFTR) Cl- channel and the 
Ca2+ -activated Cl- channel (CaCC). The tuning of these channels occurs 
through release and metabolism of ATP via a dual purinergic signalling sys-
tem (see section 1.1.2), which is illustrated in Fig. 4.1 on page 144 [227]. 
Under static conditions, airway epithelial cells continuously release a low 
basallevel of ATP (rv 300 fM . cm-2 . min- 1 [230]) to the airway lumen that 
is mostly converted into adenosine by surface ecto-nucleotidases. This basal 
concentration of adenosine (rv 100 nM [230]) on airway surfaces is sufficient to 
Figure 4.1: Dual purinergic signalling pathway for ion transport across the apical membrane of airway epithelial cells 
both pathways control ASL height in normal Lung Epithelia. 
CFTR, cystic fibrosis transmembrane conductance regulator; ENaC, epithelial sodium channel; CaCC, Ca2+ -activated 
CI--channel; CNT, concentrative nuc1eotide transporter; ATP, adenosine 5'-triphosphate; ADP, adenosine 5'-diphosphatej 
AMP, adenosine 5'-monophosphatej cAMP, 3'-5'-cyc1ic adenosine monophosphate; ADO, adenosinej INO, inosinej PIP2 , 
phosphatidylinositol bisphosphate; IP3 , inositol-1,4,5-trisphosphate 
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activate the A2B purinoceptor which generates an intracellular raise of cAMP. 
cAMP, in turn, activates CFTR, which regulates CI- secretion and ENaC 
activity to maintain the homeostatic ASL height on airway surfaces [229]. 
Under stress conditions, such as shear stress and compression, the rate of 
ATP release is greatly increased, raising ATP concentrations in the ASL to 
30-50 nM [229]. This concentration of ATP activates additionally the P2Y2 
receptor-dependent signalling pathway inhibiting Na + absorption and stim-
ulating CaCC-mediated CI- secretion [229]. 
In CF airway epithelia, ASL height regulation depends solely on the ATP-
signalling system which, under static conditions, causes ASL to be absorbed 
to the degree that the cilia collapse onto the airway surface [229]. 
The ability of the airway epithelia to determine ASL height is still an area of 
active investigation and discussion. While for a long time it was thought that 
cilia were somehow involved in sensing ASL height, it is now suggested that 
the concentrations of soluble mediators in the ASL, such as ATP, adenosine, 
and channel-activating proteins are the crucial factors in this process [230]. 
To further study how ASL height is regulated, especiaIly by extracellular 
ATP, a microscopie technique was developed in the course of this Ph.D. 
work that enables a direct observation of the fluorescently labelled ASL. 
This technique is described in chapter 6. 
Chapter 5 
Optical microscopy 
5.1 Introduction 
5.1.1 Development of the microscope 
Historians credit the invention of the compound microscope to the Dutch 
lenscrafters, Zacharias and Hans Janssen, around the year 1590 [231]. The 
compound microscope uses two converging lens systems and light to produce 
an enlarged image of an object that is too minute to be viewed by the naked 
eye. In the early 17th cent ury, Galileo Galilei, the father of modern astronomy 
and physics, heard of this invention, and developed, first, his own telescope 
and, later, a tripod microscope [231]. In 1664, Robert Hooke published "Mi-
crographia" [232], a fascinating work on optical microscopy. Hooke's work 
describes and illustrates observations he made with a compound microscope 
on a wide variety of organisms including insects, plants and bird feathers. 
Anton van Leeuwenhhoek (1632-1723), a Dutch tradesman, developed his 
own microscopes which consisted of one single magnifying glass. With his 
handcrafted simple microscopes, which reached a magnification up to 250x, 
he was the first one to observe and describe microrganisms, such as bacteria 
and yeast [231]. 
During the 1Sth cent ury, the main focus of instrument makers was on the 
development of the microscope's design to facilitate focusing and to meet the 
needs of the user [231]. In the 19th cent ury, optical improvements increased 
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magnification and resolving power. In 1830, Joseph Jackson Lister reduced 
the problem of spherical and chromatic aberration by developing the first 
apochromat. Carl Zeiss and Ernst Abbe were the first to design lenses of 
- for their time - the technically highest possible quality based on optical 
theory and the laws of physics [231]. 
The 20th cent ury was marked by the advancement of the traditional opti-
cal compound microscope and by the development of new microscopic tech-
niques, such as the ultramicroscope (Richard Adolf Zsigmondy, Nobel Prize 
1925), the phase-contrast microscope (Frits Zernike, Nobel Prize 1932), the 
electron microscope (Ernst Ruska, Nobel Prize 1938), and the scanning tun-
neling microscope (Gerd Binnig and Heinrich Rohrer, Nobel Prize 1981) [233]. 
The development of optical microscopes and their applications has proceeded 
rapidly over the last several decades. This is due both to the improvement in 
the manufacture of opticallenses and to the improvement in the design of op-
tical systems. The development of new fluorescent labels has also accelerated 
the expansion of fluorescent microscopy in research. 
5.1.2 Components of a microscope 
The performance of a good compound microscope depends on good mechan-
ical parts (stability and rigidity of the microscope, the precise holding frame 
for objectives and eyepieces, flexibility for focusing and moving a specimen) 
and excellent lenses (magnification and resolution). The components of a 
Nikon Inverted Microscope ECLIPSE TE300, which was used in the courSE) 
of this Ph.D. project, are depicted in Fig. B.1 on page 285 and Fig. B.2 on 
page 286. 
During illumination with transmitted light, the rays first pass through the 
collector lens and sorne filters and then through the condenser, microscope 
slide (if available), specimen, cover glass (if available), objective and ocular. 
Finally, it enters the observer's eyes. Additional filters, prisms and a tube 
lens (for infinity corrected optical systems) might also be necessary to com-
plete the optical setup of a compound microscope [234]. 
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There are at least nine methods to illuminate a specimen: 
1. Transmitted light with brightfield; 
2. Transmitted light with darkfield; 
3. Transmitted light with polarization; 
4. Incident light with brightfield; 
5. Incident light with darkfield; 
6. Transmitted light with phase contrast; 
7. Transmitted light with interference contrast; 
8. Incident light with fluorescent specimen (e.g. epifluorescence micros-
copy); 
9. Incident light with polarization. 
EssentialIy, there are two main principles of illumination in microscopy. One 
was devised by Edward Nelson, which is generally called critical illumination, 
and the other by August K6hler, which is named after its inventor, Kahler 
illumination. At the present time, critical illumination is preferred for use in 
simple microscopes, whereas the modern research microscopes have a built-in 
illuminator based on the Kühler principle of illumination. 
The physical principles of optical microscopy inc1ude interference, diffrac-
tion and coherence of light, which operate constructively or destructively in 
the microscope. A geometrical approach to microscopical imaging is based 
on refraction and reflection of rays, represented in the ability of lenses and 
mirrors to focus and change the convergence and divergence of light beams. 
The diffraction theory of image formation, first formulated by Ernst Abbe 
in 1873, explains sorne fundamental problems related to resolution and con-
trast [234]. AlI these principles and further fundamentals of microscopy are 
described in the following sections in order to give every reader of this thesis 
the necessary background for the understanding of chapter 6. 
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Figure 5.1: Reflection and refraction at an interface between two media: 
S = incident ray, R = reflected ray, T = transmittedjrefracted ray 
e = angle of incidence, e' = angle of refraction, e" = angle of reflection 
5.2 Sorne principles of optics 
5.2.1 Refraction and reflection of light 
Geometrie opties, employing the theory of refraction and refiection of light 
rays, is along with wave opties one of the two approaches that describe the 
ability of a microscope to both magnify and resolve. 
Refraction occurs when light passes from One medium of One optical density 
to another one with a different optical density (see Fig. 5.1, page 149). The 
measure of optical density is the refractive index n 17. The exact refractive 
index for a medium varies with the wavelength of light. This physical phe-
nomenon causes dispersion, which is the separation of white light into its 
spectral components (see Fig. 5.2, page 150). Dispersion in lenses produces 
the undesired effect of chromatic aberration, which is described in detail on 
page 161. , 
While only part of the travelling light is transmitted (refracted) through 
the second medium, the remainder refiects at the interface. The proportion 
17The refractive index n equals the speed of light in a vacuum divided by its speed in a 
material. 
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Figure 5.2: Dispersion of light by a glass prism 
of refraction to refiection depends on the refractive indices of both media, 
the direction of light travelling, the light polarization and the angle of inci-
dence [235]. 
The angle of refiection (JI! is equal to the angle of incidence (J with opposite 
sign [235]: 
(J = -(JI! 
The degree of refraction depends on the refractive indices of the two media 
and is described by Snell's law: 
sin (J n2 
-- = - =n2I 
sin (JI nI (5.1) 
(J, (J'angle of incidence, angle of refraction 
nI, n2 refractive index of first medium, refractive index of second medium 
n2I relative index of refraction 
If the first medium is optically less dense than the second one (nI < n2, e.g. 
air ~ glass), the angle of incidence (J is greater than the angle of refraction 
(J'. For (J = 90 0 , (J' reaches its maximum and is called critical angle of 
refraction (J~r [235]: 
(J' . nI cr = arCSln-
n2 
(5.2) 
If the second medium is optically less dense than the first one nI > n2, 
e.g. glass ~ air), the angle of refraction (J' is greater than the angle of 
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Figure 5.3: Two-wave interference 
El = al sin (x 7/JI) 
E2 = a2 sin (x - 7/J2) 
E = al sin (x - 7h) + a2 sin (x 7/J2) 
Ea: destructive for multiples of XE (7r + 7/JI, 7r + 7/J2) 
Eb: constructive for multiples of XE (7r + 7/J2, 7r + 7/JI) 
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incidence (J. If (J > (Jcr, in which (Jcr is related to (J' = 90 0 , the phenomenon 
of total internaI reflection occurs. In the case of (J < (JCr'l the incident ray (8) 
is only refracted (T)j in the case of (J > (Jc/') it is exclusively refiected (R), 
and for (J (Jcr, the refracted ray (T) propagates along the interface [235]. 
In accordance with the reversibility theorem of optical rays the critlcal angie 
of incidence (Jcr is equal to the critieal angle of refraction (J~r' 
5.2.2 Interference of light 
In wave op tics, whieh employs the theory of interference and diffraction, light 
is considered as a wave. The phenomenon of interference is the basis of most 
microscopie techniques, such as interference, phase contrast, and brightfield 
, ' ..... 
rnicroscopy [234]. 
Two coherent18 monochromatic waves propagating in an isotropie medium 
in the same direction with amplitudes al and a2, and phases '1/;1 and '1/;2; 
respectively, (see Fig. 5.3, page 151) can be represented by: 
(5.3) 
180nly coherent waves, which have similar optical properties (wavelength, direction, 
phase - either the same phase or a fixed phase difference), are capable ofinterfering .1235]. 
CHAPTER 5. OPTICAL MICROSCOPY 153 
Figure 5.4: Diffraction of light through a pinhole 
principle which states that each point of an advancing wave front can be 
considered as the centre of a source of a new wave. Fig.5.4 on page 153 
shows how a narrow pinhole can be considered as a source of spherical waves 
whose superposition generates a new wavefront with a non-uniform intensity 
distribution (1) around the geometric shadow limit (interference or diffrac-
tion fringes) [235]. 
In microscopy, diffraction fringes form the smallest unit of an image. This 
unit is called Airy disc, and together with a whole series of concentric rings 
Airy pattern20 , which determines the limits of optical resolution. 
In conclusion, it should be noted that diffraction interacts with interference in 
the case of coherent waves, as can be best observed in the form of diffraction 
fringes (see Fig. 5.4, page 153). 
5.3 Magnification and resolution 
The principle function of a microscope is to enhance resolution. Resolution 
can be measured as the smallest distance between two points, which the hu-
man eye is capable of seeing as distinct [236]. The microscope enlarges the 
2°after the British Astronomer Royal Sir George Biddell Airy 
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Figure 5.5: Rayleigh criterion for resolution 
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view of an object so that details of this object can be observed which oth-
erwise cannot be resolved by the human eye [236]. If image formation was 
solely based on geometric optics then magnification would increase along 
with resolution without limit. However, other factors, based on diffraction 
and interference, limit useful magnification. Additional magnificat ion that 
do es not yield higher resolution and more detail is called empty magnification. 
The limit for the microscope's resolution is set by the diffraction at the aper-
ture of the objective. For a point source, the resulting image is an Airy 
pattern (see Fig. 5.4, page 153). The Rayleigh criterion for resolution of 
two point sources in a diffraction-limited system21 is given when the first 
diffraction minimum of the Airy pattern of one source point coincides with 
the maximum of another (see Fig. 5.5, page 154). Henee, the sm aller the 
Airy discs are, the less likely they overlap and the better the resolution. The 
Airy disc projected by an objective is aIl the sm aller the higher the numerical 
aperture (NA) of the objective is. 
The NA is a crucial value that indicates the light aceeptance angle, which 
in turn determines the light gathering power, the resolving .power, and the 
21 If al! parts of an imaging system are perfect, then the resolution of any imaging pro cess 
will be limited by diffraction. 
CHAPTER 5. OPTICAL MICROSCOPY 155 
Figure 5.6: Numerical aperture of oil immersion and dry objective 
depth of field (axial resolving power) of the objective. It is given by: 
NA n· sina (5.6) 
n refractive index of medium between the coverslip and the lens system 
a half of the entrance angle of the light cone (see Fig. 5.6, page 155) 
Since the half aperture angle a cannot exceed 90 0 , the maximum possible 
NA is equal to the refractive index n of the immersion medium. Hence, for 
dry systems (immersion medium: air, n = 1) the theoretically maximum NA 
is 1. In practice, the maximum NA of dry systems cannot exceed 0.95, and 
greater values may be obtained only with immersion systems [235, 234]. 
Light-gathering power is a measure of the illumination and image bright-
ness provided. The illumination brightness as weIl as the image brightness 
are determined by the square of the condenser NA and objective NA, respec-
tively. The image brightness (Bim ) is additionally inversely proportional to 
the square of magnificat ion M l235]: 
( NA)2 Bim oc M (5.7) 
Resolving power has been defined as the ability of a microscope to form 
separate images oftwo points lying close together [234]. The resolving power 
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of a microscope can be determined by the following equations: 
1.22·,,\ 
r 
NAobj + NAcond 
(self-luminous objects; acc. to Rayleigh) (5.8) 
Î 
r 
NAobj + NAcond 
1 
(non-luminous objects; acc. to Abbe) (5.9) 
r 
minimal space between two adjacent particles while still allowing 
the particles to be perceived as separate [nm] 
NAobj 
NAcond 
wavelength of illumination [nm] 
numerical aperture of the objective 
numerical aperture of the condenser 
NA is associated with both the condenser and the objective. For the sharpest 
images in brightfield and phase contrast microscopy (see page 171), the NA 
value of the condenser should be matched by the NA value of the specific 
objective; equation (5.9) on page 156 for non-Iuminous objects applies. For 
epifluorescence microscopy (see page 171) only the NA of the objective deter-
mines the degree of resolution; equation (5.8) on page 156 for self-Iuminous 
objects applies. 
The axial resolving power of an objective, which is measured parallel to 
the optical axis, is referred to as depth of field 22 . High magnification and 
high NA objectives are also accompanied by a shallow depth of field. It can 
be calculated by the following equation [237, page 255]: 
(5.10) 
22Not to be confused with focal depth, which is the placement of the image plane in 
relation to the lens. 
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d 
À 
depth of field [nm] 
wavelength of illumination [nm]-
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n 
refractive index of medium between coverslip and objective's front 
lens 
NA numerical aperture of the objective 
5.4 Lenses 
5.4.1 Basic properties of lenses 
Lenses can be classified by two main types: the convex lenses with a thickness 
greater at the optical centre of the lens than at the edges and the concave 
lenses with a thickness greater at the edges of the lens than at the optical 
centre (see Fig. 5.7, page 158). If the optical density of the lens is higher than 
its surrounding medium (e.g. air), a convex lens converges parallellight rays 
and is also called positive lens; a concave lens, in contrast, diverges parallel 
light rays and is called negative lens [235, 234]. 
The most important parame ter of a lens is its focallength f [235, 234]. The 
object-side (front) focal length is denoted by j, and the image-side (back) 
focal length by f' (see Fig. 5.8, page 159). The focal lengths f and f' are 
al ways opposite in sign and: 
f n 
f' ni 
n refractive index of the medium in front of the lens 
n' refractive index of the medium behind the lens 
(5.11 ) 
If these media are identical, Le. n = ni, the front and back focal lengths are 
the same: 
f =-1' 
The value 
ni n 
K=- =--f' f (5.12) 
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Figure 5.7: Cornrnon types of lenses: 
Positive lenses: (A) biconvex; (B) plano-convex; (C) convergent rneniscus 
Negative lenses: (D) biconcave; (E) pIano-concave; (F) divergent rneniscus 
is known as optical power (in air: 1/ f) and is expressed in m- l or in diopters. 
For thin lenses23 the focal length of a lens surrounded by air can be roughly 
calculated according to the lensmaker equation: 
.!. ~ (n - 1) [~ - ~l f rll rl2 (5.13) 
f focal length of the lens 
n refractive index of the lens material 
rll and rl2 radii of curvature of the lens surfaces 
Two planes or points are said to be conjugate if one is the image of the other. 
Their related distances can be calculated by the Cartesian lens equation 
(applicable only for thin lenses): 
1 1 1 
-+-=-81 82 f 
23Lenses whose axial thickness t can be dismissed: t « Tll, Tl2. 
(5.14) 
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Real images are inverted, virtual images are upright. The following relations 
hold: 
SI > 2· f => IMI < 1, real 2· f > SI > f 
f > SI > 0 
=> IMI > 1, real 
SI = 2 . f => IMI = 1, real => IMI > 1, virtual 
SI distance from an object to the principle plane of the lens 
S2 distance from the principle plane of the lens to the image 
f focal length 
The magnification factor of a lens specifies the power of increasing or reducing 
an object's apparent size on its image. It is defined as: 
M magnification factor 
SI distance from an object to the principle plane of the lens 
S2 distance from the principle plane of the lens to the image 
(5.15) 
The image is larger than the object if IMI > 1, and smaller if IMI < 1. 
M is negative for real images and positive for virtual images (see Fig. 5.8, 
page 159). 
Lenses may be combined to make more complex systems, such as in objec-
tives. If thin lenses with focal lengths fI and 12, respectively, are separated 
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by a distance d, the combined focal length 1 can be calculated according to: 
1 
1 
12 (d - Id 
d - (fI + 12) 
The simplest case is when lenses are placed in contact: 
1 1 1 
- - - + - for d -t 0 1 - fI 12' 
(5.16) 
The combined magnification factor Mc for multi-Iens systems is given by: 
m 
Mc = Mcl Mc2 ... Mcm = II Mck 
k=1 
(5.17) 
Equations for multi-Iens systems can be extended limitlessly because aIl com-
bined lenses can be treated as a single system to which an additionallens is 
added. 
A compound microscope has two systems of lenses for magnification: 
1. The objective (also called object lens or object glass) (see section 5.4.3) 
is the lens closest to the observed specimen. Usually, a microscope 
accommodates four to six parfocal objectives24 , which typically consist 
of 10x, 20x, 40x and 60x magnificat ion factors. 
2. The eyepiece (also called ocular) (see section 5.4.4) is the lens closest 
to the eye. It additionally magnifies the primary image and projects it 
onto the retina of the eye. 
Three other systems of lenses are necessary for Kahler illumination: 
1. The collector Lens projects the image of the lamp filament onto the 
condenser aperture. 
240bjectives with identical parfocal distances can be interehanged while remaining in 
foeus. 
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2. The field lens focuses the image of the lamp filament at the plane of 
the substage condenser aperture diaphragm. 
3. The condenser lens system (see section 5.4.5) gathers and focuses the 
light onto the (specimen. It provides an illumination of uniform intensity 
over the entire viewfield. 
5.4.2 Optical defects 
Lenses are subject to some optical defects (also called aberrations) which 
cause non-ideal images to be formed. This topic is large and complex, there-
fore only the two most important aberrations will be discussed in the follow-
ing paragraphs. 
Spherical aberration 
Spherical aberration is an optical defect caused by spherical lens shape. Fig. 
5.9 on page 162 illustrates that the focallength of the rays entering the lens is 
dependent on the distance of the ray from the optical axis, e.g. the marginal 
rays are focused doser to the lens than the central ones (negative spherieal 
aberration). A spherically aberrated lens has, therefore, no well-defined fo-
eus [238]. 
The lateral (or transverse) spherical aberration is defined by the radius p of 
the circle of confusion in the paraxial image planes. As a result of the cirde 
of confusion, the image of a point formed by a spherieally aberrated lens is 
a dot surrounded by a halo of light [2341. 
In general, positive lenses exhibit negative spherical aberration, whereas 
negative lenses exhibit positive spherical aberration. Thus, spherical aber-
ration of optical systems is correeted by combining positive and negative 
lenses [234, 238]. 
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Figure 5.9: Spherical aberration 
Chromatic aberration 
Figure 5.10: Chr.omatic aberra-
tion 
Spherical aberration has been discussed on the assumption of the presence of 
monochromatic light. AlI aberrations are, however, wavelength dependent, 
which is known as chromatic aberration (see Fig. 5.10, page 162). 
Chromatic aberration is caused by the dispersion of light (see page 150) 
through the lens, whose refractive index n varies with the wavelehgth of 
light. Equation 5.13 on page 158 demonstrates that f is dependent on n, 
which is the reason that different wavelengths of light will have different fo-
cal lengths. The result is a halo of colours around the image that is seen 
through the lens [234, 238]. 
Chromatic aberration can be reduced using an achromat, which i~ a lens sys-
tem of two combined lenses with different dispersion characteristics. They 
usually correct chromatically for two wavelengths (red and blue), and spher-
ically for green. 
The next higher level of correction can be achieved with jtuorites. Fluorites 
contain natural or synthetic fluorite and have lower dispersion than normal 
glass. These lens systems correct chromatically for two wavelengths (red and 
blue), and also spherically for two wavelengths (blue and green). 
An apochromat uses a three-Iens system to correct chromatic aberration for 
three wavelengths (red, green and blue). The lenses are made of special 
low-dispersion glass. An apochromatic objective can minimize chromatic 
aberration to the degree that coloured halos are not seen around a point. It 
CHAPTER 5. OPTICAL MICROSCOPY 163 
also spherically corrects for two wavelengths (blue and green) [234, 238]. 
The achromat and apochromat correct chromatic aberration in the axial di-
rection (axial chromatic aberration). 
Since off-axis rays are also dispersed, images of different sizes are formed de-
pending on the wavelength of the ray. This optical defect is known as LateraL 
chromatic aberration or chromatic difference of magnification. Newer ob-
jectives and oculars with chromatic-aberration-free optics are independently 
corrected for both longitudinal chromatic aberration and chromatic differ-
ence of magnification [234, 239]. 
Other kinds of aberration include astigmatism, barrel, coma, field curvature 
and pincushion distortion (for further details see [234, 235]). 
5.4.3 Objectives 
The most important component of an optical compound microscope is the 
objective. It is responsible for primary image formation and plays, therefore, 
a crucial role in the quality of the final image, i.e. magnification, resolution 
and correction for lens aberrations. Lenses in modern objectives are made of 
high-quality glass of specifie optical properties and precise design [240]. 
Essential specifications are inscribed on the barrel of each objective and will 
be briefly discussed in the following. 
Magnification 
Magnifying power is, together with the resolving power (see section 5.3), the 
most important optical parameter in microscopy. The magnifying power from 
available objectives ranges from 0.5x (low power) to 250x (high power) [239]. 
Numerical aperture 
The numerical aperture (NA) determines primarily the resolving power of 
the objective and is usually inscribed on the barrel next to the magnification 
(see section 5.3). 
The NA of an objective depends, to a certain degree, on the amount of 
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Table III: Objective designations for cornrnon optical corrections [239] 
Abbreviation 
Achro, Achromat 
Fluor, FI, Fluar, Neofluar, Fluotar 
Apo 
Plan, Pl, Achroplan, PIano 
Plan Apo 
CF, CFI 
Type 
Achromatic aberration 
correction 
Fluorite aberration correction 
Apochromatic aberration 
correction 
Flat Field optical correction 
Apochromatic and Flat Field 
correction 
Chrome-Free, Chrome-Free 
Infinity-Corrected 
correction for optical aberration. Objectives with a high degree of optical 
correction have larger numerical apertures for the respective magnificat ion 
than for uncorrected ones [239]. Sorne objectives are designed for special 
immersion media between front lens and cover glass (see Working Distance 
on page 166), to attain even higher working numerical apertures. 
Optical corrections 
The correction for optical aberrations is crucial for good performance of an 
objective. Table III on page 164 lists the objective designations of the most 
corn mon optical corrections. 
Mechanical tube length 
The mechanical tube length is defined as the distance from the nosepiece 
opening, where the objective is mounted, to the top edge of the observation 
tubes, where the oculars are inserted. 
Until the 1980s, objectives were designed for finite tube lengths ranging from 
160-210 mm, depending on the manufacturer and the application. This sys-
tem requires that a specimen is placed between !obj and 2!obj. The objective 
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focuses the magnified image of the specimen (primary image) at the level 
of the diaphragm of the eyepiece (see section 5.5). Objectives designed for 
a fixed tube length bear the inscription of the length of mechanical tube: 
e.g. 160 [239). The drawback of these objectives is the alteration of the 
optical tube length (optical path between objective and eyepiece) whenever 
an accessory, such as a prism or a fluorescence illuminator, is placed in the 
lightpath between objective and eyepiece. To compensate for this alteration, 
the specimen has to be moved, which can be regarded as defocusing. This 
procedure introduces spherical aberration into a microscope system corrected 
for a standard mechanical tube length [234). 
Nowadays, microscopes are designed for use with infinity corrected objectives 
(inscription: 00). Their principle is described on page 170. Infinity-corrected 
systems are easier to design than finite systems. Moreover, they allow in-
sertion of accessories in the parallel light path between objective back focal 
plane and the tube lens without introducing aberrations [234]. 
Caver glass thickness 
Most objectives intended for use with a coverslip are corrected for a cover 
glass thickness t = 0.17 mm. A deviation of this conventional thickness 
causes poor image quality due to optical aberration. The larger the NAobj , 
the sm aller is the tolerable deviation tJ.t. For this reason, sorne high-power 
objectives have a correction collar adjustment of the internallens elements to 
compensate for this variation [234]. In addition to the presence of a correction 
coIlar, these objectives are labelled as Corr, w;Corr, or CR [239). 
Warking distance 
The working distance dObj is the free distance between the front lens of the 
objective and the coverslip or the object plane for no-cover-glass objectives. 
In general, the distance dobj decreases as the NAobj increases. Objectives 
with short dobj , such as immersion objectives, have a spring-Ioaded front lens 'v 
which will retract if driven onto a surface. This feature protects the lens 
from being damaged [234]. 
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In general, it is useful to have dry objectives with working distances as long 
as possible. Specially designed CFI objectives can achieve working distances 
that are several times longer th an working distances of typical objectives 
with comparable NAs [241]. Common abbreviations are: LWD (long working 
distance), ELWD (extra-long working distance), SLWD (super-long working 
distance), and ULWD (ultra-long working distance) [239]. 
Immersion medium 
Objectives requiring a liquid instead of air between the front lens and the 
coverslip are called immersion systems. Accordingly, systems having an air 
gap between the front lens and coverslip are called dry systems. The basic 
function of the immersion liquid is to increase the NAobj (see Fig. 5.6, page 
155). Common immersion liquids are special immersion oil (n = 1.51, abbrev. 
oil or oel), water (n = 1.33, abbrev. W), and glycerol (n 1.47, abbrev. 
Gly) [234]. 
Specialized objectives 
Sorne specialized micros co pic techniques require specifie objectives that house 
additional devices. For instance, objectives for phase contrast (see page 171) 
are fitted with a phase plate close to the back focal plane of the objective. 
They are designated with a Ph [239]. 
Epifluorescence applications (see page 171) require high-NA objectives in 
order to capture the highest possible amount of light emitted by fluorescing 
specimen. Fluorescence objectives are made of quartz and special glass that 
have high transmission from the UV (down to 340 nm) to the IR, and are 
extremely low in auto-fluorescence [239]. 
Coatings 
An uncoated air-glass interface reflects 4-5 % of light striking normal to its 
surface. Since there are many such air-glass interfaces within a microscope, 
the initial light intensity, the contrast and the overall quality of the micro-
scopie iqlage tend to be greatly reduced. To counteract this phenomenon, 
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optical elements are coated with antireftecting films, which interferentially 
decrease the reflections of light at air-glass interfaces [234]. A typical antire-
flective coating is magnesium fluoride [240]. 
5.4.4 Eyepiece 
The eyepiece (or ocular) is a lens system that magnifies the primary image 
and projects it either as a real image on a camera system or a virtual image 
on the human eye, depending on the location of the internaI fixed eyepiece 
field diaphragm [234]. 
The diameter of the fixed eyepiece diaphragm opening determines the field 
size observed by the microscopist. It is inscribed on the eyepiece as a field 
number (FN) and varies from 18-26 mm. Another designation present on the 
eyepiece barrel is the magnification, which ranges from '" 6x to 25x [241]. 
Eyepiecejobjective combinations should be chosen appropriate to the correc-
tion and type of objective to ensure optimal magnification of specimen detail 
without adding unnecessary artifacts. The range of useful magnification for 
an eyepiecej objective combination is defined by the numerical aperture of 
the system (see section 5.3). Therefore, the most corn mon eyepieces are in 
the range of 10x to 20x. 
5.4.5 Condenser 
The basic function of a condenser is to gather the light coming from the light 
source and to concentrate it into a cone of light that illuminates the specimen 
with uniform intensity over the entire viewfield. Conventional microscopes 
have a substage condenser that is fitted below the stage of the microscope; 
whereas inverted microscopes comprise system con den sers above the stage 
(ELWD or LWD) and a turret with components for phase contrast, differen-
tial interference or darkfield microscopy [241]. 
Condensers are available according to different levels of correction. The sim-
plest substage condenser is the Abbe condenser which can reach a NAcond 
up to 1.25. However, it is not well-corrected chromatically nor spherically. 
The best level of correction is achieved in aplanatic-achromatic condensers. 
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They are well-corrected for spherical and chromatic aberration, and are the 
condensers of choice for colour observation and recording in white light [234]. 
The size of condenser aperture (N Acond ) and the proper focusing of the con-
denser are crucial for an optimal performance of the objective. The NAcond 
should be equal or higher than NAobj to receive the highest resolution possible 
(see section 5.3). 
5.5 Light path in a compound microscope 
Fig. 5.11 on page 169 depicts a ray diagram of light microscopy under the 
condition of Kèihler illumination in which the illuminating and image-forming 
light paths are merged into one diagram. In both of the light paths (illumi-
nating and image-forming), there are four separate conjugate planes, which 
are simultaneously in focus. 
The conjugate planes in the illuminating light pathway, in which the lamp 
filament is in focus, are [242]: 
1. The lamp filament aoboco from which light is radiating out. 
2. The aperture diaphragm in the front focal plane of the condenser lens 
a1 b1c1· 
3. The back focal plane of the objective lens a2b2c2. 
4. The eyepoint (or Ramsden disc) in the back focal plane of the eyepiece 
a3b3c3 where the pupil of the microscopist's eye should be placed. 
The conjugate planes in the image-forming light pathway, in which the spec-
imen in focus, are [242]: 
1. The field diaphragm in the back focal plane of the collector lens 102030. 
2. The object plane on the back focal plane of the condenser lens 112131. 
3. The primary (or intermediate) image plane on the front focal plane of 
the eyepiece 122232. The magnification of the primary image is given 
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Figure 5.11: Symmetrical ray diagram of the light microscope; taken with permission from source {242} 
The rays a'a'a',b'b'b' and c'c'c' arising from the separate points aoboco in the lamp filament illuminate the whole area of 
the object as a series of parallel bundles of rays and are focused in the illuminating aperture series of conjugate planes 
a1b1c1 (illuminating aperture diaphragm), a2b2c2 (back focal plane of objective) and a3b3c3 (Ramsden disc). 
The parallel bundle of rays a'b'c' arising from the whole area of the filament are focused in the illuminated field series of 
conjugate planes 102030 (illuminated field diaphragm), 112131 (object) and 122232 (primary or intermediate image). The 
pupi! of the eye, focused at infinity, is situated at or near the Ramsden disc (a3b3c3) and pro duces the secondary image 
h2232 on the retina of the eye. 
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by the ratio of the image distance and the specimen distance to the 
principle plane of the objective lens system (see equation 5.15). 
4. The microscopist's retina of the eye. 
In infinity-corrected systems, the specimen is placed at the front focal plane 
ofthe objective. Hence, the rays from the object plane 112131 proceed parallel 
through the objective and its back focal plane, theoretically forming an image 
at infinity. An additional tube lens in the mechanical tube forms the primary 
image by focusing, the parallel rays at the front focal plane of the eyepiece 
122232 [242]. The magnification of the primary image in an infinity-corrected 
system is given by the ratio of the focallength of the tube lens and the focal 
length of the objective. 
5.6 Specialized methods 
A wide spectrum of microscopie techniques has been developed to enhance 
contrast and to provide better observation, such as phase contrast, darkfield, 
modulation contrast, differential interference contrast, polarized light and 
fluorescence microscopy - to mention only a few. A qualitative description 
will be given in the following as to the techniques used in connection with 
this dissertation, Le. brightfield, phase contrast and fluorescence microscopy. 
5.6.1 Brightfield 
Standard transmission of light through the specimen is called brightfield mi-
croscopy. Specimen which are coloured or thick enough to absorb a significant 
amount of light can be easily observed using this technique. However, un-
stained thin specimen do not offer much contrast and are very difficult to see. 
In this case, a fixed 25 specimen can be stained to provide contrast against 
the background [243]. 
25Pixation refers to the technique of preserving a deceased specimen for microscopie 
study in an intact and stable state. 
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5.6.2 Phase contrast 
Phase contrast microscopy is a contrast-enhancing optical technique which 
produces high-contrast images of colourless, transparent specimen without 
the exigence of staining. Invented by Frits Zernike [244] in the 1930s, it 
employs an optical mechanism to translate minute variations in phase into 
corresponding changes in amplitude that can be observed as differences in 
brightness. 
Upon application of K6hler illumination (see section 5.5), light is focused by 
a collector lens on a specialized annulus (phase plate) positioned on the front 
focal plane of the condenser lens (plane a1b1cl in Fig. 5.11, page 169). Light 
rays passing successively through the annulus and the condenser illuminate 
the specimen as partially coherent light bundles. The rays pass through 
the specimen either undeviated or diffracted and retarded in phase due to a 
variation in refractive indices. On the back focal plane of the objective (plane 
a2b2c2 in Fig. 5.11, page 169), which is a conjugate plane to the condenser's 
front focal plane, a second phase plate is positioned in a way whereby it is 
precisely aligned with the condenser phase plate. Undeviated and diffracted 
light emitted from the specimen and collected by the objective is segregated 
by this second phase plate and focused to a primary phase contrast image 
that can be observed through the eyepiece [234]. 
5.6.3 Fluorescence microscopy 
Fluorescence microscopy is a specialized technique for the study of fluores-
cent substances. The principles of fluorescence are described in detail in 
section 2.1.2. 
The first fluorescence microscope was developed by Otto Heimstadt and Hein-
rich Lehmann in 1911. It was originally employed to observe specimen with 
strong inherent (primary) fluorescence [234]. In 1933, Max Haitinger used 
for the first time secondary fluorescence to overcome the limitation of weak 
primary fluorescence of most cells and tissues [234]. Since then, myriad fluo-
rescence labels have been developed for diverse applications (e.g. see section 
2.3). 
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Figure 5.12: Schematic illustration of epifluorescence microscopy 
172 
Fig. 5.12 on page 172 schematically illustrates the principle of epifluorescence 
microscopy, which uses the objective to illuminate the sam pIe (in contrast to 
trans-fluorescence, where the sample is illuminated from the opposite side). 
As a light source, typically a mercury or a Xenon lamp is cou pIed in to the 
back of the inverted microscope. The wavelength required for fluorescence ex-
citation is selected by an excitation filter, which transmits only exciting radi-
ation (e.g. blue light). A dichromatic mirror26 (also called a dichroic mirror) 
totally reflects the exciting light, which impinges on the sample. Part of the 
exciting radiation is absorbed by the sam pIe and re-emitted at longer wave-
lengths as fluorescence light (e.g. red light). The fluorescence light passes 
first through the dichromatic mirror and subsequently through an emission 
filter that absorbs the residual reflected excitation light. A coloured image 
can be observed against a dark background [2341. 
26 A dichromatic mirror selectively passes light comprising a range of wavelengths while 
reflecting other wavelengths. 
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5.7 Photomicrography 
Photomicrography is photography through a compound microscope. The 
quality of a photomicrograph depends on the quality of the microscope. It 
is essential that the microscope uses K6hler illumination, that the field and 
condenser diaphragms are adjusted correctly and the condenser height is op-
timized. When properly adjusted, the microscope will yield images that have 
even illumination over the entire field of view and display the best compro-
mise of contrast and resolution. 
Today, digital cameras replace the traditional sensitized film with a CCD 
(charge-coupled device) photon detector, which consists of a thin silicon 
wafer divided into a geometrically regular array of small, light-sensitive re-
gions - called pixels. These pixels capture and store image information in 
the form of localized electrical charges that vary with incident light intensity 
and exposure time. The electronic signal associated with each pixel of the 
detector is read out very rapidly as an intensity value for the corresponding 
image location. The following digitization of the values enables a computer 
to reconstruct the image and to display it on a monitor virtually instanta-
neously [245]. For photomicrography with a digital camera, it is important 
that the sensor size, relay magnification and pixel dimensions are selected 
appropriately [246, 247]. 
5.7.1 Image formation on the sensor 
The objective of a compound microscope forms a circular primary image (see 
section 5.5) of the object at the aperture of the eyepiece. The diameter of 
this image, which is directed through the eyepiece to the eye, is specified by 
the FN (see page 167). In photomicrography, the primary image is projected 
onto the surface of a camera sensor by using relay optics or simply a coupler. 
If the diagonal size of the sens or matches the FN of the eyepiece, the size 
of the directly recorded image (lx magnification) will correspond roughly 
to the image size seen through the eyepiece (see Fig. 5.13, page 174). If 
the diagonal size of the sensor is smaller than the FN of the eyepiece, the 
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Figure 5.13: Field of view - monitor versus eyepiece (example: firefly) 
primary image has to be reduced in size with the relay optics (magnification 
value < 1) in order to record what is seen through the eyepiece. With a lx 
magnification, only the centre section of the eyepiece view will be recorded 
(see Fig. 5.13, page 174). The field of view size (Fa VS), which is the portion 
of the object that is visible on the monitor, varies with changes in: 
1. Size of the CCD sensor chip - height, width or diagonal (ChS [mm]) 
2. Objective magnification (DM) 
3. Relay optics coupler magnification (CM). 
Fa VS is determined by the foIlowing formula: 
ChS 
FoVS=OM.CM 
5.7.2 Image resolution 
(5.18) 
The resolution limit of a microscope (optical resolution) is determined by the 
NAs of condenser and objective, as weIl as the wavelength of light (see equa-
tion 5.9, page 156). The size of the smaIlest resolvable distance 'f between 
two points appears enlarged at the primary image, and further enlarged or 
CHAPTER 5. OPTICAL MICROSCOPY 175 
reduced by the relay opties at the sensor surface. The size of the resolution 
limit at the sensor (rsen ) can be determined by: 
rsen = r· OM· CM (5.19) 
rsen resolution limit at the sensor 
r smallest resolvable distance 
OM objective magnification 
CM relay optics coupler magnification 
The largest physical pixel size of the sensor, whieh allows us to record the 
smallest resolvable distance, is further constrained by the Nyquist-Shannon 
sampling theorem. It states that the exact reconstruction of a signal from its 
sample is possible if the sampling frequency is greater than twice the signal 
frequency. 
The required maximum pixel size (pixmax ) on the sensor is, therefore, de-
termined by the opties, which form the image, and the Nyquist-Shannon 
theorem: 
. 1 
P'/,Xmax :::; 2' . r sen (5.20) 
r sen resolution limit at the sensor 
1 
If the pixels on the sensor are larger than the maximum allowable, the sensor 
is not suit able for recording the finest detail with the opties as configured. 
In this case, the magnification of the relay opties should be increased. 
5.7.3 Requirements for digital photography 
The optical specifications of our available objectives and relay opties coupler, 
resulting magnifications, field of view size, and pixel requirements for digital 
photography are listed in table IV on page 176. A description of total mag-
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Table IV: Optical specifications and requirements for digital photography 
OM (NA) CM TMa FoVS a r b r sen b pix'maœ 
[mm] [JLm] [JLm] [JLm] 
eq. 5.21 eq. 5.18 eq.5.8 eq. 5.19 eq. 5.20 
10x (0.3) 0.6x 70 1.58 1.01 6.04 3.02 
10x (0.3) lx 116 0.95 1.01 10.07 5.03 
10x (0.3) 4x 464 0.24 1.01 40.26 20.13 
20x (0·4) 0.6x 139 0.79 0.75 9.06 4.53 
20x (0.4) lx 232 0.47 0.75 15.1 7.55 
20x (0·4) 4x 929 c 0.12 0.75 60.39 30.2 
40x (0.6) 0.6x 278 0.39 0.50 12.08 6.04 
40x (0.6) lx 464 0.24 0.50 20.13 10.07 
40x (0.6) 4x 1857c 0.06 0.50 80.52 40.26 
40x (0.75) 0.6x 279 0.39 0.40 9.66 4.83 
40x (0.75) lx 464 0.23 0.40 16.10 8.05 
40x (0.75) 4x 1857c 0.06 0.40 64.42 32.21 
60x (1·4) 0.6x 418 0.26 0.22 7.76 3.88 
60x (1.4) lx 697 0.16 0.22 12.94 6.47 
60x (1.4) 4x 2786c 0.04 0.22 51.76 25.88 
acalculated with a monitor magnification (MM = lOx), a square CCD format 
(ChSdiag = 9.5 mm) and a digital image diagonal dimension of Imdiag = llO mm 
bcalculated for À = 495 nm, regarding only N AObj 
cT M » T M max ; for more details see page 177 
nification and field of view size is briefly outlined below. 
The total magnification (TM) depends on: 
1. Objective magnification (aM) 
2. Relay optics coupler magnification (CM) 
3. CCD chip diagonal dimension (ChSdiag ; [mm]) 
4. Digital image diagonal dimension (Imdiag; [mm]) 
TM can be calculated by the following formula: 
TM=OM·CM·MM (5.21) 
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. h h . 'fi' MM Imdiag Wlt t e momtor magm catIOn = ChS. . 
dtag 
The range of useful total magnification for an objectivejrelay optics (ob-
jectivejeyepiece, resp.) combination is defined by the NA of the system 
(see section 5.3). The minimum magnification, which is necessary for the 
resolution of a detail present in an image, is arbitrarily set at 
T Mmin = 500 x NA [234]. The maximum useful magnification of an im-
age is set at T Mmax = 1000 x NA. Magnifications higher than this value 
will usually lead to empty magnification, whereby increasing magnification 
through the relay optics lens (or eyepiece) only causes the image to become 
more magnified, with no corresponding increase in detail resolution. 
Chapter 6 
Article 3: Side-viewing 
• ffilcroscopy 
6.1 Preamble 
Extracellular ATP is the major factor controlling ASL height in the con-
ductive airways (see section 4). It is thus interesting to study the effects 
of released ATP on the properties of ASL. This study required the develop-
ment of a novel system that allowed a continuous observation of the ASL. 
This approach would extend the methodological technique available in the 
group and could potentially provide a complementary aspect to the subject 
of extracellular ATP in lung epithelia. 
The objective of this research was to design and set up a side-viewing system 
based on epifluorescent microscopy that would allow time-resolved observa-
tion of ASL height alterations on in vitro air-liquid cultured cell monolayers. 
6.2 Article 
Tatur, S.; Chabot, H.; Grygorczyk, R. 
Method for Measuring Surface Liquid Height of in vitro Airway Epithelial 
Cell Cultures with Epifluorescence Microscopy. To be submitted to the Jour-
nal of Microscopy. 
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Manuscript included on pp. 180-211. 
AIl technical drawings are reproduce in appendix C. 
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Summary 
Lung epithelial cells are covered by a thin layer of airway surface liquid (ASL) whose 
height is of vital importance for proper lung functioning. The precise measurement of 
ASL height and its variations is essential to study the mechanisms of its control and 
regulation. So far, however, no technique was developed which allowed a sufficiently 
precise resolution of ASL height alterations, neither in vivo nor in vitro. 
In this study, we describe a novel side-view imaging technique which permits 
recording of ASL height variations on in vitro models of airway epithelial cell 
( 
cultures. The system requires a custom-designed side-view chamber mounted on the 
microscope stage, equipped with a temperature/humidity control system for 
maintaining the cell culture at an airlliquid interface (ALI) during the experiment. 
The set-up is not restricted to any specific type of microscopy and no modification of 
the microscope itself is necessary. A cell monolayer, grown under ALI condition on 
the filter membrane of a modified MilliceIl® insert is mounted in a side-view chamber 
perpendicular to the microscope objective. In this orientation, fluorescently labelled 
ASL height can be directly recorded by convention,al epifluorescence microscopy. 
Compared to laser scanning confocal microscopy (LSCM), it has the advantage of a 
shorter image-acquisition time. 
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INTRODUCTION 
The airway epithelium which lines the entire respiratory tract is covered by a thin 
ASL layer measuring in vivo 7 J.lm to 70 J.lm in height (Tarran, R., 2004). The ASL 
defends the lung against infectious and noxious agents, and conditions inhaled air 
which is associated with the so-called 'insensible water loss' from the ASL (Boucher, 
R.C., 1999). The height of ASL is a key parameter in airway physiology and is 
thought to be important in the pathophysiology of cystic fibrosis, asthma, and other 
diseases ofthe airways (Verkman, A.S. et al., 2003). 
So far, the ASL height ofbronchial and trachea cell cultures has been studied by laser 
scanning confocal microscopy (LSCM) (Boucher, R.e., 1999; Jayaraman, S. et al., 
2001; Roomans, G.M. et al., 2004). However, this expensive and complex technique 
has its downsides, su ch as low temporal resolution and photobleaching. Accordingly, 
the acquisition of an image or a sequence of images can take up to 1 min depending 
on the chosen image resolution. These limitations preclude the possibility to observe 
fast responses in ASL height alterations upon a cell stimulus, which lie in the range of 
few seconds. Furthermore, laser scanning causes photobleaching and photodamage to 
the cells because of the exposure to laser light of high average operating power 
(Piston, D.W., 1999), an outcome which may alter the cell response to a stimulus. 
Side-view imaging of the ASL, which would directly record the profile of the ASL, 
could obviate these problems. Several approaches for side-view imaging with a 
routine microscope have already been developed (Boocock, C.A. et al., 1985; 
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Boudreault, F. & Grygorczyk, R., 2004; Cao, J. et al., 1997; Ingram, V.M., 1969; 
Sanders, E.J. & Prasad, S., 1979; Tsai, J.W. et al., 2004). AlI ofthese techniques were 
applied to single cell observation with phase contrast illumination, and the ceUs were 
cultured on solid substrata under Iiquid-covered conditions. None of these techniques 
was, therefore, suitable for ASL height observation. 
In response to the described exigencies, we developed a novel approach for side-view 
ASL observation based on conventional epifluorescence microscopy. The cells were 
cultured on a filter membrane of a modified Millicell® insert under air-Iiquid interface 
(ALI) condition and mounted in a chamber which allowed direct side-view imaging 
of the ASL profile. The ASL height cou Id be measured with accuracy equal to LSCM 
with the advantage of faster image acquisition (100 ms to 1 s, depending on the NA 
of the system and the fluorescence intensity of the dye). Furthermore, the short 
illumination time Iimits the phototoxic effects on the cell culture. 
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MATERIALS AND METHODS 
Cell Preparation 
Fi/ter Preparation 
184 
12 mm Millieell® inserts with a 0.6 em2 membrane area (PIHA01250; Millipore 
Corp., Billerica, MA, USA) were modified as shown in Fig. lA. The rim of the 
polystyrene cylinder was eut away to obtain an unobstructed side-view of the cells 
grown on the filter in an up-side down orientation. The modification was 
aeeomplished manually with a scalpel, working under sterile conditions. The 
modified MilIieell® inserts were then placed into autoclaved biocompatible Tygon® 
tubing pieces (# 54007; United States Plastic Corp., Lima, OH, USA), as shown in 
Fig. lB, which enabled seeding and culturing cells on the outer side of the filter 
membrane. After the modification of the Millicell® inserts, the outer side of the filter 
membrane was coated with 120 III type 1 collagen (Vitrogen-lOO; Collagen Corp., 
Palo Alto, CA, USA). The collagen was left to dry ovemight at 37°C and neutralised 
by washing with PBS before seeding the cells. 
Cel! Culture 
The human bronchial epithelial ce~l-line l6HBE140-, a generous gift from Dr. D. 
Gruenert (University of Califomia at San Francisco, CA, USA), was eultured under 
ALI conditions similar to the procedure described by (Forbes, B. et al., 2003): The 
cells were seeded at a density of2.5x 105 cellsxcm-2 and were grown in DMEM:F-12 
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(Gibco, # 12400-024) supplemented with 2% Ultraser G (Life Technologies, Paisley, 
UK), 1.2 gxr' NaHC03, 100 Uxmr' penicillin, 100 jlg*mr' streptomycin, and 2 
mM L-glutamine. Ali constituents of the culture medium were from Gibco-BRL, 
Burlington, ON, Canada, unless otherwise specified. The medium was removed from 
the apical side after 2 days in culture (37°C, 5% CO2) and then maintained at an air-
liquid interface. The medium on the basal side was replaced every 24 h. The cells 
were used for experiments between day 7 and day 12 after seeding. 
Cel! Treatment 
To label the ASL, 50 jll of an Alexa Fluor 488 or 594 Dextran conjugate solution (10 
kD; Invitrogen-Molecular Probes, Kingston, ON, Canada) was added on top of the 
cell monolayer, the excess was aspirated. During the system test runs, the cells were 
left for 1 h in the incubator (37°C, 5% C02) to recover their natural ASL height. For 
future physiological experiments, the recovering time will have to be established for 
each cell culture. A concentration of2 mg*mr' Alexa Fluor Dextran in PBS was used 
for confocal microscopy measurements, whereas for epifluorescence microscopy 
measurements the solution was further diluted to 2 jlg*mr1 Alexa Fluor Dextran in 
PBS to reduce background fluorescence coming from beyond the focus. For cell-
profile observations; the ce 11 membrane was stained either with 5-
hexadecanoylaminofluorescein (HAF) or dapoxyl sulfonic acid (DSA) by covering 
the cel! culture with 30 jll PBS containing 10 jlg*mr1 HAF or 10 jlM DSA for 5 min. 
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The cells were then rinsed with PBS. During ail experiments, the cells were perfused 
from the basal side with physiological saline solution (PS) which contained (in mM): 
140 NaCI, 5 KCI, 1 MgCh, 1 CaCh, 10 glucose and 10 HEPES, pH 7.4 adjusted with 
NaOH. Ali PS components were obtained from Sigma-Aldrich Canada, Ltd., 
Oakville, ON. HAF and DSA were purchased from Invitrogen-Molecular Probes, 
Kingston, ON, Canada. 
Experimental Setup 
Side- View Cham ber 
Fig. 2A depicts the side-view chamber (made of non-fluorescent black de1rin) which 
accommodated the modified Millicell® insert with the cell culture for side-view 
observation. The Millicell® insert precisely fitted onto the holder with six inlet and 
one outlet channels. These channels were coupled, respectively, with an inlet and 
outlet metal tube connected to an in-line heater (Wamer Instrument Corp., Hamden, 
CT, USA) and a peristaltic pump (Gilson Miniplus 3, Worthington, OH, USA) which 
continuously provided the cells with warm PS (37°C, 
0.5 ml*min-1) from the basal side. The holder was designed to rotate around its axis 
within the chamber frame. This feature allowed finding the best spot for observation 
which was then secured with the retaining screw. 
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Mini-Incubator 
On the microscope stage, the side-view chamber was placed Înto a mini-incubator 
(made of non-fluorescent black delrin) with a temperature and humidity control 
system (see Fig. 2B) which provided an air compartment of controlled temperature 
(37°C) and humidity (45-60%). The temperature and humidity sensors were placed 
close to the cell monolayer on both sides of the side-view cham ber to precisely 
control its incubation conditions and, therefore, to avoid insensible water loss from 
the surface of the cells. Warm, humidified air entered the incubator from the bottom, 
whereas the opening on top of the incubator had two functions: firstly, it served as an 
outlet for the inflowing warm and humidified air to avoid condensation on the 
objective, and, secondly, it allowed brightfield illumination on the cell profile which 
was very valuable during initiallocating and focusing of the cell profile. 
Temperature and Humidity System 
An Air-Therm™ ATX Humidifier (ATX-H) was purchased from World Precision 
Instruments, Inc., Sarasota, FL, USA. It consisted of an air heater with precise 
temperature and humidity control connected to an ultrasonic humidifier (see Fig. 2C). 
The air continuously circulated in a closed circuit and was coupled to the microscope 
stage incubator. The air pressure within the closed circuit was kept constant by air 
influx through a small eut in the tubing behind the coupling valve. The warm, humid 
air was fed into the incubator from undemeath the microscope stage. This 
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arrangement prevented the objective to be in the direct flow path of the humid air 
and, thus, to fog up. The objective was, furthermore, preheated to 37°C and the whole 
set-up was flushed with warm (37°C) air for about 1 h before turning on the 
humidifier. This procedure prevented major condensation on any parts of the system 
for a relative humidity of up to 60% at a steady room temperature of -25°C. Since 
inhaled air is gradually humidified to 100% relative humidity by the ASL of the 
upper airways (Zuchner, K., 2006), the relative humidity in the mini-incubator should 
be optimized for every cell culture. It should be kept as low as possible to avoid 
condensation and as high as necessary to countervail evaporation of the ASL. If a 
humidity level of more than 60% is necessary, the microscope objective can be 
potentially equipped with an objective heater system. For the cell line 16HBEI40-, 
the humidity level was set to 55%. 
Optical Arrangement 
The side-view chamber with the incubator was placed on the stage of a Nikon TE300 
inverted microscope (1\1ikon Canada Jnc., Montréal, Qc) equipped with an extra long 
working distance (EL WD) system condenser. Fluorescently labelled cells and ASL 
were observed through an ELWD CFI objective (Nikon, 40x/0.60, WD 3.7-2.7, CR 
0-2) using epi-fluorescent illumination. The following excitation filters and emission 
filter blocks (Chroma Technology Corp., Rockingham, VT, USA) were used: a 495 
nm excitation filter with a GFP tilter block was used for Alexa 488 and HAF, a 340 
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nm excitation tilter with a Fura-2 filter block was used for OSA, and a Texas Red 
filter block was used for Alexa 594. The microscope was focused on the lower edge 
of the vertically-oriented filter with the cell culture, and the image was directly 
projected on the camera chip via a C-mount lx (or 4x) coupler (Nikon Canada Inc., 
Montréal, Qc). The cover-slip correction collar (CR) on the objective was essentially 
set to O. 
Data Acquisition and Analysis 
Image Acquisition 
Brightfield and fluorescent images of the cell profile and ASL layer were acquired 
with a monochromatic T57 Micromax CCD camera (Princeton Instruments, Trenton, 
NJ, USA) and MetaVue software version 7.0 (Molecular Deviees Corp., Sunnyvale, 
CA, USA). The camera chip had 512 x 512 imaging pixels with an individual pixel 
size of 13 ~m. 
Image Analysis 
The acquired images were processed using MetaVue software (Molecular Devices 
Corp., Sunnyvale, CA, USA). Background flattening has been applied to reduce stray 
Iight coming from fluorescence beyond the plane in focus. This procedure subtracts 
the large gradient of background fluorescence intensity and reveals additional details 
without losing image data. A line scan perpendicular through the ASL produces a 
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fluorescence intensity profile and facilitates the estimation of ASL height and to 
monitor its variations. 
Confocal Microscopy 
Images of fluorescently labelled ASL were aiso recorded using a TE300 inverted 
microscope (Nikon Canada Inc., Mississauga, ON) equipped with a confocal laser-
scanning system (BioRad MRC 1024, Hercules, CA, USA) and a monochrome 
CoolSnap-Fx CCD camera (Photometries, Tucson, AZ, USA). The camera chip had 
1300 x 1030 imaging pixels with an individual pixel size of 6.7 Ilm. 
The ASL was scanned in the x-y-plane and the x-z-plane (see Fig. 2 A), respectively. 
Each scanning plane was separated by 1.2 Ilm. The images were analysed using the 
Confocal Assistant software version 4.02 (© Todd Clark Brelje). While x-z scanning 
directly displayed side-view images of the ASL, the x-y-scanning planes had to be 
merged and processed to generate a side-view of the ASL. 
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RESUL TS AND DISCUSSION 
Cell Culture 
191 
16HBE140- cell cultures grown at ALI condition do not reflect the in vivo situation of 
the mammalian airways since they consist of only one cell type and form a very thin 
ASL layer. Nevertheless, 16HBE140- is a good choice as cell model for the 
development of a method to measure ASL height since it is a cell culture which is 
easy to culture under air-liquid conditions. The thin ASL layer may also be seen as an 
advantage to test the limits of the system in its potential to create an appropriate 
surrounding of humidity and temperature and to resolve details in the shape of the 
ASL profile. 
The Optical System 
Depth of Field 
The depth of field is defined as the range of distances within an object that appears in 
focus. Observing a curved surface with a conventional microscope, as depicted in Fig. 
3A, implies that only part the surface will be in focus. To be able to record 
fluorescently labelled ASL over a representative area, we needed to have a 
sufficiently broad section in focus. Fig. 3A sketches the depth of field (d) referring to 
the circular fiIter membrane of the Millicell® insert in observation orientation. The 
depth of field is given bythe following equation (Shillaber, c.P., 1944): 
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The equation results in d = 1.1 ~m for a numerical aperture of NAobjeclive = 0.6, a 
wavelength of Àex = 495 nm, and a refractive index of n ~ 1 for air (Lide, D.R.ed., 
2007). As a result, a maximum section of 1::::: 220 /lm of the Millicell® insert is 
theoretically in focus. This section size exceeds the field of view size (FoV) of the 
camera chip wh en using 40x TM (F 0 V = 512 pixels x 13 .um -;- 40 = 166.4 ~m). 
Accordingly, the camera chip can be used to its full capacity. 
Evaluation of the fluorescence intensity profile 
To facilitate the evaluation of the fluorescence intensity profile of the ASL, an image 
of yellow-green fluorescent microbeads (505/515) of 4 /lm diameter (# F8859 
Invitrogen-Molecular Probes, Kingston, ON, Canada) was taken and their 
fluorescence intensity profiles were plotted. As can be seen in Fig. 3B, the precise 
value of 4 /lm for the diameter lies on 0.4 of the altitude of the profile curve. 
According to this observation, the reading position for the evaluation of the ASL 
heights was set to be 0.4 of the altitude of the fluorescence profile curves. 
Resolution and Brightness 
Since ALI cultured 16HBE 140- cells are covered by a rather thin layer of ASL (~3-6 
~m, see below), we required a high resolution power to observe ASL height 
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variations. With the EL WD CFI objective (NAobjeclive = 0.6), we achieved an optical 
resolution of ropl = 0.61 x À x NA-1 = 0.5 I1m at Àex = 495 nm. To obtain a final 
image resolution of ropl ' the resolution on the camera chip rchip needed to be equal to 
or greater than (of lower value than) ropl ' If rchip was greater than 'Opl' the final image 
resolution was reduced to the value of rchip ' According to the Nyquist-Shannon 
sampling theorem, 'chip is of higher value than the two-fold individual pixel size of 
the camera chip (Pix) divided by the total optical magnification (TM) 
(rChiP > 2 x pix X TM-1 ). The TM in our optical arrangements was set either at 40x 
(40x objective magnification and lx coupler magnification) or at 160x (40x objective 
magnification and 4x coupler magnification). The camera chip from the 
epifluorescence microscopy system (pix = 13l1m) achieved a maximal resolution of 
rchip >::; 0.65 I1m> 'opl for 40x TM and 'chip >::; 0.1611m < 'OPI for 160x TM, considering 
an approximation for the pixel size of half the sampling size. An approximation of a 
smaller sampling pixel size would lead to an inferior resolution with the same 
parameters. The superior resolution for 160x TM ha s, however, its drawback to the 
image brightness (Bim ) which decreased substantially with the increased TM and the 
reduced NA of the 4x-coupler (Bim oc (NA/TM) 2 ) (Born, M. & Wolf, E., 1999)). The 
image acquisition required a ten- to twenty-fold longer illumination time, one of 
about 1000 ms (see Fig. 2B bottom right) compared to around 100 ms by direct lx-
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coupling in aIl other images taken by means of the epifluorescence microscope (Fig. 
4A-D). Before an experiment, the necessity for a (slight) increase in resolution has to 
be, therefore, weighed up against the disadvantage of a longer illumination time. 
The resolution on the camera chip from the confocal microscopy system 
(pix = 6.7 )lm) was rchip = 0.34)lm < rapt for 40x TM. However, the resolution of an 
image reconstructed from a stack of sequential images acquired by confocal 
microscopy is not only defined by rapt or r chip ' but also by the distance of the 
scanning planes. An optimal scanning distance should be chosen considering similar 
princip les as above: the smaller the scanning distance, the better is the resolution. At 
the same time, the acquisition-, and with it, the illumination:'time can increase 
enormously. On the other hand, the greater the scanning distance, the worse the 
resolution, though in exchange, the acquisition and illumination times get shorter. 
Fig. 5A shows a reconstructed image from sequential x-y-scans of the fluorescently 
labelled ASL on a 16HBE140- cell monolayer. We chose a scanning distance of 1.2 
)lm to minimize the acquisition time which resulted in rather low image resolution. 
The fluorescent ASL band appears to be straightened and missing the typical 
undulating profile of the cell mono layer which was seen on the epifluorescence 
images of higher resolution (Fig. 4B, D). Nevertheless, the ASL height can still be 
correctly estimated to be approx. 5 )lm. 
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Temperature, Humidity and Perfusion 
A precise adjustment of surrounding temperature and humidity is essential for 
accurate and reproducible measurements of the ASL height on living cell cultures. 
The temperature and humidity system with the A TX-H allowed us to control the 
temperature inside the stage incubator to ± 0.2°C and the air humidity to a precision 
of ± 3%. The perfusion system of the side-view chamber supplied the cells with warm 
(37°C) solution to nourish and to bathe them from the basal side. Both, a humidity 
level of 50-55% and a continuous perfusion of the basal side of the cell mono layer, 
were necessary to prevent the 16HBE140- cell monolayer from drying out. During 
our short-term experiments (up to 30 min), we perfused the cells with PS. They can, 
however, be also perfused with pH-adjusted cell media (bubbled through with air / 
5% C02) for experiments of longer duration. For specific cell stimulation, selected 
drugs can be added to the perfusion medium, and the perfusate temperature as weIl as 
the temperature inside the stage incubator can be changed if necessary. 
Side-View Imaging 
Conventional Microscopy 
To verify the evenness and smoothness of the MilliceIl® insert after its modification, 
we took side-view images of the Millicell® insert with and without cell culture. Fig. 
4A shows brightfield images of the modified MilliceIl® insert in profile without cell 
culture (left side) and with a cell monolayer (right side). Fig. 2B (right bottom) 
CHAPTER 6. ARTICLE 3: SIDE- VIEWING MICROSCOPY 196 
displays identical cell profiles in brightfield and epifluorescence illumination after 
labelling the cell membrane with HAF. Whereas the profile of the MiIliceIl® insert 
without cell culture is even and flat, the profiles with a cell mono layer appear 
undulating. AlI profiles in brightfield illumination clearly display an Airy pattern as a 
result of light diffraction at the air-ce Il frontier line. The fluorescence image in Fig. 
2B reveals a cell height of 3-5 !lm. The TM of aIl images was 160x with 40x 
objective magnification and 4x coupler magnifications. 
Fig. 4B shows a side-view image of fluorescently labelled ASL which was recorded 
with 40x TM and an acquisition time of 100 ms. The fluorescence intensity profiles 
of three different locations are displayed on the right side of the image and facilitate 
the estimation of the ASL height. The peak of fluorescence intensity corresponds to 
the ASL height and measures between -4 and 6 !lm. On the cell side of the peak, the 
fluorescence intensity stays slightly elevated compared to the side facing the air 
compartment. To verify if the elevated fluorescence intensity originates from the cell 
monolayer, an image of the fluorescent cell monolayer profile was superimposed with 
an image of the fluorescent ASL. Fig. 4C shows the two-coloured superimposed 
image in which the ASL layer is displayed in red colour and the cell profile in green. 
It becomes now apparent that the elevated fluorescence on the cell side in Fig. 4B is 
indeed caused by the cell monolayer - probably due to the scattering of fluorescence 
light - and measures around 5 !lm. 
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The ability to measure ASL height alterations was tested by taking pictures of the 
fluorescent ASL layer in an interval of 15 min. Fig. 4D shows two sequential images 
of the fluorescent ASL. The left picture was taken directly after labelling the ASL and 
the right after the cell mono layer with the labelled ASL stayed in the mini-incubator 
for 15 min. The enlarged fluorescence intensity profile reveals a small decrease in the 
ASL height of less than 1 ).lm, and demonstrates that ASL height variations in the 
range close to the resolution limit are detectable. 
Con/ocal Microscopy 
To validate the results obtained with epifluorescence microscopy, the ASL height was 
measured with confocal microscopy using the same side-viewing chamber system. 
Fig. 5B was recorded by x-z-scanning confocal microscopy and is displayed 
unprocessed. It resembles the image in Fig. 4B and shows fluorescent ASL with a 
height of 4-7 ).lm and a drift of fluorescent light toward the cell mono layer. 
Fig. 5A was generated from x-y-scans of the cell culture. This approach corresponds 
to the hitherto applied procedure for ASL height measurements (Tarran, R., 2004; 
Verkman, A.S. et al., 2003). The resolution is confined to the distance of the scanning 
planes which was chosen to be 1.2 flm to keep the acquisition time in a reasonable 
range. As mentioned above, although the resolution is evidently lower than in Fig. 5B 
as weil as in Fig. 4B and D, the ASL height can still be estimated to be around 5 flm. 
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CONCLUSION AND FUTURE DIRECTIONS 
The custom-designed side-viewing chamber equipped with the temperature and 
humidity control system enables fast imaging of ASL height and its variations during 
cell stimulation with epifluorescence microscopy as weil as with confocal 
microscopy. It will allow a qualitative evaluation (limited by the resolution of the 
system) of ASL height alterations with respect to time. Epifluorescence microscopy 
provides similar images to confocal microscopy with the advantage of requiring a 
considerably Jower acquisition time. Images recorded by epifluorescence microscopy 
and confocal x-z-scanning have a comparably high resolution (r 0.65 and 0.5 /lm, 
respectively), whereas the resolution ofthe calculated side-viewing images from x-y-
scanning confocal microscopy is noticeably lower (r = 1.2 /lm) and limited by the 
distance of the scanning planes. However, x-y-scanning confocal microscopy has the 
advantage of not being limited to the edge of the tilter membrane of the Millicell® 
insert and generates ASL images throughout the tilter area. 
Further advancement of the system is desirable to make the side-viewing technique 
more versatile. The installation of a microscope objective heater would allow an 
increase in the relative humidity level inside the mini-incubator close to saturation. 
Cell cultures demanding a very high level of air humidity could then be studied. The 
development of an easy access to the surface of the cell monolayer - through e.g. an 
opening in the mini-incubator - would enable cel1 stimulation from the apical side. 
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Both technical improvements would be very useful to take the full advantage of this 
newmethod. 
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FIGURE CAPTIONS 
Figure 1. Modification of MilIiceU® inserts for cell culture growth and cell side-
view observation from the outer side of the fllter membrane. 
A. Manual modification of the Millicell® insert: the rim of the polystyrene cylinder is 
cut away with a scalpel under sterile conditions for obstruction-free cell side-view 
observation .. 
B. Insertion of a modified Millicell® insert into a tubing piece: the autocJavable 
Tygon® tubing is cut into 14-mm long pieces and modified in the iIlustrated way. 
The Millicell® inserts are placed into the tubing pieces to enable cell culture on 
the outer side of the filter membrane. 
Figure 2. Set-up components and arrangement. 
A. Three-dimensional view of the side-view chamber to accomodate the Millicell® 
insert with a cell culture grown on the outer side of the filter membrane. The 
chamber consists of a chamber frame which fits on a microscope stage and a filter 
holder with inlet and outlet tubes to supply the basal side of the cell monolayer 
with physiological solution. 
B. Cross-section of the complete microscope stage assembly. The stage assembly 
consists of a stage ring with an air-in let tube, an incubator and the side-view 
chamber. The microscope condenser iIIuminates the cell profile through the top 
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opening of the incubator for brightfield images. Recorded brightfield and 
fluorescent images of the cell profile are shown at the bottom right. 
C. Temperature and humidity control system connected to the microscope stage 
assembly. The air circulates in a closed circuit and is coupled to the stage 
incubator via a coupling valve through the air-inlet tube of the stage ring. A sm ail 
opening behind the coupling valve regulates the air pressure within the circuit. 
Figure 3. Geometrical diagram of the depth of field. 
A. Radius of the Millicell® insert at the filter membrane side after its modification: 
r ~ 5.5 mm. Depth of field: d = 1.1 Ilm. Length of the Millicell® insert section 
which is simultaneously in focus: 1 = 2J r 2 - (r - d) 2 220 ~m. 
B. Yellow-green fluorescent microbeads (Â-ex=505 nm 1 Âem=515 nm) of 4 Ilm 
diameter. The fluorescent profiles of three microbeads with 4-~m section marks 
are represented below the image. 
Figure 4. Side-view images recorded by epifluorescence microscopy. 
A. Brightfield image of the p10dified Millicell® insert without cell culture (left) and 
with cell culture (right). 
B. Fluorescence image of the ASL labelled with Alexa Fluor 488 Dextran recorded 
with a conventional epifluorescence microscope (illumination time: 100 ms). The 
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fluorescence intensity profiles at three different locations are displayed separately 
on the right side and superimposed below the image. 
C. Two-colour image of superimposed fluorescent ASL layer, labelled with Alexa 
Fluor 594, and fluorescent cell profile, labelled with DSA. The ASL layer is 
displayed in red and the cell profile in green. 
D. Two sequential images taken at 15 min interval. The left fluorescent image was 
taken immediately after labelling the ASL layer with Alexa Fluor 488 Dextran. 
The right fluorescent image of the cell monolayer was taken after 15 min in the 
mini-incubator (37°C, 55% relative humidity). On the right side of the images, the 
fluorescence intensity profiles at two locations are displayed, green representing 
the fluorescence intensities of the first taken image and blue of the next one. An 
enlargement of the upper panel fluorescence intensity profiles is displayed over 
the upper panel. 
Figure 5. Side-view images by confocal microscopy. 
A. X-Z fluorescence image of the ASL reconstructed from z-y sections recorded by 
scanning confocal microscopy. 
B. X-Z fluorescence image of the ASL recorded by x-z-scannmg confocal 
mlcroscopy. 
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Chapter 7 
Conclusions and future directiol1S 
Figure 7.1 on page 213 summarizes the mechanism of Ca2+ -dependent ATP 
release discussed in sections 3.1 and 3.2: 
A 50% hypotonie shock triggers a gradual rise in intracellular Ca2+ (pre-
spike) originating from a TG-insensitive Ca2+ store, probably via a preceding 
intracellular acidification. The precise mechanism of cell acidification and the 
source of the associated Ca2+ elevation are not yet identified. The slow rise 
in intracellular Ca2+ may evoke a Ca2+ -induced Ca2+ release from RyR and 
IP3R channels, and initiates a Ca2+ -dependent release of nucleotides. The 
principal nucleotide release mechanism from A549 cells upon hypotonie shock 
is regarded as being exocytosis for the following reasons: 
• Previous results showed tight Ca2+ -dependence of ATP release [26, and 
sections 3.1.2 and 3.2.2]. 
• The ratio of co-released UTP:UDP was 2:1 which suggests a vesicular 
rather than a cytosolic source (UTP:UDP c:::: 10:1) of the nucleotides 
(see section 3.1.2). 
• Inhibitors affecting the exocytotic pathway significantly inhibited ATP 
release (see section 3.1.3). 
The released nucleotides stimulate the metabotropic purinergic receptors 
present on the A549 cell membrane (P2Y1, P2Y2 , P2Y6). From these recep-
tors, the P2Y 6 receptor, whose most potent agonist is UDP, plays a promi-
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Figure 7.1: Signalling pathway of Ca2+ -dependent ATP release from A549 
nent role in this paracrinejautocrine stimulation that leads to the activation 
of IP3R channels and evokes the rapid Ca2+ spike. The final result of the 
intensified Ca2+ signal is a regeneratively amplified exocytotic nucleotide re-
lease. 
The origin of the TG-insensitive Ca2+ elevation remains to be further investi-
gated. Although a correlation between hypotonie shock-induced intracellular 
acidification and intracellular Ca2+ increase has been found, the origin of the 
acidification and the mechanism of pHj-dependent control of the intracellu-
lar Ca2+ level are still unknown. After organelles (mitochondria and lyso-
somes) were proven not to be responsible for the intracellular acidification 
(see section 3.2.3), it seems that the intracellular pH alteration is generated 
by a mechanism involving either ion channels, co-transporters or exchang-
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ers [217-219]; this question, however, still needs to be addressed in detail. 
pH-sensitive proteins are probably responsible for the pH-dependent increase 
in the intracellular Ca2+ level (see section 3.2.3); also, these proteins need to 
be identified. 
Chapter 6 describes a novel technique for visualizing ASL height on in vitro 
air-liquid cultured lung epithelial cells in a temperature- and humidity-con-
trolled environment. It enables time-resolved (100 ms) side viewing of a 
ftuorescently marked cell monolayer and/or ASL with a conventional epiftuo-
rescence microscope. A further development of the system would inc1ude the 
installation of a microscope objective heater that would prevent condensation 
on the objective at relative humidity levels ab ove 60%. This improvement 
would allow to study cell cultures demanding very high levels of air humidity. 
In addition, the insertion of an opening in the mini-incubator would give easy 
access to the surface of the cell monolayer and would en able cell stimulation 
from the apical side. 
To further investigate the ATP-dependence of ASL regulation, the choice of 
an appropriate in vitro cell culture system that reproduces an in vivo air-
way epithelial morphology is essential. Several continuous cell lines, such 
as HBE1 (immortalized human bronchial epithelial cell line [248]), MM-39 
(transformed human tracheal gland cell line [249]), NuLi (normallung, air-
way epithelial cellline [250]), and CuFi (cystic fibrosis, airway epithelial cell 
line [250]) are capable of becoming fully polarized at an air-liquid interface 
and should be tested for their suitability for ATP-dependent ASL height 
studies. Methods for the development of new, well-differentiated human air-
way epithelial cell cultures have been described in [251-253]. 
To find ways to stimulate ATP secretion from these cell cultures and to study 
the relationship between these stimuli and the ASL height alterations will be 
another important issue in the investigation of ATP-dependent ASL height 
control. Knowledge about the ATP release mechanism from lung epithelial 
cells (see sections 3.1 and 3.2) is crucial in this context and suggests the 
stimulation of exocytosis. 
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In conclusion, the understanding of the physiological mechanisms of ATP 
release from lung epithelial cells and the resulting ATP-dependent ASL con-
trol are the basis for developing novel therapies for diseases of impaired ASL 
regulation, such as cystic fibrosis and asthma. 
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ApPENDICES 
Appendix A 
Materials 
A.1 Cell lines 
A.I.I 16HBE14o-
Nomenclature 
Clone number 16 of a Ruman Branchial Epithelial cell line; 14th sample of 
human branchial epithelial cells received in the laboratory; transformed by 
an origin-defective simian virus 40 (pSVori-) [254]. 
Description 
Figure 
16HBE14o-
A.1: 
Epithelial cells of mainstream, second-generation 
bronchi from a l-year-old, male heart-Iung trans-
plant patient were transformed by calcium phos-
phate transfection with the pSVori- plasmid [255]. 
The established cell line, 16HBE14o-, shows the 
presence of tight junctions and retains vectorial 
ion transport in vitro. When cells are grown at 
an airjliquid-interface, they develop cilia [255]. 
Bath the mRN A for CFTR and the protein itself 
are present in the cell [256]. 
The choice of culture conditions is highly relevant for the proliferation and 
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differentiation of the cells. In addition to the choice of culture medium, sub-
stratum coating and cell-seeding density, the volumes of media on each side 
of the epithelial barrier is crucial for the differentiated phenotype of the cells 
[257]. 
Cultured under liquid-covered conditions, 16HBE14o- cells form layers with 
a height of 1-5 cells, comparable with bronchial epithelium in vivo. These cell 
layers form well-defined, tight adherens and gap junctions, as weIl as highly 
organized actin filaments which lead to high transepithelial electrical resis-
tance (TEER) values (up to rv 800 n . cm2) [256]. In contrast, 16HBE14o-
cells, cultured at an airjliquid interface, display no clear polar organization 
and form cell layers of 10-16 ce lis in thickness. Cellular contacts are weak, 
and the actin filaments show characteristics similar to cells growing separated 
from each other. The TE ER values are not greater than 130 - 250 n . cm2 
[256,258]. 
Subculturing 
1) Liquid-covered culture condition: 
1. Check the confluence of the cells in a Petri dish (0 100 mm) under the 
microscope. 
2. Warm up MEM (see section A.2.1), PBS (see section A.2.2) and trypsin 
(0.05 %) to 37 0 C. 
3. Wash the cells twice with 10 ml of PBS. 
4. Cover the cells with 4 ml of trypsin and incubate at 37 0 C for 5 min. 
5. Shake the Petri dish until all cells are detached. 
6. Add 10 ml of MEM, to neutralize the trypsin. 
7. Transfer the cell suspension into a sterile 50 ml tube. 
8. Pellet the cells by centrifugation at 1400 rpm for 5 min. 
9. Resuspend the cells in 10 ml of MEM. 
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10. Add 3 ml of cell suspension to each Petri dish containing 7 ml of MEM. 
l1. Rock the Petri dishes gently to evenly distribute the cells. 
12. Leave them in the incubator at 37 0 C and 5 % CÛ2. 
13. Replace the growth medium every 2-3 days. 
Time to obtain confluent monolayer: '" 1 week. 
2) Air/liquid culture condition: 
L Coat the inverted, modified Millicell® Culture Plate Inserts (MCPI) 
(0 6 mm2; see section CA) with 120,.tl of PureCol (Type 1 collagen, 
3 mg/ml, pH 2; INAMED Corporation). 
2. Leave the filters to dry overnight under laminar air flow. 
3. Wash the filters with PBS and distribute them into 6-well plates. 
4. Proceed with the cells as described above until number 9. 
5. Warm up DMEM:F-12 (see section A.2.1) to 37 0 C. 
6. Count the cells using a hemocytometer. 
7. Pellet the cells by centrifugation at 1400 rpm for 5 min. 
8. Resuspend the cells in an adequate volume of DMEM:F-12 to receive 
a final concentration of 1.25· 106 cells/ml. 
9. Fill the basal chamber of the coated MCPI with DMEM:F-12 (l'V 9 ml). 
10. Add 200 j.tl of cell suspension on the apical si de of the MCPI. 
11. Leave them in the incubator at 37 0 C and 5 % CÛ2. 
12. Replace the growth medium on the basal side every day. 
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13. Remove the growth medium from the apical side after 2 days in culture. 
Keep removing the growth medium from the apical si de until the cells 
are confluent. 
Culture time: 6-12 days. 
A.1.2 A549 
Nomenclature 
Epithelial Adherent Cells growing in monolayers; colony number 549 [259]. 
Description 
Figure A.2: A549 
The A549 cell Hne was established from an ex-
planted alveolar adenocarcinoma which was re-
moved from a 58-year-old Caucasian man in 1972 
[259]. 
A549 cells synthesize lecithin with a high per-
cent age of disaturated fatty acids and contain 
multilamellar cytoplasmic inclusion bodies typ-
ical of those found in type II alveolar epithelial 
cells (AT II) which are responsible for pulmonary 
surfactant secretion [260]. They are cultured un-
der liquid-covered conditions and grow adherently as monolayers. 
In contrast to 16HBE14o-, A549 does not contain endogenous CFTR chan-
nels [261]. 
Subcult uring 
Liquid-covered culture condition: 
1. Check the confluence of the cells in a Petri dish (0 100 mm) un der the 
microscope. 
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2. Warm up DMEM (see section A.2.1), PBS (see section A.2.2) and 
trypsin (0.05 %) to 37· C. 
3. Wash the cells twice with 10 ml of PBS. 
4. Coyer the cells with 4 ml of trypsin and incubate at 37 0 C for 3 min. 
5. Shake the Petri dish until aH cells are detached. 
6. Add 10 ml of DMEM, to neutralize the trypsin. 
7. Transfer the cell suspension into a steril 50 ml tube. 
8. Pellet the cells by centrifugation at 1400 rpm for 5 min. 
9. Resuspend the cells in 10 ml of DMEM. 
10. Add: 
<> 1 ml of cell suspension to a Petri dish containing 9 ml of DMEM 
to receive a confluent monolayer after 5 days of culture. 
<> 2 ml of cell suspension to a Petri dish containing 8 ml of DMEM 
to receive a confluent mono layer after 4 days of culture. 
11. Rock the Petri dishes gently to evenly distribute the cells. 
12. Leave them in the incubator at 37 0 C and 5 % CO2 • 
13. Replace the growth medium every 2-3 days. 
Doubling time: 22 h. 
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A.2 Solutions 
A.2.1 Growth media 
Recipes for growth media can vary in pH, glucose concentration, growth fac-
tors, and the presence of other nutrient components. The growth factors 
used to supplement media are often derived from animal blood, such as calf 
serum. 
The medium in which cells are cultured has to be changed regularly to re-
plenish nutrients and avoid the build up of potentially harmful metabolic 
biproducts and dead cells. 
Dulbecco's Modified Eagel's Medium (DMEM) was used for the culture 
of A549, and the Minimum Essential Medium (MEM) for the culture of 
16HBE14o- cells under liquid-covered conditions on culture petri-dishes or 
glass coverslips. 
A l:l-mixture of DMEM and Ham's Nutrient Mixture F-12 (F-12) was taken 
for culture of 16HBE14o- cells at an airjliquid-interface on filters. 
DMEM 
Preparation of 1 l: 
1. Dissolve a bag of DMEM (Gibco-BRL #12100-046) in 500 ml Millipore 
water27 . Rinse the bag well! 
2. Add 3.7 g of NaHC03 . 
3. Adjust the pH to 7.0 with 1 M HCL 
4. Fill up to 900 ml with Millipore water. 
5. Filter through a 0.22 I1m filter under the sterile hood. 
6. Store at 4 a C. 
7. Before utilization add to each 500 ml: 
27 purest water (deionized water additionally purified of organic impurities; resistance: 
18.2 MW . cm @ 25 0 C) 
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o 50 ml of FBS to reach 10% final concentration. 
o 2.8 ml of penicillin-streptomycin (10 000 U /ml and 10 000 g/ml, 
respecti vely ). 
o 5 ml of glutamine (200 mM). 
The DMEM must be pink. It turns red as soon as it is too old. penicillin-
streptomycin and glutamine have to be added every 3-4 weeks. 
MEM 
Preparation of 1 l: 
1. Dissolve a bag of MEM (Gibco-BRL #61100-061) in 500 ml Millipore 
water. Rinse the bag well! 
2. Add 2.2 g of NaHC03 . 
3. Adjust the pH to 7.0 with 1 M HCL 
4. Fill up to 900 ml with Millipore water. 
5. Filter through a 0.22 /lm filter under the sterile hood. 
6. Store at 4 0 C. 
7. Before utilization add to each 500 ml: 
o 50 ml of FBS to reach 10% final concentration. 
o 5 ml of penicillin-streptomycin (10 000 U Iml and 10 000 g/ml, 
respectively) . 
o 5 ml of glutamine (200 mM). 
DMEM:F-12 (1:1 mixture) 
Preparation of 1 l: 
1. Dissolve a bag of DMEM 1 F-12 (Gibco-BRL #12400-024) in 500 ml 
Millipore water. Rinse the bag weIl! 
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2. Add 1.2 g of NaHC03 . 
3. Adjust the pH to 7.0 with 1 M NaOH. 
4. Fill up to 960 ml with Millipore water. 
5. Complete to 1 1 with 20 ml Ultroser G (light sensitive) to reach 2% 
final concentration. 
6. Filter through a 0.22 /-Lm filter under the sterile hood. 
7. Store at 4 0 C. 
8. Before utilization add to each 500 ml: 
<> 5 ml of penicillin-streptomycin (10 000 U Iml and 10 000 g/ml, 
respectively) . 
<> 5 ml glutamine (200 mM). 
A.2.2 Balanced salt solutions (BSS) 
BSSs are aqueous solutions of inorganic salts with the following principle 
functions: 
• They serve as irrigating, transporting and diluting fluids while main-
taining intra- and extra-cellular osmotic balance. 
• They provide cells with water and certain bulk inorganic ions essential 
for normal cell metabolism. 
• Combined with a carbohydrate, such as glucose, they provide the prin-
ciple energy source for cell metabolism. 
• They provide a buffering system to maintain the medium within the 
physiological pH range (7.2-7.6). 
Different BSSs have been developed since the discovery that cells basically 
require five ions: Ca2+, Mg2+, K+, Na+, and CI-. 
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Physiological solution (PS) 
PS is an isotonie BSS (also physiologie isotonie solution (IS)) containing a 
synthetic buffer, e.g. HEPES, and is used for short-time experiments (up to 
2 h for A549). 
Preparation of 1 l: 
Concentrations [mM] 1 F. W. [g/mol] 1 Amount [g] 
140 NaCI 58.443 8.18 
5 KCI 74.561 0.37 (5 ml of 1 M stock) 
10 HEPES 238.301 2.38 
1 MgCI2 · 6H20 
1 CaCb· 2H20 
10 glucose 
203.302 
147.016 
180.157 
0.20 (10 ml of 100 mM stock) 
0.15 (10 ml of 100 mM stock) 
1.80 
o Adjust the pH to 7.4 with NaOH. 
o Filter the solution under the sterile hood. 
o Store at 4 0 C. 
Ringer solution (RS) 
RS is an isotonie BSS comparable with PS. It contains, however, inorganic 
phosphate and carbonate salts as a buffer. It is used in case synthetic organic 
buffers interfere with the experiments. 
Preparation of 1 l: 
Concentrations [mM] 1 F. W. [g/mol]1 Amount [g] 
110.5 NaCI 58.443 6.46 
24 NaHC03 84.007 2.02 
1.3 KCI 74.561 0.0969 (1.3 ml of 1 M stock) 
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1 MgCI2 ·6H2O 203.302 0.20 (10 ml of 100 mM stock) 
1 CaClz·2H2O 147.016 0.15 (10 ml of 100 mM stock) 
2.5 Na2HP04 141.947 0.355 
or 2.5 N a2HPO 4 . 7H2O 268.053 0.67 
2.5 KH2P04 136.085 0.34 
1.2 K2HP04 174.175 0.21 
10 glucose 180.157 1.80 
<> Filter the solution under the sterile hood. 
<> Store at 4 0 C. 
<> Before use, adjust the pH to 7.4 bubbling through 5% CO2. 
Phosphate buffered saline (PBS) 
PBS is an isotonie BSS mainly used to wash cells. It also can be used to 
dilute substances. 
Preparation of 1 1: 
Concentrations [mM] 1 F. W. [g/mol] 1 Amount [g] 
137.0 NaCl 58.443 8.01 
2.7 KCI 74.561 0.22 (3 ml of 1 M stock) 
7.7 Na2HP04 141.959 1.09 
2.3 KH2P04 136.085 0.31 
<> Adjust the pH to 7.4 with HCL 
<> Filter the solution under the sterile hood. 
<> Store at 4 0 C. 
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A.2.3 Hypotonie solution (HS) 
A hypotonie solution contains a lower concentration of solutes relative to 
an isotonie BSSs. When a cell is placed in a hypotonie solution, the water 
diffuses into the ceIl, causing the cell to swell. 
Preparation: 
Hypotonie solutions were prepared starting from isotonie solutions (e.g. phys-
iological solution, Ringer solution). The isotonie solutions were diluted to the 
desired concentration with Millipore water containing ImM of CaCl2 and 
ImM of MgCl2 to keep the concentration of the divalent cations constant. 
The osmolarity was controlled with a freezing point osmometer (Micro Os-
mometer 3300, Advanced Instruments Inc., Norwood, MA, USA). 
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A.3 Chemicals and active agents 
Adenosine 5'-diphosphate (ADP) 
Figure A.3: ADP 
Molecular formula: ClOH15N501OP2 
Molecular weight: 427.2 
Description 
ADP, such as ATP (see page 264), con-
sists of an adenine ring and a ribose sugar 
(together called adenosine). It is the prod-
uct of ATP dephosphorylation by ATPases and possesses two phosphate 
groups compared to three in ATP. ADP is converted back to ATP through an 
oxidative phosphorylation process in the mitochondrial matrix [262]. ADP 
also acts as an important signalling molecule. Especially in platelets, it is 
involved in the regulation of thrombosis and hemostasis [263]. Extracellular 
ADP interacts with the purinergic receptors P2YI, P2Y12 and P2X1, lead-
ing to further platelet activation [264]. In the blood, ADP is, eventually, 
converted to adenosine by the action of ecto-ADPases [265]. 
Adenosine-3'-phosphate-5'-phosphosulfate (A3P5PS) 
Figure A.4: A3P5PS 
Molecular formula: ClOH15N5013P2S 
Molecular weight: 507.26 
Stock solution: 1 mM in H20 
Active concentration: 1 MM 
Description 
A3P5PS is a competitive P2Y1 receptor 
antagonist. The presence of a phosphate 
in the 2'- or 3'-position appears to be crucial for antagonist activity, because 
adenosine-3' -phosphate-5' -phosphate and adenosine-2' -phosphate-5'-
phosphate also exhibit antagonist/partial agonist activities,whereas other 
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3'-substituted analogues, such as 3'-amino-ATP, are full agonists with no 
antagonist activity [266]. 
Alexa Fluor® 488 dextran 
Figure A.5: 
Alexa Fluor® 
Molecular weight: la 000 
Stock solution: 2 mg/ml 
Description 
Alexa Fluor® 488 is a green-fluorescent dye that ex-
hibits the following unique features: the fluorescence 
spectra are almost identical to those offluorescein, with 
excitation/emission maxima of 495/519 nm; the ab-
488 
sorption is strong with an extinction coefficient greater 
than 65 000 cm -1 M - \ the photostability is much greater than that of fluores-
cein, allowing more time for observation and image capture; the fluorescence 
is pH-insensitive between pH 4 and la [267]. 
In Alexa Fluor® 488 dextran, the Alexa Fluor® 488 dye is conjugated to 
la kDa dextran (1-2 dyes per dextran). Dextrans are hydrophilic polysac-
charides synthesized by Leuconostoc bacteria. They are characterized by 
their high molecular weight, good water solubility, low toxicity and relative 
inertness. They easily dissolve in the ASL, without penetrating across the 
epithelium [268]. 
2-Aminoethoxy-diphenylborate (2-APB) 
Figure A.6: 
Molecular formula: (C6H5hBOCH2CH2NH2 
Molecular weight: 225.09 
Stock solution: 75 mM in DMSO 
Active concentration: 75 JLM 
2-APB Description 
2-APB is a low-cost, cell-permeable inositol-1,4,5-triphos-
phate receptor (InP3R) antagonist. In addition to attenuating the release 
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of internaI Ca2+ stores, 2-APB can also inhibit the store-operated channels 
(SOCs) that replenish the Ca2+ pool, and affect phospholipase C activity 
as weIl as IPa production [269, 270]. 2-APB can, therefore, be very useful 
in analyzing certain aspects of Ca2+ -signalling. It should, however, be used 
with care. 
Apyrase 
Activity: t".I 200 units/mg Protein 
Stock solution: 1 mg/ml in H20 
Active concentration: 2 units/ml 
Description 
ATP diphosphohydrolases, commonly called apyrases, are made up of a sin-
gle polypeptide chain. The molecular weight of known plant apyrases varies 
from 40 51 kDa. Sorne apyrases from animal sources are known to be gly-
copeptide with a molecular weight between 50 and 189 kDa. 
Apyrases are nucleotide hydrolyzing enzymes. In contrast to ATPases, which 
use the energy stored in ATP for metabolite and ion transport processes, 
apyrases reveallow substrate specificity, hydrolyzing different di- and triphos-
phonucleotides to their monophosphates. Their physiological role is to con-
trol the concentration of nucleotides destined for information transmission. 
The optimal range of pH and temperature for apyrase activity varies from 
6.5 7 and from 30 - 37 0 C, respectively, depending on the origin (plant or 
animal) of the enzyme [271]. 
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6-N,N -diethyl-j3, ,-dibromomethylene-D-adenosine-5'-
triphosphate (ARL 67156) 
Figure A.7: ARL 
Molecular formula: C15H21Br2N5Na3012P3 
Formula weight: 785.05 
Stock solution: 10 mM in H20 
Active concentration: 100 /LM 
Description 
ARL 67156 is a non-hydrolyzable structural ana-
logue of ATP and inhibits non-specifically ecto-
triphosphate nucleotidases. It prevents hydrolysis of ATP without signifi-
cantly acting on purinergic receptors [57]. 
Adenosine 5'-triphosphate (ATP) 
Figure A.8: ATP 
Molecular formula: ClOH16N5013P3 
Molecular weight: 507.18 
Stock solution: 10 mM in H20 
Description 
ATP consists of an adenine ring and 
a ribose sugar (together called ade-
nosine) and three phosphate groups. The phosphoryl groups, starting with 
the group closest to the ribose ring, are referred to as the a, {J, and T phos-
phates. ATP is highly soluble in water and is quite stable in solutions between 
pH 6.8 7.4. However, it is rapidly hydrolyzed at extreme pH and should 
be best stored as an anhydrous salt [2721. 
ATP is the main energy source for the majority of cellular functions. This 
includes the synthesis of macromolecules and their transportation within the 
cytoplasma and across membranes. Beyond this, ATP - and its hydrolysis 
products ADP (see page 261), AMP and adenosine - functions as a signalling 
molecule in the extracellular space of almost aIl cells of the body [38]. 
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Bafilomycin Al 
Molecular formula: C35H5S09 
Molecular weight: 622.83 
Stock solution: 100 /LM in DMSO 
Active concentration: l /LM 
Description 
Figure A.9: Bafilomycin Al Bafilomycin Al is a macrolide an-
tibiotic produced by Streptomyces griseus. It is a highly specifie inhibitor of 
vacuolar type H+ -ATPase (V-ATPase). However, it is not selective for any 
particular subclass, but, instead generally inhibits aIl essential V-ATPases 
[273]. 
1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic 
acid (BAPTA) 
Figure A.lO: 
BAPTA 
Molecular formula: C22H24N2010 
Molecular weight: 476.43 
Stock solution: 5 mM in H20 
Active concentration: 25 /LM. 
Description 
BAPTA is a Ca2+ -specifie chelator. The presence 
of four carboxylic acid functional groups makes the binding of two Ca2+ ions 
possible. The flexibility of the functional groups is crucial for the coordina-
tion geometry of the divalent Ca2+ ions. 
BAPTA has a high affinity to Ca2+ with a dissociation constant Kd ~ 100 nM 
[274]. It has fast buffer kinetics and is used in the AM-form for noninvasive 
ceIlloading as intracellular Ca2+ -buffer [275]. 
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2',7'-bis-(2-carboxyethyl)-5,6-carboxyfluorescein 
(BCECF) 
Molecular formula: C27H150n 
Molecular weight: 515.41 
Stock solution: 1 mM in DMSO 
Active concentration: 2.5 {tM 
Description 
266 
Figure A.ll: BCECF, free acid BCECF is the most widely used fluores-
cent indicator for intracellular pH with 
a pKa of 7.0, which matches the normal range of cytoplasmic pH ( ....... 6.8 
- 7.4). It belongs - such as Fura-2 (see page 270) - to the group of ra-
tiometric indicators with excitation wavelengths of 440 and 495 nm. The 
acetoxymethyl ester derivative (BCECF-AM) is membrane-permeable and 
allows non-invasive bulk loading of cells [167]. 
Brefeldin A (BFA) 
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Figure A.12: 
Brefeldin A 
Molecular formula: C16H2404 
Molecular weight: 280.36 
Stock solution: 5 mg/ml in DMSO 
Active concentration: 10 {tg/ml 
Description 
Brefeldin A is a macrolide antibiotic produced by fun-
gal organisms such as Eupenicillium brefeldianum. It 
strongly inhibits protein transport from the ER to the Golgi complex [276]. 
The main target of Brefeldin A appears to be a GTP-exchange factor re-
sponsible for activating the GTP-binding protein ADP-ribosylation factor 
(ARF1). ARF1 is involved in the formation of transport vesicles by recruit-
ing coat proteins to intracellular membranes [277]. 
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Caffeine 
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Figure A.13: 
Caffeine 
Molecular formula: CsHlQN40 2 
Molecular weight: 194.19 
Active concentration: 10 mM 
Description 
Caffeine is a xanthine alkaloid compound which can be found 
in the leaves and beans of the coffee plant, in tea, as weIl as in the beans, 
leaves and fruits of more than 60 plants [278]. 
Caffeine is a central nervous system stimulant believed to act through adeno-
sine receptors. It is an adenosine receptor antagonist and adenosine 3',5'-
cyclic monophosphate (cAMP) phosphodiesterase inhibitor [279]. 
It also affects intracellular calcium levels, acting as an agonist for the ryan-
odine receptor and as an inhibitor of the InP3R on the ER [280]. 
Cytochalasin D 
Figure A.14: Cytocha-
lasin D 
Molecular formula: C30H37N06 
Molecular weight: 507.62 
Stock solution: 10 mM in H20 
Active concentration: 2 p,M 
Description 
Cytochalasins are a group of fungal metabo-
lites which permeate the cell membrane, bind 
to one end of actin filaments and inhibit the 
association and dissociation of su bu nits [281]. Cytochalasin D was found to 
be very effective in binding to the barbed end of actin filaments [281]. 
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Dapoxyl® sulfonic acid, sodium salt 
Figure A.15: Dapoxyl® 
Description 
Molecular formula: C17H15N2Na04S 
Molecular weight: 366.37 
Stock solution: 10 mM in H20 
Active concentration: 10 /LM 
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5-( 4"-Dimethylaminophenyl)-2-( 4'-phenyl)oxazoles are fluorescent solvato-
chromic dyes who se fluorescence strongly depends on solvent polarity. The 
fluorescence-environ ment dependence, large extinction coefficients, high fluo-
rescence quantum yields, and large Stokes shift of the fluorophores are used 
for the development of fluorescent molecular probes to study a variety of bi-
ological events and pro cesses [282]. Dapoxyl sulfonic acid is an amphiphilic 
dapoxyl derivative with an absorption maxima near 370 nm, and an emis-
sion maximum close to 520 nm wh en bound to phospholipid bilayer mem-
branes [283]. 
Dimethylsulfoxide (DMSO) 
0, 
iH3Ç(4~ç8j,; 
Figure A.16: 
DMSO 
Description 
Molecular formula: (CH3 hSO 
Molecular weight: 78.13 
Solubility: miscible in water, ethanol, chloroform, benzene 
Melting point: 18.5 0 C 
Boiling point: 189 0 C 
DMSO is a colourless polar aprotic solvent. It readily dissolves a variety of 
organic substances as weIl as many inorganic salts and gases. Pure DMSO 
is not considered toxic. However, DMSO increases the rate of absorption 
of sorne compounds through organic tissues including skin, which makes it 
potentiaIly dangerous [284]. On the other hand, DMSO can be used as a 
drug delivery system, when properly administered, on account of this prop-
erty [285]. 
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Ethylene glycol-bis(j3-aminoethylether)-N,N,N',N'-tetra-
acetic acid (EG TA) 
Figure A.17: EGTA 
Molecular formula: C14H2401ON2 
Molecular weight: 380.35 
Active concentration: 100 MM 
Description 
EGTA is a chelating agent that is related to 
the better known ethylenediaminetetraacetic acid (EDTA), but with a much 
higher affinity for Ca2+ than for Mg2+ ions. It has a similar affinity to Ca2+ 
as BAPTA (see page 265), but its buffer kinetics is slow [274, 275]. It is 
usually used for making BSSs with a low content of Ca2+. 
Ethidium bromide 
Figure A.18: 
Ethidium bromide 
Molecular formula: C21H20BrN3 
Formula weight: 394.31 
Stock solution: 10 mg/ml in H20 
Active concentration: 10 Mg/ml 
Description 
Ethidium bromide (systematic nomenclature: 2,7-
Diamino-1O-ethyl-6-phenylphenan thridinium bromi-
de) is a fluorescent, intercalating agent for nucleic 
acid. It is commonly used to detect nucleic acids from PCRs, restriction 
digests, etc. It can aiso be used to differentiate between viable and necrotic 
cells. 
Ethidium bromide is a very strong mutagen, carcinogen and teratogen [272]. 
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FCCP (Carbonylcyanide-4-( trifluoromethoxy )phenyl-
hydrazone) 
'CN 
0). ,N==< ... ,.p '.,' .~, CN Fe.' 'H 
'. 3 .. '. . 
Figure 
FCCP 
A.19: 
Molecular formula: ClOH5F3N40 
Molecular weight: 254.17 
Stock solution: 0.5 mM in DMSO 
Active concentration: 10 /LM 
Description 
FCCP is a protonophore (H+ ionophore) and an uncoupler of mitochondrial 
phosphorylation. Tt reduces intracellular pH and is capable of depolarizing 
the mitochondrial membranes and the plasma membrane [286]. Treatment 
of cells with FCCP at varying concentrations leads to partial (100 nM) or 
complete (10 /LM) depolarization and apoptosis [287]. 
Fura-2-AM (Fura-2 pentakis( acetoxymethyl) ester ) 
Figure A.20: Fura 2-AM 
Molecular formula: C44H47N3024 
Molecular weight: 1001.85 
Stock solution: 0.5 mM in DMSO 
Active concentration: 2.5 /LM 
Description 
Fura-2 is an intracellular fluorescent 
indicator with a high selectivity and 
low affinity for Ca2+ (Kd ~ 224 nM) 
[164]. Tt belongs to the group of ra-
tiometric indicators (see also BCECF page 266) with excitation wavelengths 
of 340 and 380 nm. The intensity of fluorescent emission depends on the 
concentration of the dye, the thickness of the ceIl, an optical constant of the 
set-up, and a non-linear function of the Ca2+ -concentration. Ratioing has, 
therefore, the advantage of reducing the effects of uneven dye-Ioading, dye-
leakage, and photo-bleaching [164]. The AM form is used for noninvasive 
intracellular loading [164]. 
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G lycyl-L-Phenylalanin-{3-N aphthylamide (G PN) 
Figure A.21: GPN 
Molecular formula: C21 H21 N 302 
Molecularweight: 347.41 
Stock solution: 100 mM in DMSO 
Active concentration: 100 j.tM 
Description 
GPN is a substrate for cathepsin C, a pro-
tease located exclusively in lysosomes. GPN 
diffuses to the lysosomes after permeabilization of the cell membrane. It is 
hydrolyzed by cathepsin C and the hydrolysis products are trapped inside 
the lysosomes due to their increased polarity. The accumulation of these 
substrates causes an osmotic lysis of the lysosomes [288]. GPN appears to 
be an excellent tool for the specifie disruption of lysosomes. 
5-Hexadecanoylaminofluorescein (HAF) 
Figure A.22: 5-Hexade-
canoylaminofluorescein 
Molecular formula: C36H43N06 
Molecular weight: 585.74 
Stock solution: la mg/ml DMSO 
Active concentration: la j.tg/ml 
Description 
Fluorescein is a hydrophilic fluorophore with a 
pH-dependent absorption maximum at 494 nm 
and emission maximum at 521 nm in water [272]. 
5-Hexadecanoylaminofluorescein is an amphiphilic 
isocyanate-derivative of fluorescein with an alkyl tail. It is a fluorescent mem-
brane probe that localizes at the aqueous interface of cell membranes. The 
lipophilic alkyl tail anchors in the outer lipid layer, and the polar fluorescein-
group resides on the outer surface of the cell membrane [289]. To minimize 
dye internalization, experiments should be carried out between 21 - 23 0 C. 
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Hexokinase 
Activity: 2:: 135 units/mg Protein 
Stock solution: 1 mg/ml in H20 
Active concentration: 10 units/ml 
Description 
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Hexokinase is a dimeric protein made of two equal rv 54 kDa monomers 
[290]. It catalyzes the phosphorylation of D-hexose sugars at the C6 position 
utilizing ATP as a phosphate source, which is the first step of intracellular 
metabolic processes such as glycolysis and glycogen synthesis [291]. 
The rate of phosphorylation varies with different hexoses and Nucleotides 
triphosphates, and is highest with D-glucose and ATP. The optimal range of 
pH and temperature for hexokinase activity lies between 7.5 9 and from 
25 - 33 0 C depending on its isoform [292]. 
Ionomycin 
Molecular formula: C41 H70CaOg 
Formula weight: 747.07 
Stock solution: 1 mM in DMSO 
Active concentration: 1-5 p,M 
Description 
Ionomycin is a nonfluorescent Ca2+ -ionophore 
Figure A.23: Ionomycin used to transport Ca2+ across biological 
membranes [272]. In the presence of high extracellular Ca2+ -concentrations 
it can induce apoptotic degeneration of the cell due to the sudden increase 
of intracellular Ca2+ [272]. 
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J asplakinolide 
Figure A.24: Jas-
plakinolide 
Molecular formula: C36H45BrN406 
Molecular weight: 709.68 
Stock solution: 1 mM in DMSO 
Active concentration: 1 J.LM 
Description 
Jasplakinolide is a membrane-permeable cyclic pep-
tide produced by the marine sponge Jaspis johnstoni. 
It is composed of three amino acids, D-alanin as weIl 
as the rare D-,B-tyrosine and D-2-bromoabrine [293]. 
It induces actin polymerization and stabilizes actin 
filaments. The peptide has a much greater effect on Mg2+ -actin than on 
Ca2+ -actin [294]. 
Latrunculin A 
Figure A.25: La-
trunculin A 
Molecular formula: C22H31N05S 
Molecular weight: 421.55 
Stock solution: 1 mM in DMSO 
Active concentration: 1 J.LM 
Description 
Latrunculin A is a membrane-permeable macrolide toxin 
produced by the Red Sea sponge Latrunculia magnifica. 
Besides the macrolide ring, it is composed of a rare 2-
thiazolidinone ring as weIl as a tetrahydropyran~lactol ring [295]. Latrunculin 
A is an actin-disrupting agent, which prevents microfilament polymerization 
due to one-to-one binding with monomeric G-actin. Lantrunculin does not, 
however, alter the microtubular structure [296]. 
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2-(Methylthio )adenosine 5'-diphosphate (2-MeSADP) 
Figure A.26: 2-MeSADP 
Monensin 
Molecular formula: CllH17N501OP2S 
Molecular weight: 539.24 
Description 
2-MeSADP is an ADP analogue with a 
lO-times higher affinity to the human 
P2Yl-receptor than ADP [297]. 
Molecular formula: C36H61 NaOll 
Formula weight: 692.85 
Stock solution: 10 mM in DMSO 
Active concentration: 10 /LM 
Description Figure A.27: Monensin 
Monensin, a polyether antibiotic, is 
a monovalent ionophore that exchanges Na +, K+ ions and protons across 
membranes. It affects the acidification of acidic compartments and has been 
shown to influence the function of the Golgi apparatus. It causes swelling of 
Golgi cisternae and secretory vesicles; slows or arrests intra-Golgi transport of 
newly synthesized secretory proteins; interferes with the late Golgi functions, 
such as proteolytic processing and attaching of terminal sugars to N-linked 
glycoproteins; and leads to the accumulation of membrane and secret ory 
protein precursors in medial or trans-Golgi cisternae [298]. 
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N -Ethylmaleimide (NEM) 
Figure A.28: 
NEM 
Molecular formula: C6H7N02 
Molecular weight: 125.13 
Stock solution: 1 M in Methanol 
Active concentration: 1 mM 
Description 
NEM is a chemical derivative of maleic acid imide. It alky-
lates sulfhydryl groups, thereby irreversibly inhibiting the formation of cys-
tine linkages in proteins. As a result ofthe alkylation ofthe N -ethylmaleimide 
sensitive fusion protein (NSF), NEM blocks vesicular transport [2721. 
Nigericin 
Figure A.29: 
Nigericin 
Molecular formula: C4oH68011 
Molecular weight: 724.97 
Stock solution: 10 mM in DMSO 
Active concentration: 10-50,uM 
Description 
Nigericin is a polyether antibiotic produced by Strep-
tomyces hygroscopicus. It acts as an ionophore for 
monovalent cations with an ion selectivity such as K+, 
H+, Rb + and Na +. It most commonly functions as an anti porter of H+ and 
K+ [2721. 
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Nocodazole 
Figure A.3D: Nocoda-
Molecular formula: C14HuN303S 
Molecular weight: 301.32 
Stock solution: 20 mM in DMSO 
Active concentration: 20 j.tM 
zole Description 
Nocodazole is a synthetic antimitotic agent that 
disrupts microtubules by binding to tJ-tubulin. It prevents the formation of 
interchain disulfide linkage, thus inhibiting microtubule dynamics, disrupting 
the mitotic spindle function, and fragmenting the Golgi complex [299]. 
5-Nitro-2-(3-phenylpropylamino)benzoic acid .(NPPB) 
Figure A.31: NPPB 
Molecular formula: C16H16N204 
Molecular weight: 300.31 
Stock solution: 125 mM in DMSO 
Active concentration: 125 j.tM 
Description 
NPPB is a chloride channel blocker, which is highly membrane permeable. 
It blocks unselectively an kinds of chloride channels in a reversible manner. 
In addition, it has been shown to have protonophoric activity, potential1y 
disturbing cytosolic pH and mitochondrial ATP synthesis [300]. 
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Oligomycins 
Oligomycin A 
Molecular formula: C4sH740ll 
Molecular weight: 791.06 
Stock solution: 10 mM in DMSO 
Active concentration: 10 fLM 
Description 
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Figure A.32: 
Oligomycin A 
Oligomycin A, B, C and D are a complex of sev-
eral closely related compounds of macrolide antibi-
otics produced by Streptomyces diastatochromogenes. 
They inhibit oxidative phosphorylation in the mitochondria [272]. 
Pluronic® F-127 
Figure A.33: Pluronic® F-127 
Description 
Average molecular formula: 
(EO)98(PO)67(EO)9828 
Average molecular weight: 12 600 
Pluronie® F-127 is a polyoxypropylenepolyoxyethylene block copolymer with 
a low absorbance in UV. It is a non-ionie detergent which ean be dissolved in 
DMSO up to a final concentration of 0.2% (w Iv). It is non-toxie and often 
used to facilitate cellioading with AM-eompounds. The 0.2% (w Iv) solution 
can be used to prepare the compound stock solution [301]. 
28(EO) ethylene oxidej (PO) propylene oxide. 
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Phorbol 12-myristate 13-acetate (PMA) 
Molecular formula: C36H560S 
Molecular weight: 616.83 
Stock solution: 1 mM in DMSO 
Active concentration: 1 /LM 
Description 
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Figure A.34: 
PMA 
PMA is an activator of the signal transduction enzyme 
protein kinase C (PKC). The effects of PMA on PKC 
result from its similarity to diacylglycerol (DAG), which is one of the natural 
activators of sorne PKC isoforms [302]. It has also been shown to be a highly 
potent tumor promotor and mitogen [272]. 
Pyridoxal phosphate-6-azo (benzene-2 ,4-disulfonic acid) 
tetrasodium salt (PPADS) 
Figure A.35: PPADS 
Molecular formula: C14HlON3Na4012PS2 
Molecular weight: 599.31 
Stock solution: 100 mM in H20 
Active concentration: 100 /LM 
Description 
PPADS is a highly specifie, non-selective (but 
non-universal) P2 antagonist with a small pref-
erence for P2X1 receptors. It also blocks P2X2, P2X3, P2X5 and P2Y1 re-
ceptors with similar potencies. It is weaker as an antagonist for homomeric 
P2X4, P2X6 and P2X7 , P2Y4, P2Y6, P2Yl1 and P2Y12 receptors [303]. 
Probenecid 
Molecular formula: C13H19N04S 
Molecular weight: 285.36 
Active concentration: 2.5 mM 
---------- -----
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Figure A.36: Pro-
benecid 
Description 
Probenecid is commonly used to inhibit organic-
anion transporters located in the cell membrane. 
Such transport ers can extrude dyes and indicators 
and thus contribute to poor loading or a high back-
ground signal in assays based on retention of the 
dyes or indicators inside cells [163]. 
Ruthenium Red 
Molecular formula: N 14H4202Cl6Ru3 
Formula weight: 786.35 
Stock solution: 100 mM in H20 
Active concentration: 100 ILM 
Figure A.37: Ruthenium Red Description 
Ruthenium red is a polycationic rea-
gent that is effective in inhibiting ER Ca2+ release channels. In contrast to 
heparin and caffeine, it inhibits only the ryanodine receptor without affecting 
the InP3R [280, 304]. 
Ryanodine 
Figure A.38: Ryan-
odine 
Molecular formula: C25H35NOg 
Molecular weight: 493.63 
Stock solution: 100 mM in H20 
Active concentration: 100 ILM 
Description 
Ryanodine is a naturally occurring alkaloid which 
binds specifically to a Ca2+ release channel on the 
ER with high affinity. It also accounts for the 
name of this Ca2+ release channel, the ryanodine receptor channel (RyR). 
APPENDIX A. MATERIALS 280 
Stimulation or inhibition of Ca2+ effiux by ryanodine is influenced by di-
valent cation concentration, temperature and time of incubation, as weil as 
by the concentration of ryanodine itself. At low concentrations « 10 {lM), 
ryanodine sensitizes the channel to activation and dissociates along with the 
closure of the channel [305]. At high concentrations (> 10 {lM), ryanodine 
blocks the release of Ca2+ through the RyR Ca2+ channels [306]. 
Suramin 
Figure A.39: Suramin 
Mol. formula: CSIH34N6Na6023S6 
Molecular weight: 1429.17 
Stock solution: 100 mM in H20 
Active concentration: 100 {lM 
Description 
Suramin is a symmetric polysulfo-
nated naphthylurea. It releases Ca2+ 
from skeletal muscle sarcoplasmic reticulum vesicles in a concentration-de-
pendent manner and is also a ligand for P2 receptors [307]. However, its 
interaction with a large range of other proteins, in addition to P2 recep-
tors, limits the application of this agent as a tool for the characterization 
of P2 receptors. These proteins include interleukin, glutamate, nicotinic, 5-
hydroxytryptamine and GABA receptors, various proteases, Na+ /K+- and 
Ca2+ -ATPases, ecto-nucleotidases, G protein-coupled receptor kinases, as 
weil as G protein subunits, basic fibroblast growth factor and reverse tran-
scriptase [303]. 
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Thapsigargin 
Molecular formula: C34H50012 
Molecular weight: 650.75 
Stock solution: 1 mM in DMSO 
Active concentration: 1 JLM 
Description 
Thapsigargin is a plant-derived sesquiterpene 
Figure A.40: Thapsigargin lactone, and functions as a membrane-perme-
able, tight-binding inhibitor of the sarcojendoplasmic reticulum Ca2+ -ATPase 
(SERCA). It increases the concentration of cytosolic free Ca2+ in sensitive 
cells by an acute and highly specifie arrest of the sarcojendoplasmic reticu-
lum Ca2+ pump, followed by a rapid Ca2+ leak from the IP3R and RyR Ca2+ 
channels [308]. 
Uridine 5'-diphosphate (UDP) 
Molecular formula: C9H14N2012P2 
Molecular weight: 404.16 
Stock solution: 10 mM in H20 
Description 
UDP serves as a carrier for hexoses, hex-
Figure A.41: UDP 
osamines and hexuronic acids in the syn-
thesis of glycogen, glycoproteins and glycosaminoglycans. It is also an agonist 
of P2Y6 receptors [272]. 
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Uridine 5'-diphosphoglucose (UDP-glc) 
Figure AA2: UDP-glucose 
Molecular formula: C15H22N2017P2 
Molecular weight: 564.29 
Stock solution: 10 mM in H20 
Description 
UDP-glucose is used in cells as an 
activated form of glucose, as a sub-
strate for glycosyltransferases as weIl as for glycogen and glycoprotein meta-
bolism. In the extracellular space, it functions as a specifie agonist for the 
P2Y 14 receptor [309]. 
Uridine 5'-triphosphate (UTP) 
Molecular formula: . C9HlSN201SP3 
Molecular weight: 484.14 
Stock solution: 10 mM in H20 
Description 
UTP is a pyrimidine analog of ATP. 
Figure AA3: UTP 
It is an activated precursor in the 
synthesis of RNA, and in glycogen and glycoprotein metabolism. It is also 
an agoni st of P2Y 2 and P2Y 4 receptors that activate chloride channels in 
epithelial ceIls, increasing ciliary beat frequency and inducing degranulation 
of goblet ce Ils in airway epithelia [272J. 
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Xestospongin C 
Figure A.44: 
Molecular formula: C2sHsoN202 
Molecular weight: 446.71 
Stock solution: 1 mM in DMSO 
Active concentration: 3-10 MM 
Description 
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Xestospongin C 
Xestospongin C is a marine alkaloid isolated from 
the Okinawan sponge Xestospongia Sp .. It is a potent, cell-permeable inhib-
itor of IP3R-mediated Ca2+ -release. It also sensitizes RyR-mediated CICR 
[310]. 
Appendix B 
Microscope components 
The components of a Nikon Inverted Microscope ECLIPSE TE300, which 
was used in the course of this Ph.D. project, are depicted on the following 
two pages. 
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Power supply 
(TE'·PS100 or 
TECP$El00) 
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Rectangular 
mechanicalstage 
Figure B.1: Right-hand view of the Nikon inverted microscope TE300; 
taken from the microscope operation manual 
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Bertrandlans 
focusing screw. 
Fr.ont port' 
Figure B.2: Left-hand view of the Nikon inverted microscope TE300; 
taken /rom the microscope operation manual 
Appendix C 
Technical drawings 
C.I Side-view microscopy set-up 
- Essential elements 
Figure C.I: Assembled view of the entire stage set-up 
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Figure C.2: Cross-section of the entire stage set-up 
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Figure C.3: Exploded view of the entire stage set-up: 
(1) Stage ring with air-inlet (see section C.2) 
(2) Side-view chamber (see section C.3) 
(3) Incubator (see section C.5) 
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C.2 Stage ring 
Figure C.4: 3D view of the stage ring with air inlet 
Figure C.5: Cross-section of the stage ring with air inlet 
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Figure C.6: Detailed 2D engineering drawing of the stage ring with air inlet 
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C.3 Side-view chamber 
C.3.1 Assembly 
Figure C.7: Assembled view of the side-view chamber 
Figure C.8: Cross-section of the side-view chamber 
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Figure C.g: Exploded view of the side-view chamber: 
(1) Chamber frame (see section C.3.2) 
(2) Retaining screw 
(3) Filter holder (see section C.3.3) 
(4) lnlet tube 
(5) Outlet tube 
(6) Modified Millicell® Culture Plate Insert (see section C.4) 
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C.3.2 Chamber frame 
Figure C.lO: 3D view of the chamber frame including the section plane for 
Fig. C.ll 
Figure C.ll: Cross-section of the chamber frame 
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Figure C.12: Detailed 2D engineering drawing of the chamber frame 
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C.3.3 Filter holder 
Figure C.13: 3D view of the filter holder 
Figure C.14: Cross-section of the filter holder 
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Figure C.l5: Detailed 2D engineering drawing of the fllter holder 
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C.4 Cell culture filter inserts 
CA.1 Modification of the Millicell® culture plate in-
serts (M CPI) 
Figure C.16: Original MCPI Figure C.17: Modified MCPI 
, 
i 
: 1 
Figure C.18: Dimensions of the modified MCPI 
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C.4.2 Preparation of the MCPI for cell culture 
Figure C.19: Design of the MCPI holding tube 
Figure C.20: Inserting the modified MCPI into the tube 
APPENDIX C. TECHNICAL DRAWINGS 300 
Figure C.21: 3D view of modified MCPI in the tube 
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C.5 Incubator 
C.5.1 Assembly 
Figure C.22: Assembled view of the incubator 
Figure C.23: Cross-section of the incubator 
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Figure C.24: Exploded view of the incubator: 
(1) Main chamber (see section C.5.2) 
(2) Cover (see section C.5.3) 
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C.5.2 Main chamber 
Figure C.25: 3D view of the main incubator chamber 
Figure C.26: Cross-section of the main incubator chamber 
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Figure C.27: Detailed 2D engineering drawing of the main incubator chamber 
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C.5.3 Cover 
Figure C.28: 3D view of the chamber cover 
Figure C.29: Cross-section of the chamber cover 
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Figure C.30: Detailed 2D engineering drawing of the chamber cover 
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C.6 Valve 
C.6.1 Assembly 
Figure C.31: Assernbled view of the valve 
Figure C.32: Cross-section of the valve 
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Figure C.33: Exploded view of the valve: 
(1) Main valve tube (see section C.6.2) 
(2) Reducing tube (see section C.6.3) 
(3) Shutter (see section C.6.3) 
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C.6.2 Main valve tube 
Figure C.34: 3D view of the main valve tube 
Figure C.35: Cross-section of the main valve tube 
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Figure C.36: Detailed 2D engineering drawing of the main valve tube 
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C.6.3 Valve tube accessories 
Figure C.37: 3D view of the 
reducing tube 
Figure C.39: 3D view of the 
valve shutter 
Figure C.38: Dimensions of the re-
ducing tube 
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Figure CAO: Dimensions of the valve 
shutter 
